Cayman公司成立于1980年，在过去20多年的发展过程中，始终保持着为科研工作者提供高质、优价研究产品的宗旨。该公司目前可以提供2,138 多种生化和免疫试剂，涉及肿瘤、氧化氮、神经学、凋亡、氧化性损伤、内分泌学等研究领域。非常有特色的检测试剂盒包括类花生酸类物质、游离的生物标志、环核苷、激素及氧化氮等。此外，还提供多种高质量试剂，如类花生酸类物质、氧化氮试剂及许多相关脂质、脂肪酸、酶和抗体等。Cayman非常愿意接受各地客户的要求，合成复杂和不稳定分子。
品牌商名称：Cayman Chemical
：(734) 971-3335
地址：1180 East Ellsworth Road Ann Arbor, Michigan 48108 USA
公司：http://www.caymanchem。。ｃｏｍ/
世界*实验材料供应商Cayman正式授权上海起发为其中国代理，Cayman在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海起发一直秉承为中国科研客户带来的产品，的服务， 签约Cayman就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获
Cayman中国代理，Cayman上海代理，Cayman北京代理，Cayman广东代理，Cayman江苏代理 Cayman湖北代理, Cayman天津, Cayman黑龙江代理, Cayman内蒙古代理, Cayman吉林代理, Cayman福建代理, Cayman江苏代理, Cayman浙江代理, Cayman四川代理,
部分报价6
| 品牌 | 目录号 | 产品 | 规格 | 2015目录价 |
| Cayman2015 | 15716 | 2C-C (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15717 | 2C-N (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15718 | 2C-P (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15719 | 2C-T-4 (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15720 | AM694 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15721 | 2C-D (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15723 | 25B-NBOMe (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15724 | 25C-NBOMe (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 15726 | GPR41 (C-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 15727 | GPR43 (Internal) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 15729 | PPARγ (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15729 | PPARγ (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15729 | PPARγ (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15730 | PPARα (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15730 | PPARα (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15730 | PPARα (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15731 | PPARδ (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15731 | PPARδ (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15731 | PPARδ (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15732 | PPAR (human) Reporter Assays Panel | 96 Well | 12208 |
| Cayman2015 | 15733 | GR (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15733 | GR (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15733 | GR (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15734 | LXRβ (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15734 | LXRβ (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15734 | LXRβ (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15735 | LXRα (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15735 | LXRα (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15735 | LXRα (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15736 | LXR (human) Reporter Assays Panel | 96 Well | 12208 |
| Cayman2015 | 15737 | ERα (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15737 | ERα (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15737 | ERα (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15738 | ERβ (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15738 | ERβ (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15738 | ERβ (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15739 | ER (human) Reporter Assays Panel | 96 Well | 12208 |
| Cayman2015 | 15740 | MR (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15740 | MR (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15740 | MR (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15741 | FXR (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15741 | FXR (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15741 | FXR (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15742 | VDR (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15742 | VDR (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15742 | VDR (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15743 | RXRα (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15743 | RXRα (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15743 | RXRα (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15744 | RXRβ (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15744 | RXRβ (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15744 | RXRβ (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15745 | RXRγ (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15745 | RXRγ (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15745 | RXRγ (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15746 | RXR (human) Reporter Assays Panel | 96 Well | 12208 |
| Cayman2015 | 15747 | CAR3 (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15747 | CAR3 (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15747 | CAR3 (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15748 | CAR1 (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15748 | CAR1 (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15748 | CAR1 (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15749 | TRα (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15749 | TRα (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15749 | TRα (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15750 | TRβ (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15750 | TRβ (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15750 | TRβ (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15751 | TR (human) Reporter Assays Panel | 96 Well | 12208 |
| Cayman2015 | 15752 | RARγ (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15752 | RARγ (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15752 | RARγ (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15753 | RARβ (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15753 | RARβ (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15753 | RARβ (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15754 | RARα (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15754 | RARα (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15754 | RARα (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15755 | RAR (human) Reporter Assays Panel | 96 Well | 12208 |
| Cayman2015 | 15756 | AR (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15756 | AR (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15756 | AR (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15757 | RORγ (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15757 | RORγ (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15757 | RORγ (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15759 | PR (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15759 | PR (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15759 | PR (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15760 | ERRα (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15760 | ERRα (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15760 | ERRα (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15761 | PPARγ (mouse/rat) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15761 | PPARγ (mouse/rat) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15761 | PPARγ (mouse/rat) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15762 | PPARα (mouse) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15762 | PPARα (mouse) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15762 | PPARα (mouse) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15763 | PPARδ (mouse) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15763 | PPARδ (mouse) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15763 | PPARδ (mouse) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15764 | PPARα (rat) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15764 | PPARα (rat) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15764 | PPARα (rat) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15765 | PPARδ (rat) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 15765 | PPARδ (rat) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 15765 | PPARδ (rat) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 15766 | Live Cell Multiplex Assay Kit | 480 Well | 6762 |
| Cayman2015 | 15766 | Live Cell Multiplex Assay Kit | 96 Well | 1624 |
| Cayman2015 | 15766 | Live Cell Multiplex Assay Kit | 960 Well | 12740 |
| Cayman2015 | 15767 | Mitochondrial RNA Polymerase (human recombinant) | 10 μg | 6258 |
| Cayman2015 | 15767 | Mitochondrial RNA Polymerase (human recombinant) | 40 μg | 23464 |
| Cayman2015 | 15768 | Mitochondrial Transcription Factor A (human recombinant) | 10 μg | 6258 |
| Cayman2015 | 15768 | Mitochondrial Transcription Factor A (human recombinant) | 40 μg | 23464 |
| Cayman2015 | 15769 | Mitochondrial Transcription Factor B (human recombinant) | 10 μg | 6258 |
| Cayman2015 | 15769 | Mitochondrial Transcription Factor B (human recombinant) | 40 μg | 23464 |
| Cayman2015 | 15771 | Metamizole (sodium salt) | 25 g | 532 |
| Cayman2015 | 15771 | Metamizole (sodium salt) | 50 g | 966 |
| Cayman2015 | 15772 | CFTR Inhibitor II | 1 mg | 392 |
| Cayman2015 | 15772 | CFTR Inhibitor II | 10 mg | 3136 |
| Cayman2015 | 15772 | CFTR Inhibitor II | 5 mg | 1764 |
| Cayman2015 | 15773 | Tiotropium (bromide) | 1 mg | 826 |
| Cayman2015 | 15773 | Tiotropium (bromide) | 25 mg | 4956 |
| Cayman2015 | 15773 | Tiotropium (bromide) | 5 mg | 1610 |
| Cayman2015 | 15773 | Tiotropium (bromide) | 50 mg | 7854 |
| Cayman2015 | 15774 | 6-Thioguanine | 1 g | 770 |
| Cayman2015 | 15774 | 6-Thioguanine | 250 mg | 350 |
| Cayman2015 | 15774 | 6-Thioguanine | 5 g | 2730 |
| Cayman2015 | 15774 | 6-Thioguanine | 500 mg | 532 |
| Cayman2015 | 15776 | Cefazolin (sodium salt) | 1 g | 1302 |
| Cayman2015 | 15776 | Cefazolin (sodium salt) | 100 mg | 350 |
| Cayman2015 | 15776 | Cefazolin (sodium salt) | 250 mg | 616 |
| Cayman2015 | 15776 | Cefazolin (sodium salt) | 500 mg | 966 |
| Cayman2015 | 15777 | Metaxalone | 10 mg | 686 |
| Cayman2015 | 15777 | Metaxalone | 100 mg | 6202 |
| Cayman2015 | 15777 | Metaxalone | 25 mg | 1960 |
| Cayman2015 | 15777 | Metaxalone | 50 mg | 3304 |
| Cayman2015 | 15778 | Keracyanin (chloride) | 1 mg | 490 |
| Cayman2015 | 15778 | Keracyanin (chloride) | 5 mg | 1960 |
| Cayman2015 | 15779 | Oseltamivir Acid | 1 mg | 924 |
| Cayman2015 | 15779 | Oseltamivir Acid | 10 mg | 8190 |
| Cayman2015 | 15779 | Oseltamivir Acid | 5 mg | 4368 |
| Cayman2015 | 15779 | Oseltamivir Acid | 500 μg | 546 |
| Cayman2015 | 15781 | ISCK03 | 1 mg | 350 |
| Cayman2015 | 15781 | ISCK03 | 10 mg | 1820 |
| Cayman2015 | 15781 | ISCK03 | 25 mg | 4116 |
| Cayman2015 | 15781 | ISCK03 | 5 mg | 1134 |
| Cayman2015 | 15782 | PTP1B Inhibitor | 1 mg | 1134 |
| Cayman2015 | 15782 | PTP1B Inhibitor | 10 mg | 4158 |
| Cayman2015 | 15782 | PTP1B Inhibitor | 5 mg | 2520 |
| Cayman2015 | 15782 | PTP1B Inhibitor | 500 μg | 630 |
| Cayman2015 | 15783 | SB 290157 (trifluoroacetate salt) | 1 mg | 350 |
| Cayman2015 | 15783 | SB 290157 (trifluoroacetate salt) | 10 mg | 1372 |
| Cayman2015 | 15783 | SB 290157 (trifluoroacetate salt) | 25 mg | 3066 |
| Cayman2015 | 15783 | SB 290157 (trifluoroacetate salt) | 5 mg | 882 |
| Cayman2015 | 15784 | STAT5 Inhibitor | 1 mg | 686 |
| Cayman2015 | 15784 | STAT5 Inhibitor | 10 mg | 3094 |
| Cayman2015 | 15784 | STAT5 Inhibitor | 5 mg | 1302 |
| Cayman2015 | 15785 | Tubastatin A | 10 mg | 574 |
| Cayman2015 | 15785 | Tubastatin A | 25 mg | 938 |
| Cayman2015 | 15785 | Tubastatin A | 5 mg | 406 |
| Cayman2015 | 15785 | Tubastatin A | 50 mg | 1302 |
| Cayman2015 | 15787 | Norketamine (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 15787 | Norketamine (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 15787 | Norketamine (hydrochloride) | 50 mg | 3780 |
| Cayman2015 | 15790 | 17,20-dimethyl Prostaglandin F1α | 1 mg | 714 |
| Cayman2015 | 15790 | 17,20-dimethyl Prostaglandin F1α | 10 mg | 5712 |
| Cayman2015 | 15790 | 17,20-dimethyl Prostaglandin F1α | 25 mg | 12502 |
| Cayman2015 | 15790 | 17,20-dimethyl Prostaglandin F1α | 5 mg | 3220 |
| Cayman2015 | 15865 | ARM1 | 10 mg | 1302 |
| Cayman2015 | 15865 | ARM1 | 100 mg | 9604 |
| Cayman2015 | 15865 | ARM1 | 5 mg | 686 |
| Cayman2015 | 15865 | ARM1 | 50 mg | 5488 |
| Cayman2015 | 15866 | Darunavir | 1 mg | 826 |
| Cayman2015 | 15866 | Darunavir | 10 mg | 4130 |
| Cayman2015 | 15866 | Darunavir | 5 mg | 2268 |
| Cayman2015 | 15867 | Fialuridine | 1 mg | 350 |
| Cayman2015 | 15867 | Fialuridine | 10 mg | 1890 |
| Cayman2015 | 15867 | Fialuridine | 25 mg | 4032 |
| Cayman2015 | 15867 | Fialuridine | 5 mg | 1050 |
| Cayman2015 | 15868 | Ivabradine (hydrochloride) | 10 mg | 826 |
| Cayman2015 | 15868 | Ivabradine (hydrochloride) | 100 mg | 5782 |
| Cayman2015 | 15868 | Ivabradine (hydrochloride) | 250 mg | 10332 |
| Cayman2015 | 15868 | Ivabradine (hydrochloride) | 50 mg | 3094 |
| Cayman2015 | 15869 | Moxalactam (sodium salt) | 1 g | 1918 |
| Cayman2015 | 15869 | Moxalactam (sodium salt) | 250 mg | 686 |
| Cayman2015 | 15869 | Moxalactam (sodium salt) | 500 mg | 1302 |
| Cayman2015 | 15870 | MreB Perturbing Compound A22 | 10 mg | 826 |
| Cayman2015 | 15870 | MreB Perturbing Compound A22 | 25 mg | 1358 |
| Cayman2015 | 15870 | MreB Perturbing Compound A22 | 50 mg | 2478 |
| Cayman2015 | 15871 | Zolmitriptan | 10 mg | 882 |
| Cayman2015 | 15871 | Zolmitriptan | 25 mg | 2044 |
| Cayman2015 | 15871 | Zolmitriptan | 5 mg | 630 |
| Cayman2015 | 15871 | Zolmitriptan | 50 mg | 3780 |
| Cayman2015 | 15872 | Androsterone | 1 g | 2730 |
| Cayman2015 | 15872 | Androsterone | 100 mg | 546 |
| Cayman2015 | 15872 | Androsterone | 250 mg | 1022 |
| Cayman2015 | 15872 | Androsterone | 500 mg | 1498 |
| Cayman2015 | 15873 | Dehydroepiandrostero?ne Sulfate (sodium salt) | 1 g | 3052 |
| Cayman2015 | 15873 | Dehydroepiandrostero?ne Sulfate (sodium salt) | 100 mg | 406 |
| Cayman2015 | 15873 | Dehydroepiandrostero?ne Sulfate (sodium salt) | 250 mg | 812 |
| Cayman2015 | 15874 | Dihydrotestosterone | 1 g | 700 |
| Cayman2015 | 15874 | Dihydrotestosterone | 100 mg | 350 |
| Cayman2015 | 15874 | Dihydrotestosterone | 500 mg | 532 |
| Cayman2015 | 15875 | epi-Testosterone | 10 mg | 1372 |
| Cayman2015 | 15875 | epi-Testosterone | 5 mg | 756 |
| Cayman2015 | 15875 | epi-Testosterone | 50 mg | 4088 |
| Cayman2015 | 15876 | Progesterone | 1 g | 210 |
| Cayman2015 | 15876 | Progesterone | 5 g | 490 |
| Cayman2015 | 15878 | 4-Hydroxyalprazolam | 1 mg | 490 |
| Cayman2015 | 15878 | 4-Hydroxyalprazolam | 5 mg | 980 |
| Cayman2015 | 15881 | Amitriptyline (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 15881 | Amitriptyline (hydrochloride) | 100 mg | 1232 |
| Cayman2015 | 15881 | Amitriptyline (hydrochloride) | 50 mg | 686 |
| Cayman2015 | 15882 | Amobarbital (sodium salt) | 10 mg | 350 |
| Cayman2015 | 15882 | Amobarbital (sodium salt) | 100 mg | 1232 |
| Cayman2015 | 15882 | Amobarbital (sodium salt) | 50 mg | 784 |
| Cayman2015 | 15884 | Clomipramine (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 15884 | Clomipramine (hydrochloride) | 100 mg | 1232 |
| Cayman2015 | 15884 | Clomipramine (hydrochloride) | 50 mg | 742 |
| Cayman2015 | 15885 | Cyclobenzaprine (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 15885 | Cyclobenzaprine (hydrochloride) | 100 mg | 1232 |
| Cayman2015 | 15885 | Cyclobenzaprine (hydrochloride) | 50 mg | 742 |
| Cayman2015 | 15886 | Dextrorphan (tartrate) | 100 mg | 672 |
| Cayman2015 | 15886 | Dextrorphan (tartrate) | 50 mg | 350 |
| Cayman2015 | 15886 | Dextrorphan (tartrate) | 500 mg | 1484 |
| Cayman2015 | 15888 | Doxepin (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 15888 | Doxepin (hydrochloride) | 100 mg | 1232 |
| Cayman2015 | 15888 | Doxepin (hydrochloride) | 50 mg | 742 |
| Cayman2015 | 15890 | Imipramine (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 15890 | Imipramine (hydrochloride) | 100 mg | 1232 |
| Cayman2015 | 15890 | Imipramine (hydrochloride) | 50 mg | 742 |
| Cayman2015 | 15892 | Maprotiline (hydrochloride) | 100 mg | 672 |
| Cayman2015 | 15892 | Maprotiline (hydrochloride) | 50 mg | 350 |
| Cayman2015 | 15892 | Maprotiline (hydrochloride) | 500 mg | 2632 |
| Cayman2015 | 15895 | 17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F1α | 1 mg | 714 |
| Cayman2015 | 15895 | 17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F1α | 10 mg | 5712 |
| Cayman2015 | 15895 | 17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F1α | 5 mg | 3220 |
| Cayman2015 | 15900 | Norfluoxetine | 1 mg | 504 |
| Cayman2015 | 15900 | Norfluoxetine | 10 mg | 3178 |
| Cayman2015 | 15900 | Norfluoxetine | 5 mg | 2268 |
| Cayman2015 | 15904 | Nortriptyline (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 15904 | Nortriptyline (hydrochloride) | 100 mg | 1232 |
| Cayman2015 | 15904 | Nortriptyline (hydrochloride) | 50 mg | 742 |
| Cayman2015 | 15907 | Desmethyldoxepin (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 15907 | Desmethyldoxepin (hydrochloride) | 10 mg | 1050 |
| Cayman2015 | 15907 | Desmethyldoxepin (hydrochloride) | 5 mg | 700 |
| Cayman2015 | 15908 | Desmethylene Paroxetine (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 15908 | Desmethylene Paroxetine (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 15908 | Desmethylene Paroxetine (hydrochloride) | 50 mg | 3780 |
| Cayman2015 | 15910 | 19(R)-hydroxy Prostaglandin F1α | 100 μg | 1330 |
| Cayman2015 | 15910 | 19(R)-hydroxy Prostaglandin F1α | 50 μg | 700 |
| Cayman2015 | 15910 | 19(R)-hydroxy Prostaglandin F1α | 500 μg | 5320 |
| Cayman2015 | 15912 | Pentazocine | 1 mg | 490 |
| Cayman2015 | 15912 | Pentazocine | 10 mg | 4172 |
| Cayman2015 | 15912 | Pentazocine | 5 mg | 2212 |
| Cayman2015 | 15915 | Ritalinic Acid | 10 mg | 1736 |
| Cayman2015 | 15915 | Ritalinic Acid | 5 mg | 910 |
| Cayman2015 | 15915 | Ritalinic Acid | 50 mg | 3192 |
| Cayman2015 | 15919 | cis-Tramadol (hydrochloride) | 10 mg | 490 |
| Cayman2015 | 15919 | cis-Tramadol (hydrochloride) | 5 mg | 350 |
| Cayman2015 | 15919 | cis-Tramadol (hydrochloride) | 50 mg | 2282 |
| Cayman2015 | 15920 | 15(R),19(R)-hydroxy Prostaglandin F1α | 100 μg | 770 |
| Cayman2015 | 15920 | 15(R),19(R)-hydroxy Prostaglandin F1α | 50 μg | 406 |
| Cayman2015 | 15920 | 15(R),19(R)-hydroxy Prostaglandin F1α | 500 μg | 3248 |
| Cayman2015 | 15922 | BCECF-Acetoxymethyl ester | 25 mg | 8940 |
| Cayman2015 | 15922 | BCECF-Acetoxymethyl ester | 5 mg | 2235 |
| Cayman2015 | 15923 | Caspofungin (acetate) | 1 mg | 350 |
| Cayman2015 | 15923 | Caspofungin (acetate) | 10 mg | 1750 |
| Cayman2015 | 15923 | Caspofungin (acetate) | 25 mg | 3934 |
| Cayman2015 | 15923 | Caspofungin (acetate) | 5 mg | 966 |
| Cayman2015 | 15924 | CID-755673 | 1 mg | 546 |
| Cayman2015 | 15924 | CID-755673 | 10 mg | 2184 |
| Cayman2015 | 15924 | CID-755673 | 25 mg | 4774 |
| Cayman2015 | 15924 | CID-755673 | 5 mg | 1372 |
| Cayman2015 | 15925 | Clorgyline (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 15925 | Clorgyline (hydrochloride) | 100 mg | 1750 |
| Cayman2015 | 15925 | Clorgyline (hydrochloride) | 25 mg | 616 |
| Cayman2015 | 15925 | Clorgyline (hydrochloride) | 50 mg | 1050 |
| Cayman2015 | 15926 | 5-Cyano-2,3-di-(p-tolyl)tetrazolium (chloride) | 10 mg | 350 |
| Cayman2015 | 15926 | 5-Cyano-2,3-di-(p-tolyl)tetrazolium (chloride) | 100 mg | 2282 |
| Cayman2015 | 15926 | 5-Cyano-2,3-di-(p-tolyl)tetrazolium (chloride) | 25 mg | 658 |
| Cayman2015 | 15926 | 5-Cyano-2,3-di-(p-tolyl)tetrazolium (chloride) | 50 mg | 1232 |
| Cayman2015 | 15927 | 3,3'-Diindolylmethane | 100 mg | 350 |
| Cayman2015 | 15927 | 3,3'-Diindolylmethane | 250 mg | 532 |
| Cayman2015 | 15927 | 3,3'-Diindolylmethane | 500 mg | 700 |
| Cayman2015 | 15928 | Edrophonium (chloride) | 1 g | 1302 |
| Cayman2015 | 15928 | Edrophonium (chloride) | 100 mg | 350 |
| Cayman2015 | 15928 | Edrophonium (chloride) | 250 mg | 574 |
| Cayman2015 | 15928 | Edrophonium (chloride) | 500 mg | 966 |
| Cayman2015 | 15929 | 10058-F4 | 10 mg | 1162 |
| Cayman2015 | 15929 | 10058-F4 | 25 mg | 2058 |
| Cayman2015 | 15929 | 10058-F4 | 5 mg | 686 |
| Cayman2015 | 15929 | 10058-F4 | 50 mg | 3780 |
| Cayman2015 | 15933 | Prednisolone Phosphate (sodium salt) | 1 g | 490 |
| Cayman2015 | 15933 | Prednisolone Phosphate (sodium salt) | 10 g | 3920 |
| Cayman2015 | 15933 | Prednisolone Phosphate (sodium salt) | 25 g | 7350 |
| Cayman2015 | 15933 | Prednisolone Phosphate (sodium salt) | 5 g | 2212 |
| Cayman2015 | 15935 | Taurodeoxycholic Acid (sodium salt) | 1 g | 490 |
| Cayman2015 | 15935 | Taurodeoxycholic Acid (sodium salt) | 25 g | 4900 |
| Cayman2015 | 15935 | Taurodeoxycholic Acid (sodium salt) | 5 g | 1232 |
| Cayman2015 | 15936 | Volinanserin | 1 mg | 546 |
| Cayman2015 | 15936 | Volinanserin | 10 mg | 2730 |
| Cayman2015 | 15936 | Volinanserin | 5 mg | 1498 |
| Cayman2015 | 15937 | AKB48 N-(4-fluorobenzyl) analog | 1 mg | 490 |
| Cayman2015 | 15937 | AKB48 N-(4-fluorobenzyl) analog | 10 mg | 3920 |
| Cayman2015 | 15937 | AKB48 N-(4-fluorobenzyl) analog | 5 mg | 2212 |
| Cayman2015 | 15938 | Delorazepam | 1 mg | 406 |
| Cayman2015 | 15938 | Delorazepam | 10 mg | 2030 |
| Cayman2015 | 15938 | Delorazepam | 5 mg | 1316 |
| Cayman2015 | 15941 | AdipoRon | 10 mg | 975 |
| Cayman2015 | 15941 | AdipoRon | 50 mg | 4395 |
| Cayman2015 | 15943 | MK2 Inhibitor III | 1 mg | 1246 |
| Cayman2015 | 15943 | MK2 Inhibitor III | 5 mg | 2576 |
| Cayman2015 | 15943 | MK2 Inhibitor III | 500 μg | 826 |
| Cayman2015 | 15944 | ERK Inhibitor | 1 mg | 560 |
| Cayman2015 | 15944 | ERK Inhibitor | 5 mg | 1330 |
| Cayman2015 | 15944 | ERK Inhibitor | 500 μg | 350 |
| Cayman2015 | 15945 | SMAD3 Inhibitor, SIS3 | 1 mg | 1232 |
| Cayman2015 | 15945 | SMAD3 Inhibitor, SIS3 | 5 mg | 3710 |
| Cayman2015 | 15945 | SMAD3 Inhibitor, SIS3 | 500 μg | 686 |
| Cayman2015 | 15946 | JNK Inhibitor VIII | 1 mg | 630 |
| Cayman2015 | 15946 | JNK Inhibitor VIII | 10 mg | 2520 |
| Cayman2015 | 15946 | JNK Inhibitor VIII | 5 mg | 1582 |
| Cayman2015 | 15947 | OTX015 | 1 mg | 686 |
| Cayman2015 | 15947 | OTX015 | 10 mg | 5152 |
| Cayman2015 | 15947 | OTX015 | 5 mg | 3094 |
| Cayman2015 | 15948 | Galangin | 10 mg | 868 |
| Cayman2015 | 15948 | Galangin | 25 mg | 1372 |
| Cayman2015 | 15948 | Galangin | 5 mg | 546 |
| Cayman2015 | 15949 | Clonidine (hydrochloride) | 1 g | 630 |
| Cayman2015 | 15949 | Clonidine (hydrochloride) | 5 g | 2030 |
| Cayman2015 | 15949 | Clonidine (hydrochloride) | 500 mg | 350 |
| Cayman2015 | 15950 | Vitamin K3 | 100 g | 1204 |
| Cayman2015 | 15950 | Vitamin K3 | 25 g | 336 |
| Cayman2015 | 15950 | Vitamin K3 | 250 g | 2520 |
| Cayman2015 | 15950 | Vitamin K3 | 50 g | 644 |
| Cayman2015 | 15954 | Amodiaquine | 1 mg | 406 |
| Cayman2015 | 15954 | Amodiaquine | 10 mg | 2716 |
| Cayman2015 | 15954 | Amodiaquine | 5 mg | 1526 |
| Cayman2015 | 15954 | Amodiaquine | 50 mg | 8330 |
| Cayman2015 | 15956 | Dutasteride | 10 mg | 1456 |
| Cayman2015 | 15956 | Dutasteride | 5 mg | 840 |
| Cayman2015 | 15956 | Dutasteride | 50 mg | 4368 |
| Cayman2015 | 15958 | MMP Inhibitor II | 1 mg | 686 |
| Cayman2015 | 15958 | MMP Inhibitor II | 10 mg | 2744 |
| Cayman2015 | 15958 | MMP Inhibitor II | 5 mg | 1890 |
| Cayman2015 | 15959 | (R)-Prunasin | 1 mg | 1890 |
| Cayman2015 | 15959 | (R)-Prunasin | 5 mg | 6300 |
| Cayman2015 | 15959 | (R)-Prunasin | 500 μg | 1050 |
| Cayman2015 | 15961 | 2-Methylami-phenylbutane (hydrochloride) | 10 mg | 938 |
| Cayman2015 | 15961 | 2-Methylami-phenylbutane (hydrochloride) | 25 mg | 2212 |
| Cayman2015 | 15961 | 2-Methylami-phenylbutane (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 15961 | 2-Methylami-phenylbutane (hydrochloride) | 50 mg | 3920 |
| Cayman2015 | 15962 | 3-CAF | 1 mg | 910 |
| Cayman2015 | 15962 | 3-CAF | 10 mg | 7280 |
| Cayman2015 | 15962 | 3-CAF | 5 mg | 4102 |
| Cayman2015 | 15964 | TZ9 | 1 mg | 350 |
| Cayman2015 | 15964 | TZ9 | 10 mg | 2800 |
| Cayman2015 | 15964 | TZ9 | 25 mg | 6132 |
| Cayman2015 | 15964 | TZ9 | 5 mg | 1582 |
| Cayman2015 | 15967 | 25B-NBF (hydrochloride) | 1 mg | 784 |
| Cayman2015 | 15967 | 25B-NBF (hydrochloride) | 10 mg | 6272 |
| Cayman2015 | 15967 | 25B-NBF (hydrochloride) | 5 mg | 3528 |
| Cayman2015 | 15968 | Palmitoyl Alkyne-Coenzyme A (trifluoroacetate salt) | 1 mg | 10640 |
| Cayman2015 | 15968 | Palmitoyl Alkyne-Coenzyme A (trifluoroacetate salt) | 100 μg | 1330 |
| Cayman2015 | 15968 | Palmitoyl Alkyne-Coenzyme A (trifluoroacetate salt) | 250 μg | 3164 |
| Cayman2015 | 15968 | Palmitoyl Alkyne-Coenzyme A (trifluoroacetate salt) | 500 μg | 5992 |
| Cayman2015 | 15969 | 25C-NBF (hydrochloride) | 1 mg | 784 |
| Cayman2015 | 15969 | 25C-NBF (hydrochloride) | 10 mg | 6272 |
| Cayman2015 | 15969 | 25C-NBF (hydrochloride) | 5 mg | 3528 |
| Cayman2015 | 15970 | MMB018 | 1 mg | 686 |
| Cayman2015 | 15970 | MMB018 | 10 mg | 5488 |
| Cayman2015 | 15970 | MMB018 | 5 mg | 3094 |
| Cayman2015 | 15971 | MMB2201 | 1 mg | 686 |
| Cayman2015 | 15971 | MMB2201 | 10 mg | 5488 |
| Cayman2015 | 15971 | MMB2201 | 5 mg | 3094 |
| Cayman2015 | 15973 | MF498 | 1 mg | 770 |
| Cayman2015 | 15973 | MF498 | 10 mg | 6160 |
| Cayman2015 | 15973 | MF498 | 25 mg | 13482 |
| Cayman2015 | 15973 | MF498 | 5 mg | 3472 |
| Cayman2015 | 15975 | L-Norpseudoephedrine | 10 mg | 1302 |
| Cayman2015 | 15975 | L-Norpseudoephedrine | 5 mg | 686 |
| Cayman2015 | 15975 | L-Norpseudoephedrine | 50 mg | 5488 |
| Cayman2015 | 15977 | LC3 Interact Kit | 1 ea | 6300 |
| Cayman2015 | 15978 | Ubiquitin Interact Kit | 1 ea | 5320 |
| Cayman2015 | 15979 | Ubiquitinated Protein Capture Kit | 1 ea | 5110 |
| Cayman2015 | 15981 | DUB Activity Assay Kit | 96 Well | 5810 |
| Cayman2015 | 15986 | Alprenolol (hydrochloride) | 100 mg | 1638 |
| Cayman2015 | 15986 | Alprenolol (hydrochloride) | 25 mg | 546 |
| Cayman2015 | 15986 | Alprenolol (hydrochloride) | 250 mg | 3822 |
| Cayman2015 | 15986 | Alprenolol (hydrochloride) | 50 mg | 868 |
| Cayman2015 | 15987 | Metolazone | 10 mg | 350 |
| Cayman2015 | 15987 | Metolazone | 100 mg | 1932 |
| Cayman2015 | 15987 | Metolazone | 25 mg | 658 |
| Cayman2015 | 15987 | Metolazone | 50 mg | 1232 |
| Cayman2015 | 15988 | 7-methyl Guanosine | 100 mg | 1008 |
| Cayman2015 | 15988 | 7-methyl Guanosine | 25 mg | 350 |
| Cayman2015 | 15988 | 7-methyl Guanosine | 250 mg | 2072 |
| Cayman2015 | 15988 | 7-methyl Guanosine | 50 mg | 672 |
| Cayman2015 | 15989 | Lofexidine (hydrochloride) | 1 g | 840 |
| Cayman2015 | 15989 | Lofexidine (hydrochloride) | 250 mg | 350 |
| Cayman2015 | 15989 | Lofexidine (hydrochloride) | 500 mg | 560 |
| Cayman2015 | 15990 | Cefoxitin (sodium salt) | 1 g | 2100 |
| Cayman2015 | 15990 | Cefoxitin (sodium salt) | 250 mg | 700 |
| Cayman2015 | 15990 | Cefoxitin (sodium salt) | 500 mg | 1260 |
| Cayman2015 | 15991 | Dibutyryl-cGMP (sodium salt) | 10 mg | 1204 |
| Cayman2015 | 15991 | Dibutyryl-cGMP (sodium salt) | 5 mg | 756 |
| Cayman2015 | 15991 | Dibutyryl-cGMP (sodium salt) | 50 mg | 4536 |
| Cayman2015 | 15992 | 8-bromo-cGMP (sodium salt) | 10 mg | 686 |
| Cayman2015 | 15992 | 8-bromo-cGMP (sodium salt) | 25 mg | 1428 |
| Cayman2015 | 15992 | 8-bromo-cGMP (sodium salt) | 5 mg | 406 |
| Cayman2015 | 15992 | 8-bromo-cGMP (sodium salt) | 50 mg | 2646 |
| Cayman2015 | 15994 | Calpain Inhibitor II | 1 mg | 406 |
| Cayman2015 | 15994 | Calpain Inhibitor II | 10 mg | 1540 |
| Cayman2015 | 15994 | Calpain Inhibitor II | 5 mg | 952 |
| Cayman2015 | 15995 | PKG Inhibitor | 1 mg | 546 |
| Cayman2015 | 15995 | PKG Inhibitor | 10 mg | 3276 |
| Cayman2015 | 15995 | PKG Inhibitor | 5 mg | 1778 |
| Cayman2015 | 15996 | PKA Inhibitor (5-24) | 1 mg | 1316 |
| Cayman2015 | 15996 | PKA Inhibitor (5-24) | 5 mg | 5390 |
| Cayman2015 | 15996 | PKA Inhibitor (5-24) | 500 μg | 770 |
| Cayman2015 | 15997 | Mildronate (hydrate) | 10 mg | 350 |
| Cayman2015 | 15997 | Mildronate (hydrate) | 100 mg | 1680 |
| Cayman2015 | 15997 | Mildronate (hydrate) | 25 mg | 784 |
| Cayman2015 | 15997 | Mildronate (hydrate) | 50 mg | 1232 |
| Cayman2015 | 15998 | Luzindole | 10 mg | 1470 |
| Cayman2015 | 15998 | Luzindole | 25 mg | 3080 |
| Cayman2015 | 15998 | Luzindole | 5 mg | 770 |
| Cayman2015 | 15998 | Luzindole | 50 mg | 5782 |
| Cayman2015 | 15999 | Etifoxine | 10 mg | 1372 |
| Cayman2015 | 15999 | Etifoxine | 25 mg | 3192 |
| Cayman2015 | 15999 | Etifoxine | 5 mg | 910 |
| Cayman2015 | 15999 | Etifoxine | 50 mg | 5740 |
| Cayman2015 | 16000 | Fosmidomycin (sodium salt) | 1 mg | 490 |
| Cayman2015 | 16000 | Fosmidomycin (sodium salt) | 10 mg | 3682 |
| Cayman2015 | 16000 | Fosmidomycin (sodium salt) | 25 mg | 7840 |
| Cayman2015 | 16000 | Fosmidomycin (sodium salt) | 5 mg | 1960 |
| Cayman2015 | 160003 | Prostaglandin D Synthase (lipocalin-type) Polyclonal Antibody | 1 ea | 2478 |
| Cayman2015 | 16001 | Roseoflavin | 1 mg | 630 |
| Cayman2015 | 16001 | Roseoflavin | 10 mg | 2016 |
| Cayman2015 | 16001 | Roseoflavin | 25 mg | 3780 |
| Cayman2015 | 16001 | Roseoflavin | 5 mg | 1106 |
| Cayman2015 | 160013 | Prostaglandin D Synthase (hematopoietic-type) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16002 | Sp-8-bromo-Cyclic AMPS (sodium salt) | 1 mg | 2534 |
| Cayman2015 | 16002 | Sp-8-bromo-Cyclic AMPS (sodium salt) | 5 mg | 8652 |
| Cayman2015 | 16002 | Sp-8-bromo-Cyclic AMPS (sodium salt) | 500 μg | 1330 |
| Cayman2015 | 16003 | 5-chloro NNEI | 1 mg | 910 |
| Cayman2015 | 16003 | 5-chloro NNEI | 10 mg | 7280 |
| Cayman2015 | 16003 | 5-chloro NNEI | 5 mg | 4130 |
| Cayman2015 | 16004 | Zoniporide (hydrochloride) | 10 mg | 1806 |
| Cayman2015 | 16004 | Zoniporide (hydrochloride) | 50 mg | 7672 |
| Cayman2015 | 16005 | L-Selenomethionine | 1 g | 6090 |
| Cayman2015 | 16005 | L-Selenomethionine | 100 mg | 1106 |
| Cayman2015 | 16005 | L-Selenomethionine | 250 mg | 2212 |
| Cayman2015 | 16006 | DL-Lauroylcarnitine (chloride) | 25 mg | 770 |
| Cayman2015 | 16006 | DL-Lauroylcarnitine (chloride) | 250 mg | 2702 |
| Cayman2015 | 16006 | DL-Lauroylcarnitine (chloride) | 50 mg | 1386 |
| Cayman2015 | 16006 | DL-Lauroylcarnitine (chloride) | 500 mg | 4312 |
| Cayman2015 | 16007 | 1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose | 10 mg | 1316 |
| Cayman2015 | 16007 | 1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose | 25 mg | 2072 |
| Cayman2015 | 16007 | 1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose | 5 mg | 826 |
| Cayman2015 | 160070 | IP Receptor (mouse) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16008 | L-Leucyl-L-Leucine methyl ester (hydrochloride) | 1 g | 882 |
| Cayman2015 | 16008 | L-Leucyl-L-Leucine methyl ester (hydrochloride) | 100 mg | 350 |
| Cayman2015 | 16008 | L-Leucyl-L-Leucine methyl ester (hydrochloride) | 250 mg | 574 |
| Cayman2015 | 16009 | Salmeterol xinafoate | 10 mg | 1190 |
| Cayman2015 | 16009 | Salmeterol xinafoate | 100 mg | 9520 |
| Cayman2015 | 16009 | Salmeterol xinafoate | 25 mg | 2674 |
| Cayman2015 | 16009 | Salmeterol xinafoate | 50 mg | 5054 |
| Cayman2015 | 16010 | Prostaglandin F2α | 1 mg | 406 |
| Cayman2015 | 16010 | Prostaglandin F2α | 10 mg | 3248 |
| Cayman2015 | 16010 | Prostaglandin F2α | 5 mg | 1834 |
| Cayman2015 | 16010 | Prostaglandin F2α | 50 mg | 13804 |
| Cayman2015 | 160103 | COX Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 160106 | COX-2 (mouse) Polyclonal Antibody (aa 570-598) | 1 ea | 3206 |
| Cayman2015 | 160106 | COX-2 (mouse) Polyclonal Antibody (aa 570-598) | 1 Trial | 1610 |
| Cayman2015 | 160107 | COX-2 (human) Polyclonal Antibody | 1 ea | 2730 |
| Cayman2015 | 160108 | COX-1 (ovine) Polyclonal Antiserum | 1 ea | 2618 |
| Cayman2015 | 160109 | COX-1 (mouse) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16011 | Prostaglandin F2α methyl ester | 1 mg | 672 |
| Cayman2015 | 16011 | Prostaglandin F2α methyl ester | 10 mg | 4900 |
| Cayman2015 | 16011 | Prostaglandin F2α methyl ester | 5 mg | 2800 |
| Cayman2015 | 16011 | Prostaglandin F2α methyl ester | 500 μg | 350 |
| Cayman2015 | 160110 | COX-1 Monoclonal Antibody (Clone CX111) | 1 ea | 3780 |
| Cayman2015 | 160111 | COX-1 Monoclonal FITC Antibody (Clone CX111) | 250 μg | 3346 |
| Cayman2015 | 160112 | COX-2 Monoclonal Antibody (Clone CX229) | 1 ea | 3066 |
| Cayman2015 | 160112 | COX-2 Monoclonal Antibody (Clone CX229) | 1 Trial | 1386 |
| Cayman2015 | 160113 | COX-2 Monoclonal FITC Antibody (Clone CX229) | 1 ea | 3346 |
| Cayman2015 | 160116 | COX-2 (mouse) Polyclonal Antiserum | 1 ea | 1582 |
| Cayman2015 | 16012 | Prostaglandin F2α Alcohol | 1 mg | 574 |
| Cayman2015 | 16012 | Prostaglandin F2α Alcohol | 10 mg | 5712 |
| Cayman2015 | 16012 | Prostaglandin F2α Alcohol | 5 mg | 3220 |
| Cayman2015 | 160120 | COX-1 Monoclonal PE Antibody (Clone CX111) | 1 ea | 3346 |
| Cayman2015 | 160126 | COX-2 (mouse) Polyclonal Antibody (aa 584-598) | 1 ea | 3206 |
| Cayman2015 | 160126 | COX-2 (mouse) Polyclonal Antibody (aa 584-598) | 1 Trial | 1386 |
| Cayman2015 | 16013 | Prostaglandin F2α Ethanolamide | 1 mg | 798 |
| Cayman2015 | 16013 | Prostaglandin F2α Ethanolamide | 10 mg | 6384 |
| Cayman2015 | 16013 | Prostaglandin F2α Ethanolamide | 5 mg | 3598 |
| Cayman2015 | 16014 | Prostaglandin F2α Alcohol methyl ether | 1 mg | 714 |
| Cayman2015 | 16014 | Prostaglandin F2α Alcohol methyl ether | 10 mg | 5712 |
| Cayman2015 | 16014 | Prostaglandin F2α Alcohol methyl ether | 5 mg | 3220 |
| Cayman2015 | 160140 | Prostaglandin E Synthase-1 (microsomal) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 160140 | Prostaglandin E Synthase-1 (microsomal) Polyclonal Antibody | 1 Trial | 1386 |
| Cayman2015 | 160145 | Prostaglandin E Synthase-2 (microsomal) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 160150 | Prostaglandin E Synthase (cytosolic) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16016 | Prostaglandin F2α ethyl amide | 1 mg | 588 |
| Cayman2015 | 16016 | Prostaglandin F2α ethyl amide | 10 mg | 4704 |
| Cayman2015 | 16016 | Prostaglandin F2α ethyl amide | 5 mg | 2646 |
| Cayman2015 | 16017 | Vitamin K1 2,3-epoxide | 1 mg | 2450 |
| Cayman2015 | 16017 | Vitamin K1 2,3-epoxide | 5 mg | 4970 |
| Cayman2015 | 16017 | Vitamin K1 2,3-epoxide | 500 μg | 1344 |
| Cayman2015 | 16018 | Camostat (mesylate) | 10 mg | 490 |
| Cayman2015 | 16018 | Camostat (mesylate) | 25 mg | 1134 |
| Cayman2015 | 16018 | Camostat (mesylate) | 5 mg | 350 |
| Cayman2015 | 16018 | Camostat (mesylate) | 50 mg | 1750 |
| Cayman2015 | 16019 | Zalcitabine | 100 mg | 1120 |
| Cayman2015 | 16019 | Zalcitabine | 25 mg | 350 |
| Cayman2015 | 16019 | Zalcitabine | 250 mg | 2450 |
| Cayman2015 | 16019 | Zalcitabine | 500 mg | 3850 |
| Cayman2015 | 16020 | Prostaglandin F2α (tromethamine salt) | 1 mg | 364 |
| Cayman2015 | 16020 | Prostaglandin F2α (tromethamine salt) | 10 mg | 2688 |
| Cayman2015 | 16020 | Prostaglandin F2α (tromethamine salt) | 25 mg | 5922 |
| Cayman2015 | 16020 | Prostaglandin F2α (tromethamine salt) | 5 mg | 1512 |
| Cayman2015 | 16023 | Prostaglandin F2α diethyl amide | 1 mg | 588 |
| Cayman2015 | 16023 | Prostaglandin F2α diethyl amide | 10 mg | 4704 |
| Cayman2015 | 16023 | Prostaglandin F2α diethyl amide | 5 mg | 2646 |
| Cayman2015 | 160250 | Leukotriene A4 Hydrolase Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16028 | ?3,3',5-Triiodo-L-thyronine (sodium salt) | 1 g | 2450 |
| Cayman2015 | 16028 | ?3,3',5-Triiodo-L-thyronine (sodium salt) | 100 mg | 490 |
| Cayman2015 | 16028 | ?3,3',5-Triiodo-L-thyronine (sodium salt) | 250 mg | 1036 |
| Cayman2015 | 16028 | ?3,3',5-Triiodo-L-thyronine (sodium salt) | 500 mg | 1344 |
| Cayman2015 | 16030 | Prostaglandin F2α isopropyl ester | 1 mg | 798 |
| Cayman2015 | 16030 | Prostaglandin F2α isopropyl ester | 10 mg | 6384 |
| Cayman2015 | 16030 | Prostaglandin F2α isopropyl ester | 5 mg | 3598 |
| Cayman2015 | 16032 | Prostaglandin F2α dimethyl amide | 1 mg | 798 |
| Cayman2015 | 16032 | Prostaglandin F2α dimethyl amide | 10 mg | 6384 |
| Cayman2015 | 16032 | Prostaglandin F2α dimethyl amide | 5 mg | 3598 |
| Cayman2015 | 16033 | Prostaglandin F2α dimethyl amine | 1 mg | 588 |
| Cayman2015 | 16033 | Prostaglandin F2α dimethyl amine | 10 mg | 4704 |
| Cayman2015 | 16033 | Prostaglandin F2α dimethyl amine | 5 mg | 2646 |
| Cayman2015 | 16037 | N-Ethylpentylone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 16037 | N-Ethylpentylone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 16037 | N-Ethylpentylone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 16039 | Imipenem (hydrate) | 10 mg | 882 |
| Cayman2015 | 16039 | Imipenem (hydrate) | 100 mg | 3654 |
| Cayman2015 | 16039 | Imipenem (hydrate) | 25 mg | 1232 |
| Cayman2015 | 16039 | Imipenem (hydrate) | 5 mg | 630 |
| Cayman2015 | 16040 | Cefotaxime (sodium salt) | 1 g | 840 |
| Cayman2015 | 16040 | Cefotaxime (sodium salt) | 250 mg | 350 |
| Cayman2015 | 16040 | Cefotaxime (sodium salt) | 5 g | 1120 |
| Cayman2015 | 16040 | Cefotaxime (sodium salt) | 500 mg | 630 |
| Cayman2015 | 160402 | 5-Lipoxygenase Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16041 | Enalapril | 1 g | 616 |
| Cayman2015 | 16041 | Enalapril | 10 g | 3654 |
| Cayman2015 | 16041 | Enalapril | 5 g | 2030 |
| Cayman2015 | 16041 | Enalapril | 500 mg | 406 |
| Cayman2015 | 16042 | Cinacalcet (hydrochloride) | 10 mg | 910 |
| Cayman2015 | 16042 | Cinacalcet (hydrochloride) | 100 mg | 6370 |
| Cayman2015 | 16042 | Cinacalcet (hydrochloride) | 25 mg | 2044 |
| Cayman2015 | 16042 | Cinacalcet (hydrochloride) | 50 mg | 3416 |
| Cayman2015 | 16043 | Rivaroxaban | 1 mg | 910 |
| Cayman2015 | 16043 | Rivaroxaban | 10 mg | 3640 |
| Cayman2015 | 16043 | Rivaroxaban | 5 mg | 2282 |
| Cayman2015 | 16043 | Rivaroxaban | 50 mg | 9100 |
| Cayman2015 | 16044 | SDB-006 N-phenyl analog | 1 mg | 686 |
| Cayman2015 | 16044 | SDB-006 N-phenyl analog | 10 mg | 5488 |
| Cayman2015 | 16044 | SDB-006 N-phenyl analog | 5 mg | 3094 |
| Cayman2015 | 16045 | AB-FUBINACA (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16046 | ADB-PINACA (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16047 | PB-22 (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16049 | 4-Methylethcathinone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16050 | 1a,1b-dihomo Prostaglandin F2α | 1 mg | 714 |
| Cayman2015 | 16050 | 1a,1b-dihomo Prostaglandin F2α | 10 mg | 5712 |
| Cayman2015 | 16050 | 1a,1b-dihomo Prostaglandin F2α | 5 mg | 3220 |
| Cayman2015 | 160500 | sPLA2 (human Type IIA) Monoclonal Antibody (Clone SCACC353) | 1 ea | 2618 |
| Cayman2015 | 160502 | sPLA2 (human Type IIA) Polyclonal Antiserum | 1 ea | 2786 |
| Cayman2015 | 160507 | iPLA2 (Type VI) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16051 | 4'-methyl-α-Pyrrolidinopropiophenone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 160510 | sPLA2 (human Type V) Monoclonal Antibody (Clone MCL-3G1) | 100 μg | 2786 |
| Cayman2015 | 160512 | sPLA2 (mouse Type V) Polyclonal Antibody | 1 ea | 2478 |
| Cayman2015 | 16052 | Pentedrone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16053 | Pentylone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16054 | 4-Fluoromethcathinone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16055 | 3-Fluoromethcathinone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16056 | Naphyrone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16057 | α-Pyrrolidinobutiophenone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16059 | Butylone (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16060 | Guanosine 5′-triphosphate (sodium salt hydrate) | 10 mg | 350 |
| Cayman2015 | 16060 | Guanosine 5′-triphosphate (sodium salt hydrate) | 100 mg | 1050 |
| Cayman2015 | 16060 | Guanosine 5′-triphosphate (sodium salt hydrate) | 25 mg | 476 |
| Cayman2015 | 16060 | Guanosine 5′-triphosphate (sodium salt hydrate) | 50 mg | 616 |
| Cayman2015 | 160600 | PAF Receptor (human) Monoclonal Antibody (11A4, Clone 21) | 1 ea | 3206 |
| Cayman2015 | 160602 | PAF Receptor (human) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 160603 | PAF Acetylhydrolase (human) Polyclonal Antibody | 1 ea | 2478 |
| Cayman2015 | 160604 | PAF Receptor Blocking Peptide (Polyclonal) | 200 μg | 1498 |
| Cayman2015 | 16061 | L-(+)-Cystathionine | 10 mg | 784 |
| Cayman2015 | 16061 | L-(+)-Cystathionine | 25 mg | 1596 |
| Cayman2015 | 16061 | L-(+)-Cystathionine | 5 mg | 490 |
| Cayman2015 | 16061 | L-(+)-Cystathionine | 50 mg | 2450 |
| Cayman2015 | 160615 | 15-hydroxy Prostaglandin Dehydrogenase Polyclonal Antibody | 1 ea | 3010 |
| Cayman2015 | 16062 | Adenosine 2′-monophosphate | 100 mg | 1316 |
| Cayman2015 | 16062 | Adenosine 2′-monophosphate | 250 mg | 2478 |
| Cayman2015 | 16062 | Adenosine 2′-monophosphate | 50 mg | 826 |
| Cayman2015 | 16063 | Corticosterone | 100 mg | 280 |
| Cayman2015 | 16063 | Corticosterone | 250 mg | 490 |
| Cayman2015 | 16063 | Corticosterone | 500 mg | 840 |
| Cayman2015 | 160630 | Prostaglandin I Synthase Monoclonal Antibody (Clone isn-1) | 1 ea | 3206 |
| Cayman2015 | 16064 | Lisdexamfetamine (hydrochloride) (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 160640 | Prostaglandin I Synthase Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16065 | ARN1203 | 1 mg | 672 |
| Cayman2015 | 16065 | ARN1203 | 10 mg | 5600 |
| Cayman2015 | 16065 | ARN1203 | 5 mg | 3150 |
| Cayman2015 | 16065 | ARN1203 | 500 μg | 350 |
| Cayman2015 | 16066 | Remodelin (hydrobromide) | 1 mg | 406 |
| Cayman2015 | 16066 | Remodelin (hydrobromide) | 10 mg | 3248 |
| Cayman2015 | 16066 | Remodelin (hydrobromide) | 5 mg | 1834 |
| Cayman2015 | 16067 | Muscone | 1 g | 5390 |
| Cayman2015 | 16067 | Muscone | 100 mg | 784 |
| Cayman2015 | 16067 | Muscone | 50 mg | 490 |
| Cayman2015 | 16067 | Muscone | 500 mg | 3192 |
| Cayman2015 | 16068 | Meropenem | 10 mg | 490 |
| Cayman2015 | 16068 | Meropenem | 100 mg | 3430 |
| Cayman2015 | 16068 | Meropenem | 25 mg | 1106 |
| Cayman2015 | 16068 | Meropenem | 50 mg | 1960 |
| Cayman2015 | 16069 | Cytarabine | 1 g | 714 |
| Cayman2015 | 16069 | Cytarabine | 10 g | 2184 |
| Cayman2015 | 16069 | Cytarabine | 5 g | 1372 |
| Cayman2015 | 16069 | Cytarabine | 500 mg | 546 |
| Cayman2015 | 16070 | Oseltamivir (phosphate) | 100 mg | 546 |
| Cayman2015 | 16070 | Oseltamivir (phosphate) | 250 mg | 1302 |
| Cayman2015 | 16070 | Oseltamivir (phosphate) | 500 mg | 2464 |
| Cayman2015 | 160704 | 15-Lipoxygenase-1 (rabbit) Polyclonal Antiserum | 1 ea | 2142 |
| Cayman2015 | 16071 | Raltegravir (potassium salt) | 1 mg | 546 |
| Cayman2015 | 16071 | Raltegravir (potassium salt) | 10 mg | 2730 |
| Cayman2015 | 16071 | Raltegravir (potassium salt) | 5 mg | 1498 |
| Cayman2015 | 16071 | Raltegravir (potassium salt) | 50 mg | 9016 |
| Cayman2015 | 160715 | Thromboxane Synthase Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16072 | Pheophorbide a | 100 mg | 2772 |
| Cayman2015 | 16072 | Pheophorbide a | 25 mg | 770 |
| Cayman2015 | 16072 | Pheophorbide a | 50 mg | 1470 |
| Cayman2015 | 160720 | Thromboxane B2 11-dehydrogenase Polyclonal Antiserum | 1 ea | 2450 |
| Cayman2015 | 16073 | Iodonitrotetrazolium (chloride) | 1 g | 938 |
| Cayman2015 | 16073 | Iodonitrotetrazolium (chloride) | 250 mg | 406 |
| Cayman2015 | 16073 | Iodonitrotetrazolium (chloride) | 5 g | 3248 |
| Cayman2015 | 16073 | Iodonitrotetrazolium (chloride) | 500 mg | 616 |
| Cayman2015 | 160737 | ARC Polyclonal Antibody | 1 ea | 2254 |
| Cayman2015 | 16074 | Prothionamide | 1 g | 728 |
| Cayman2015 | 16074 | Prothionamide | 10 g | 1708 |
| Cayman2015 | 16074 | Prothionamide | 5 g | 1134 |
| Cayman2015 | 16074 | Prothionamide | 500 mg | 406 |
| Cayman2015 | 160745 | Caspase-3 (human) Polyclonal Antibody | 1 ea | 2870 |
| Cayman2015 | 16075 | Cefpodoxime (free acid) | 10 mg | 826 |
| Cayman2015 | 16075 | Cefpodoxime (free acid) | 100 mg | 2646 |
| Cayman2015 | 16075 | Cefpodoxime (free acid) | 25 mg | 1344 |
| Cayman2015 | 16075 | Cefpodoxime (free acid) | 50 mg | 2072 |
| Cayman2015 | 160750 | TRAIL Polyclonal Antibody | 1 ea | 4300 |
| Cayman2015 | 160755 | DcR2 Polyclonal Antibody | 1 ea | 3010 |
| Cayman2015 | 16076 | A-7 (hydrochloride) | 10 mg | 616 |
| Cayman2015 | 16076 | A-7 (hydrochloride) | 25 mg | 812 |
| Cayman2015 | 16076 | A-7 (hydrochloride) | 5 mg | 406 |
| Cayman2015 | 16077 | NAD+ (free acid) | 1 g | 686 |
| Cayman2015 | 16077 | NAD+ (free acid) | 5 g | 2212 |
| Cayman2015 | 16077 | NAD+ (free acid) | 500 mg | 490 |
| Cayman2015 | 160773 | AIF Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 160777 | Nod2 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16078 | NADH (sodium salt) | 1 g | 686 |
| Cayman2015 | 16078 | NADH (sodium salt) | 5 g | 2940 |
| Cayman2015 | 16078 | NADH (sodium salt) | 500 mg | 490 |
| Cayman2015 | 160780 | Apaf-1 Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 160785 | RICK Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16079 | TPT-260 (hydrochloride) | 1 mg | 490 |
| Cayman2015 | 16079 | TPT-260 (hydrochloride) | 10 mg | 2702 |
| Cayman2015 | 16079 | TPT-260 (hydrochloride) | 25 mg | 5516 |
| Cayman2015 | 16079 | TPT-260 (hydrochloride) | 5 mg | 1596 |
| Cayman2015 | 160790 | Caspase-9 Polyclonal Antibody | 1 ea | 4580 |
| Cayman2015 | 16084 | M-144 | 1 mg | 910 |
| Cayman2015 | 16084 | M-144 | 10 mg | 7280 |
| Cayman2015 | 16084 | M-144 | 5 mg | 4102 |
| Cayman2015 | 160840 | VE-Cadherin Polyclonal Antibody | 1 ea | 10880 |
| Cayman2015 | 16086 | CAY10685 | 1 mg | 350 |
| Cayman2015 | 16086 | CAY10685 | 10 mg | 2800 |
| Cayman2015 | 16086 | CAY10685 | 25 mg | 6132 |
| Cayman2015 | 16086 | CAY10685 | 5 mg | 1582 |
| Cayman2015 | 160862 | iNOS Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16087 | Clomiphene (citrate) | 1 g | 350 |
| Cayman2015 | 16087 | Clomiphene (citrate) | 10 g | 1750 |
| Cayman2015 | 16087 | Clomiphene (citrate) | 25 g | 3500 |
| Cayman2015 | 16087 | Clomiphene (citrate) | 5 g | 1316 |
| Cayman2015 | 160870 | nNOS Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16088 | Fibrinogen (human) | 100 mg | 728 |
| Cayman2015 | 16088 | Fibrinogen (human) | 250 mg | 1386 |
| Cayman2015 | 16088 | Fibrinogen (human) | 50 mg | 406 |
| Cayman2015 | 160880 | eNOS Polyclonal Antiserum | 1 ea | 2744 |
| Cayman2015 | 16089 | 4-Methylumbelliferyl Palmitate | 1 g | 3052 |
| Cayman2015 | 16089 | 4-Methylumbelliferyl Palmitate | 100 mg | 826 |
| Cayman2015 | 16089 | 4-Methylumbelliferyl Palmitate | 250 mg | 1442 |
| Cayman2015 | 16089 | 4-Methylumbelliferyl Palmitate | 500 mg | 2268 |
| Cayman2015 | 160895 | Guanylate Cyclase α subunit (soluble) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 160897 | Guanylate Cyclase β1 subunit (soluble) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 160897 | Guanylate Cyclase β1 subunit (soluble) Polyclonal Antibody | 1 Trial | 1568 |
| Cayman2015 | 16090 | 5,15-DPP | 10 mg | 350 |
| Cayman2015 | 16090 | 5,15-DPP | 100 mg | 2716 |
| Cayman2015 | 16090 | 5,15-DPP | 25 mg | 1232 |
| Cayman2015 | 16090 | 5,15-DPP | 50 mg | 2100 |
| Cayman2015 | 16091 | N-?Acetylneuraminic Acid | 1 g | 1050 |
| Cayman2015 | 16091 | N-?Acetylneuraminic Acid | 100 mg | 350 |
| Cayman2015 | 16091 | N-?Acetylneuraminic Acid | 250 mg | 700 |
| Cayman2015 | 16091 | N-?Acetylneuraminic Acid | 5 g | 1750 |
| Cayman2015 | 16092 | Oenin | 1 mg | 1890 |
| Cayman2015 | 16092 | Oenin | 10 mg | 7770 |
| Cayman2015 | 16092 | Oenin | 5 mg | 4522 |
| Cayman2015 | 16092 | Oenin | 500 μg | 1050 |
| Cayman2015 | 16093 | Myrtillin | 1 mg | 2142 |
| Cayman2015 | 16093 | Myrtillin | 10 mg | 8330 |
| Cayman2015 | 16093 | Myrtillin | 5 mg | 5362 |
| Cayman2015 | 16093 | Myrtillin | 500 μg | 1190 |
| Cayman2015 | 16094 | (-)-Apomorphine (hydrochloride) | 10 mg | 490 |
| Cayman2015 | 16094 | (-)-Apomorphine (hydrochloride) | 100 mg | 1960 |
| Cayman2015 | 16094 | (-)-Apomorphine (hydrochloride) | 50 mg | 1078 |
| Cayman2015 | 16096 | Teicoplanin A2-2 | 10 mg | 1204 |
| Cayman2015 | 16096 | Teicoplanin A2-2 | 25 mg | 2044 |
| Cayman2015 | 16096 | Teicoplanin A2-2 | 5 mg | 630 |
| Cayman2015 | 16096 | Teicoplanin A2-2 | 50 mg | 3150 |
| Cayman2015 | 16097 | Hedgehog Antagonist VIII | 1 mg | 1386 |
| Cayman2015 | 16097 | Hedgehog Antagonist VIII | 10 mg | 4130 |
| Cayman2015 | 16097 | Hedgehog Antagonist VIII | 5 mg | 2478 |
| Cayman2015 | 16097 | Hedgehog Antagonist VIII | 500 μg | 826 |
| Cayman2015 | 16098 | DL-Sulforaphane N-acetyl-L-cysteine | 1 mg | 490 |
| Cayman2015 | 16098 | DL-Sulforaphane N-acetyl-L-cysteine | 10 mg | 3920 |
| Cayman2015 | 16098 | DL-Sulforaphane N-acetyl-L-cysteine | 5 mg | 2212 |
| Cayman2015 | 16099 | PD 123319 (trifluoroacetate salt) | 10 mg | 1890 |
| Cayman2015 | 16099 | PD 123319 (trifluoroacetate salt) | 25 mg | 4256 |
| Cayman2015 | 16099 | PD 123319 (trifluoroacetate salt) | 5 mg | 1050 |
| Cayman2015 | 16099 | PD 123319 (trifluoroacetate salt) | 50 mg | 7672 |
| Cayman2015 | 16100 | trans-3'-Hydroxycotinine | 1 mg | 630 |
| Cayman2015 | 16100 | trans-3'-Hydroxycotinine | 10 mg | 3780 |
| Cayman2015 | 16100 | trans-3'-Hydroxycotinine | 5 mg | 2212 |
| Cayman2015 | 16101 | Penta-N-acetylchitopentaose | 1 mg | 532 |
| Cayman2015 | 16101 | Penta-N-acetylchitopentaose | 10 mg | 3192 |
| Cayman2015 | 16101 | Penta-N-acetylchitopentaose | 5 mg | 1750 |
| Cayman2015 | 16102 | GDF11 (human recombinant) | 10 μg | 1610 |
| Cayman2015 | 16102 | GDF11 (human recombinant) | 25 μg | 3360 |
| Cayman2015 | 16102 | GDF11 (human recombinant) | 50 μg | 4830 |
| Cayman2015 | 16103 | Phenylacetone | 10 mg | 350 |
| Cayman2015 | 16103 | Phenylacetone | 100 mg | 1232 |
| Cayman2015 | 16103 | Phenylacetone | 50 mg | 784 |
| Cayman2015 | 16104 | GPR41 (N-Term) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16106 | 5-Octyl D-glutamate | 1 mg | 532 |
| Cayman2015 | 16106 | 5-Octyl D-glutamate | 10 mg | 4256 |
| Cayman2015 | 16106 | 5-Octyl D-glutamate | 5 mg | 2394 |
| Cayman2015 | 16107 | 5-Octyl L-glutamate | 1 mg | 532 |
| Cayman2015 | 16107 | 5-Octyl L-glutamate | 10 mg | 4256 |
| Cayman2015 | 16107 | 5-Octyl L-glutamate | 5 mg | 2394 |
| Cayman2015 | 16108 | ONO-AE3-208 (sodium salt) | 1 mg | 490 |
| Cayman2015 | 16108 | ONO-AE3-208 (sodium salt) | 10 mg | 2450 |
| Cayman2015 | 16108 | ONO-AE3-208 (sodium salt) | 5 mg | 1470 |
| Cayman2015 | 16108 | ONO-AE3-208 (sodium salt) | 50 mg | 10290 |
| Cayman2015 | 16110 | Prostaglandin F2α 1,11-lactone | 1 mg | 980 |
| Cayman2015 | 16110 | Prostaglandin F2α 1,11-lactone | 10 mg | 7840 |
| Cayman2015 | 16110 | Prostaglandin F2α 1,11-lactone | 5 mg | 4410 |
| Cayman2015 | 16111 | 5-Methylcytidine | 100 mg | 1386 |
| Cayman2015 | 16111 | 5-Methylcytidine | 25 mg | 406 |
| Cayman2015 | 16111 | 5-Methylcytidine | 250 mg | 2352 |
| Cayman2015 | 16111 | 5-Methylcytidine | 50 mg | 728 |
| Cayman2015 | 16112 | TIQ-A | 1 mg | 630 |
| Cayman2015 | 16112 | TIQ-A | 10 mg | 4550 |
| Cayman2015 | 16112 | TIQ-A | 5 mg | 2632 |
| Cayman2015 | 16112 | TIQ-A | 500 μg | 350 |
| Cayman2015 | 16113 | Cefoperazone (sodium salt) | 1 g | 546 |
| Cayman2015 | 16113 | Cefoperazone (sodium salt) | 10 g | 3556 |
| Cayman2015 | 16113 | Cefoperazone (sodium salt) | 5 g | 2184 |
| Cayman2015 | 16114 | 5-hydroxy Tryptophol | 10 mg | 602 |
| Cayman2015 | 16114 | 5-hydroxy Tryptophol | 100 mg | 3150 |
| Cayman2015 | 16114 | 5-hydroxy Tryptophol | 25 mg | 1316 |
| Cayman2015 | 16114 | 5-hydroxy Tryptophol | 5 mg | 350 |
| Cayman2015 | 16115 | N-Acetyl-4-benzoquinone imine | 1 mg | 2534 |
| Cayman2015 | 16115 | N-Acetyl-4-benzoquinone imine | 5 mg | 10640 |
| Cayman2015 | 16115 | N-Acetyl-4-benzoquinone imine | 500 μg | 1330 |
| Cayman2015 | 16116 | (±)-Talinolol | 1 mg | 490 |
| Cayman2015 | 16116 | (±)-Talinolol | 10 mg | 3920 |
| Cayman2015 | 16116 | (±)-Talinolol | 5 mg | 2086 |
| Cayman2015 | 16117 | Tris(4,7-diphenyl-1,10-phenanthroline)ruthenium II dichloride complex | 1 mg | 616 |
| Cayman2015 | 16117 | Tris(4,7-diphenyl-1,10-phenanthroline)ruthenium II dichloride complex | 10 mg | 1232 |
| Cayman2015 | 16117 | Tris(4,7-diphenyl-1,10-phenanthroline)ruthenium II dichloride complex | 25 mg | 2002 |
| Cayman2015 | 16117 | Tris(4,7-diphenyl-1,10-phenanthroline)ruthenium II dichloride complex | 5 mg | 924 |
| Cayman2015 | 16118 | Boc-D-FMK | 1 mg | 1386 |
| Cayman2015 | 16118 | Boc-D-FMK | 5 mg | 5096 |
| Cayman2015 | 16118 | Boc-D-FMK | 500 μg | 728 |
| Cayman2015 | 16120 | Prostaglandin F2α 1,15-lactone | 1 mg | 980 |
| Cayman2015 | 16120 | Prostaglandin F2α 1,15-lactone | 10 mg | 7840 |
| Cayman2015 | 16120 | Prostaglandin F2α 1,15-lactone | 5 mg | 4410 |
| Cayman2015 | 16121 | 3-Iodothyronamine (hydrochloride) | 1 mg | 1890 |
| Cayman2015 | 16121 | 3-Iodothyronamine (hydrochloride) | 5 mg | 8190 |
| Cayman2015 | 16121 | 3-Iodothyronamine (hydrochloride) | 500 μg | 1050 |
| Cayman2015 | 16122 | 7-Ethoxyresorufin | 1 mg | 585 |
| Cayman2015 | 16122 | 7-Ethoxyresorufin | 10 mg | 1470 |
| Cayman2015 | 16123 | Coelenterazine | 1 mg | 1092 |
| Cayman2015 | 16123 | Coelenterazine | 5 mg | 5152 |
| Cayman2015 | 16123 | Coelenterazine | 500 μg | 686 |
| Cayman2015 | 16124 | (±)4-Hydroxymephenytoin | 10 mg | 1666 |
| Cayman2015 | 16124 | (±)4-Hydroxymephenytoin | 25 mg | 3864 |
| Cayman2015 | 16124 | (±)4-Hydroxymephenytoin | 5 mg | 1190 |
| Cayman2015 | 16125 | DIDS (sodium salt) | 100 mg | 1078 |
| Cayman2015 | 16125 | DIDS (sodium salt) | 25 mg | 490 |
| Cayman2015 | 16125 | DIDS (sodium salt) | 250 mg | 1722 |
| Cayman2015 | 16125 | DIDS (sodium salt) | 50 mg | 742 |
| Cayman2015 | 16126 | N-Desmethyl-loperamide | 1 mg | 3780 |
| Cayman2015 | 16126 | N-Desmethyl-loperamide | 5 mg | 11340 |
| Cayman2015 | 16126 | N-Desmethyl-loperamide | 500 μg | 2100 |
| Cayman2015 | 16127 | Cefsulodin (sodium salt) | 1 g | 1750 |
| Cayman2015 | 16127 | Cefsulodin (sodium salt) | 100 mg | 350 |
| Cayman2015 | 16127 | Cefsulodin (sodium salt) | 250 mg | 742 |
| Cayman2015 | 16127 | Cefsulodin (sodium salt) | 500 mg | 1316 |
| Cayman2015 | 16128 | Levosimendan | 100 mg | 980 |
| Cayman2015 | 16128 | Levosimendan | 250 mg | 2240 |
| Cayman2015 | 16128 | Levosimendan | 50 mg | 630 |
| Cayman2015 | 16128 | Levosimendan | 500 mg | 4032 |
| Cayman2015 | 16129 | Chlorpromazine (hydrochloride) | 1 g | 490 |
| Cayman2015 | 16129 | Chlorpromazine (hydrochloride) | 25 g | 1232 |
| Cayman2015 | 16129 | Chlorpromazine (hydrochloride) | 5 g | 630 |
| Cayman2015 | 16129 | Chlorpromazine (hydrochloride) | 500 mg | 350 |
| Cayman2015 | 16130 | Prostaglandin F2α 1,9-lactone | 1 mg | 980 |
| Cayman2015 | 16130 | Prostaglandin F2α 1,9-lactone | 10 mg | 7840 |
| Cayman2015 | 16130 | Prostaglandin F2α 1,9-lactone | 5 mg | 4410 |
| Cayman2015 | 16131 | Riimin | 1 g | 1330 |
| Cayman2015 | 16131 | Riimin | 100 mg | 490 |
| Cayman2015 | 16131 | Riimin | 5 g | 4900 |
| Cayman2015 | 16131 | Riimin | 500 mg | 910 |
| Cayman2015 | 16132 | 1-Aminocyclopropanecarboxylic Acid | 1 g | 1470 |
| Cayman2015 | 16132 | 1-Aminocyclopropanecarboxylic Acid | 100 mg | 350 |
| Cayman2015 | 16132 | 1-Aminocyclopropanecarboxylic Acid | 250 mg | 616 |
| Cayman2015 | 16132 | 1-Aminocyclopropanecarboxylic Acid | 500 mg | 784 |
| Cayman2015 | 16133 | Procarbazine (hydrochloride) | 1 g | 2870 |
| Cayman2015 | 16133 | Procarbazine (hydrochloride) | 100 mg | 630 |
| Cayman2015 | 16133 | Procarbazine (hydrochloride) | 50 mg | 350 |
| Cayman2015 | 16133 | Procarbazine (hydrochloride) | 500 mg | 1820 |
| Cayman2015 | 16134 | Clodronate (sodium salt hydrate) | 10 mg | 686 |
| Cayman2015 | 16134 | Clodronate (sodium salt hydrate) | 100 mg | 2030 |
| Cayman2015 | 16134 | Clodronate (sodium salt hydrate) | 5 mg | 406 |
| Cayman2015 | 16134 | Clodronate (sodium salt hydrate) | 50 mg | 1218 |
| Cayman2015 | 16135 | Phentolamine (mesylate) | 1 g | 4900 |
| Cayman2015 | 16135 | Phentolamine (mesylate) | 100 mg | 882 |
| Cayman2015 | 16135 | Phentolamine (mesylate) | 50 mg | 490 |
| Cayman2015 | 16135 | Phentolamine (mesylate) | 500 mg | 3192 |
| Cayman2015 | 16136 | Sotalol (hydrochloride) | 10 mg | 350 |
| Cayman2015 | 16136 | Sotalol (hydrochloride) | 100 mg | 1372 |
| Cayman2015 | 16136 | Sotalol (hydrochloride) | 25 mg | 616 |
| Cayman2015 | 16136 | Sotalol (hydrochloride) | 50 mg | 882 |
| Cayman2015 | 16137 | Isofagomine (D-tartrate) | 1 mg | 1610 |
| Cayman2015 | 16137 | Isofagomine (D-tartrate) | 10 mg | 7252 |
| Cayman2015 | 16137 | Isofagomine (D-tartrate) | 5 mg | 4676 |
| Cayman2015 | 16138 | trans-Clovamide | 10 mg | 1316 |
| Cayman2015 | 16138 | trans-Clovamide | 25 mg | 2310 |
| Cayman2015 | 16138 | trans-Clovamide | 5 mg | 770 |
| Cayman2015 | 16138 | trans-Clovamide | 50 mg | 3626 |
| Cayman2015 | 16139 | Pyronaridine (phosphate) | 100 mg | 1386 |
| Cayman2015 | 16139 | Pyronaridine (phosphate) | 250 mg | 2310 |
| Cayman2015 | 16139 | Pyronaridine (phosphate) | 50 mg | 770 |
| Cayman2015 | 16140 | Kanamycin A | 1 g | 350 |
| Cayman2015 | 16140 | Kanamycin A | 10 g | 1932 |
| Cayman2015 | 16140 | Kanamycin A | 25 g | 3066 |
| Cayman2015 | 16140 | Kanamycin A | 5 g | 1232 |
| Cayman2015 | 16143 | Sinomenine (hydrochloride) | 100 mg | 490 |
| Cayman2015 | 16143 | Sinomenine (hydrochloride) | 50 mg | 350 |
| Cayman2015 | 16143 | Sinomenine (hydrochloride) | 500 mg | 2282 |
| Cayman2015 | 16144 | TTNPB | 1 mg | 490 |
| Cayman2015 | 16144 | TTNPB | 10 mg | 1918 |
| Cayman2015 | 16144 | TTNPB | 5 mg | 1232 |
| Cayman2015 | 16145 | 20-Hydroxyecdysone | 10 mg | 952 |
| Cayman2015 | 16145 | 20-Hydroxyecdysone | 25 mg | 2212 |
| Cayman2015 | 16145 | 20-Hydroxyecdysone | 5 mg | 630 |
| Cayman2015 | 16145 | 20-Hydroxyecdysone | 50 mg | 3598 |
| Cayman2015 | 16146 | 17α,20β-Dihydroxy-4-pregnen-3-one | 1 mg | 490 |
| Cayman2015 | 16146 | 17α,20β-Dihydroxy-4-pregnen-3-one | 10 mg | 2702 |
| Cayman2015 | 16146 | 17α,20β-Dihydroxy-4-pregnen-3-one | 5 mg | 1470 |
| Cayman2015 | 16147 | Coenzyme A | 10 mg | 770 |
| Cayman2015 | 16147 | Coenzyme A | 100 mg | 3080 |
| Cayman2015 | 16147 | Coenzyme A | 25 mg | 1092 |
| Cayman2015 | 16148 | 1-Oxyl-2,2,5,5-tetramethylpyrroline-3-carboxylate NHS ester | 10 mg | 2072 |
| Cayman2015 | 16148 | 1-Oxyl-2,2,5,5-tetramethylpyrroline-3-carboxylate NHS ester | 25 mg | 3556 |
| Cayman2015 | 16148 | 1-Oxyl-2,2,5,5-tetramethylpyrroline-3-carboxylate NHS ester | 5 mg | 1092 |
| Cayman2015 | 16148 | 1-Oxyl-2,2,5,5-tetramethylpyrroline-3-carboxylate NHS ester | 50 mg | 6552 |
| Cayman2015 | 16149 | L-DOPA methyl ester (hydrochloride) | 1 g | 1904 |
| Cayman2015 | 16149 | L-DOPA methyl ester (hydrochloride) | 5 g | 4452 |
| Cayman2015 | 16149 | L-DOPA methyl ester (hydrochloride) | 500 mg | 1190 |
| Cayman2015 | 16150 | 1-(1-Naphthyl) piperazine (hydrochloride) | 100 mg | 2268 |
| Cayman2015 | 16150 | 1-(1-Naphthyl) piperazine (hydrochloride) | 25 mg | 630 |
| Cayman2015 | 16150 | 1-(1-Naphthyl) piperazine (hydrochloride) | 250 mg | 5040 |
| Cayman2015 | 16150 | 1-(1-Naphthyl) piperazine (hydrochloride) | 50 mg | 1204 |
| Cayman2015 | 16151 | O-Phospho-L-Serine | 1 g | 266 |
| Cayman2015 | 16151 | O-Phospho-L-Serine | 10 g | 1330 |
| Cayman2015 | 16151 | O-Phospho-L-Serine | 5 g | 728 |
| Cayman2015 | 16152 | AGK7 | 1 mg | 630 |
| Cayman2015 | 16152 | AGK7 | 10 mg | 2842 |
| Cayman2015 | 16152 | AGK7 | 25 mg | 6300 |
| Cayman2015 | 16152 | AGK7 | 5 mg | 1582 |
| Cayman2015 | 16153 | IQ-1 | 10 mg | 2030 |
| Cayman2015 | 16153 | IQ-1 | 25 mg | 4760 |
| Cayman2015 | 16153 | IQ-1 | 5 mg | 1190 |
| Cayman2015 | 16153 | IQ-1 | 50 mg | 8932 |
| Cayman2015 | 16154 | CH 223191 | 10 mg | 1806 |
| Cayman2015 | 16154 | CH 223191 | 25 mg | 4284 |
| Cayman2015 | 16154 | CH 223191 | 5 mg | 952 |
| Cayman2015 | 16154 | CH 223191 | 50 mg | 7616 |
| Cayman2015 | 16155 | Estradiol 3-(β-D-glucuronide) (sodium salt) | 1 mg | 686 |
| Cayman2015 | 16155 | Estradiol 3-(β-D-glucuronide) (sodium salt) | 10 mg | 4802 |
| Cayman2015 | 16155 | Estradiol 3-(β-D-glucuronide) (sodium salt) | 25 mg | 10290 |
| Cayman2015 | 16155 | Estradiol 3-(β-D-glucuronide) (sodium salt) | 5 mg | 2576 |
| Cayman2015 | 16156 | Estradiol 17-(β-D-glucuronide) (sodium salt) | 10 mg | 1568 |
| Cayman2015 | 16156 | Estradiol 17-(β-D-glucuronide) (sodium salt) | 25 mg | 2898 |
| Cayman2015 | 16156 | Estradiol 17-(β-D-glucuronide) (sodium salt) | 5 mg | 826 |
| Cayman2015 | 16156 | Estradiol 17-(β-D-glucuronide) (sodium salt) | 50 mg | 4550 |
| Cayman2015 | 16157 | Coelenterazine 400a | 1 mg | 1890 |
| Cayman2015 | 16157 | Coelenterazine 400a | 5 mg | 8302 |
| Cayman2015 | 16157 | Coelenterazine 400a | 500 μg | 1050 |
| Cayman2015 | 16158 | Seco Rapamycin (sodium salt) | 1 mg | 1638 |
| Cayman2015 | 16158 | Seco Rapamycin (sodium salt) | 5 mg | 7280 |
| Cayman2015 | 16158 | Seco Rapamycin (sodium salt) | 500 μg | 910 |
| Cayman2015 | 16159 | 5-Methyltetrahydrofolic Acid | 1 mg | 490 |
| Cayman2015 | 16159 | 5-Methyltetrahydrofolic Acid | 10 mg | 3682 |
| Cayman2015 | 16159 | 5-Methyltetrahydrofolic Acid | 5 mg | 2212 |
| Cayman2015 | 16160 | Acetyl Coenzyme A (sodium salt) | 1 mg | 350 |
| Cayman2015 | 16160 | Acetyl Coenzyme A (sodium salt) | 10 mg | 1582 |
| Cayman2015 | 16160 | Acetyl Coenzyme A (sodium salt) | 25 mg | 3500 |
| Cayman2015 | 16160 | Acetyl Coenzyme A (sodium salt) | 5 mg | 882 |
| Cayman2015 | 16161 | PluriSln 1 | 10 mg | 1232 |
| Cayman2015 | 16161 | PluriSln 1 | 25 mg | 2408 |
| Cayman2015 | 16161 | PluriSln 1 | 5 mg | 686 |
| Cayman2015 | 16161 | PluriSln 1 | 50 mg | 3430 |
| Cayman2015 | 16162 | LY411575 | 1 mg | 350 |
| Cayman2015 | 16162 | LY411575 | 10 mg | 2100 |
| Cayman2015 | 16162 | LY411575 | 25 mg | 4732 |
| Cayman2015 | 16162 | LY411575 | 5 mg | 1106 |
| Cayman2015 | 16163 | KP372-1 | 1 mg | 350 |
| Cayman2015 | 16163 | KP372-1 | 10 mg | 1932 |
| Cayman2015 | 16163 | KP372-1 | 25 mg | 3934 |
| Cayman2015 | 16163 | KP372-1 | 5 mg | 1050 |
| Cayman2015 | 16164 | GSA 10 | 10 mg | 2268 |
| Cayman2015 | 16164 | GSA 10 | 5 mg | 1190 |
| Cayman2015 | 16164 | GSA 10 | 50 mg | 9520 |
| Cayman2015 | 16165 | ISX-9 | 1 mg | 350 |
| Cayman2015 | 16165 | ISX-9 | 10 mg | 1750 |
| Cayman2015 | 16165 | ISX-9 | 25 mg | 3934 |
| Cayman2015 | 16165 | ISX-9 | 5 mg | 1050 |
| Cayman2015 | 16166 | 5-Methyl-2'-deoxycytidine | 1 g | 938 |
| Cayman2015 | 16166 | 5-Methyl-2'-deoxycytidine | 5 g | 3920 |
| Cayman2015 | 16166 | 5-Methyl-2'-deoxycytidine | 500 mg | 490 |
| Cayman2015 | 16167 | Ochratoxin B | 1 mg | 2268 |
| Cayman2015 | 16167 | Ochratoxin B | 5 mg | 6552 |
| Cayman2015 | 16167 | Ochratoxin B | 500 μg | 1190 |
| Cayman2015 | 16168 | MAZ51 | 1 mg | 630 |
| Cayman2015 | 16168 | MAZ51 | 10 mg | 3024 |
| Cayman2015 | 16168 | MAZ51 | 25 mg | 6300 |
| Cayman2015 | 16168 | MAZ51 | 5 mg | 1890 |
| Cayman2015 | 16169 | 2-Hydroxypropyl-β-cyclodextrin | 1 g | 350 |
| Cayman2015 | 16169 | 2-Hydroxypropyl-β-cyclodextrin | 10 g | 882 |
| Cayman2015 | 16169 | 2-Hydroxypropyl-β-cyclodextrin | 25 g | 1316 |
| Cayman2015 | 16169 | 2-Hydroxypropyl-β-cyclodextrin | 5 g | 532 |
| Cayman2015 | 16172 | Citrulline-specific Probe | 1 mg | 6230 |
| Cayman2015 | 16172 | Citrulline-specific Probe | 250 μg | 1946 |
| Cayman2015 | 16172 | Citrulline-specific Probe | 500 μg | 3500 |
| Cayman2015 | 16175 | EPZ5676 | 1 mg | 686 |
| Cayman2015 | 16175 | EPZ5676 | 10 mg | 3430 |
| Cayman2015 | 16175 | EPZ5676 | 25 mg | 6860 |
| Cayman2015 | 16175 | EPZ5676 | 5 mg | 2058 |
| Cayman2015 | 16176 | GGTI 298 (trifluoroacetate salt) | 1 mg | 2100 |
| Cayman2015 | 16176 | GGTI 298 (trifluoroacetate salt) | 5 mg | 9408 |
| Cayman2015 | 16176 | GGTI 298 (trifluoroacetate salt) | 500 μg | 1190 |
| Cayman2015 | 16177 | NU 6027 | 1 mg | 350 |
| Cayman2015 | 16177 | NU 6027 | 10 mg | 1582 |
| Cayman2015 | 16177 | NU 6027 | 5 mg | 966 |
| Cayman2015 | 16177 | NU 6027 | 50 mg | 6132 |
| Cayman2015 | 16178 | WHI-P154 | 10 mg | 1456 |
| Cayman2015 | 16178 | WHI-P154 | 25 mg | 3416 |
| Cayman2015 | 16178 | WHI-P154 | 5 mg | 910 |
| Cayman2015 | 16179 | Pyrintegrin | 1 mg | 910 |
| Cayman2015 | 16179 | Pyrintegrin | 10 mg | 3458 |
| Cayman2015 | 16179 | Pyrintegrin | 5 mg | 2464 |
| Cayman2015 | 16181 | WWL113 | 1 mg | 826 |
| Cayman2015 | 16181 | WWL113 | 10 mg | 4130 |
| Cayman2015 | 16181 | WWL113 | 5 mg | 2268 |
| Cayman2015 | 16182 | WWL229 | 1 mg | 826 |
| Cayman2015 | 16182 | WWL229 | 10 mg | 4130 |
| Cayman2015 | 16182 | WWL229 | 5 mg | 2268 |
| Cayman2015 | 16200 | MDMB-CHMINACA | 1 mg | 910 |
| Cayman2015 | 16200 | MDMB-CHMINACA | 10 mg | 7280 |
| Cayman2015 | 16200 | MDMB-CHMINACA | 5 mg | 4102 |
| Cayman2015 | 16201 | PX 1 | 1 mg | 910 |
| Cayman2015 | 16201 | PX 1 | 10 mg | 7280 |
| Cayman2015 | 16201 | PX 1 | 5 mg | 4102 |
| Cayman2015 | 16203 | Cannabidiol-d9 | 1 mg | 1736 |
| Cayman2015 | 16203 | Cannabidiol-d9 | 500 μg | 910 |
| Cayman2015 | 16205 | Δ8-THC-d9 | 1 mg | 2940 |
| Cayman2015 | 16205 | Δ8-THC-d9 | 100 μg | 490 |
| Cayman2015 | 16205 | Δ8-THC-d9 | 500 μg | 2212 |
| Cayman2015 | 16206 | Δ9-THC-d9 | 1 mg | 2940 |
| Cayman2015 | 16206 | Δ9-THC-d9 | 100 μg | 490 |
| Cayman2015 | 16206 | Δ9-THC-d9 | 500 μg | 2212 |
| Cayman2015 | 16207 | Ingenol-3-angelate | 1 mg | 1736 |
| Cayman2015 | 16207 | Ingenol-3-angelate | 10 mg | 9100 |
| Cayman2015 | 16207 | Ingenol-3-angelate | 5 mg | 6370 |
| Cayman2015 | 16207 | Ingenol-3-angelate | 500 μg | 910 |
| Cayman2015 | 16208 | Hydroxy Dimetridazole | 1 g | 1302 |
| Cayman2015 | 16208 | Hydroxy Dimetridazole | 5 g | 4802 |
| Cayman2015 | 16208 | Hydroxy Dimetridazole | 500 mg | 686 |
| Cayman2015 | 16209 | p-nitro-Pifithrin-α | 1 mg | 490 |
| Cayman2015 | 16209 | p-nitro-Pifithrin-α | 10 mg | 2450 |
| Cayman2015 | 16209 | p-nitro-Pifithrin-α | 25 mg | 5516 |
| Cayman2015 | 16209 | p-nitro-Pifithrin-α | 5 mg | 1344 |
| Cayman2015 | 16210 | 5-trans Prostaglandin F2α | 1 mg | 714 |
| Cayman2015 | 16210 | 5-trans Prostaglandin F2α | 10 mg | 5712 |
| Cayman2015 | 16210 | 5-trans Prostaglandin F2α | 5 mg | 3220 |
| Cayman2015 | 16211 | Phenoxybenzamine (hydrochloride) | 1 g | 490 |
| Cayman2015 | 16211 | Phenoxybenzamine (hydrochloride) | 10 g | 3920 |
| Cayman2015 | 16211 | Phenoxybenzamine (hydrochloride) | 25 g | 4900 |
| Cayman2015 | 16211 | Phenoxybenzamine (hydrochloride) | 5 g | 2212 |
| Cayman2015 | 16213 | Chlorthalidone | 10 mg | 770 |
| Cayman2015 | 16213 | Chlorthalidone | 25 mg | 1834 |
| Cayman2015 | 16213 | Chlorthalidone | 5 mg | 406 |
| Cayman2015 | 16213 | Chlorthalidone | 50 mg | 3248 |
| Cayman2015 | 16214 | Benztropine (mesylate) | 1 g | 266 |
| Cayman2015 | 16214 | Benztropine (mesylate) | 10 g | 1330 |
| Cayman2015 | 16214 | Benztropine (mesylate) | 25 g | 2996 |
| Cayman2015 | 16214 | Benztropine (mesylate) | 5 g | 714 |
| Cayman2015 | 16215 | Taurocholic Acid (sodium salt) | 1 g | 350 |
| Cayman2015 | 16215 | Taurocholic Acid (sodium salt) | 10 g | 2282 |
| Cayman2015 | 16215 | Taurocholic Acid (sodium salt) | 25 g | 4816 |
| Cayman2015 | 16215 | Taurocholic Acid (sodium salt) | 5 g | 1316 |
| Cayman2015 | 162150 | DYKDDDDK Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16216 | Juglone | 1 g | 490 |
| Cayman2015 | 16216 | Juglone | 500 mg | 350 |
| Cayman2015 | 16217 | Guanethidine (sulfate) | 1 g | 2772 |
| Cayman2015 | 16217 | Guanethidine (sulfate) | 100 mg | 630 |
| Cayman2015 | 16217 | Guanethidine (sulfate) | 500 mg | 1736 |
| Cayman2015 | 16218 | 2'-Deoxyadenosine-5'-monophosphate | 1 g | 560 |
| Cayman2015 | 16218 | 2'-Deoxyadenosine-5'-monophosphate | 5 g | 1932 |
| Cayman2015 | 16218 | 2'-Deoxyadenosine-5'-monophosphate | 500 mg | 350 |
| Cayman2015 | 16219 | Uric Acid (sodium salt) | 2 mg | 1185 |
| Cayman2015 | 16220 | 5-trans Prostaglandin F2α (tromethamine salt) | 1 mg | 406 |
| Cayman2015 | 16220 | 5-trans Prostaglandin F2α (tromethamine salt) | 10 mg | 3248 |
| Cayman2015 | 16220 | 5-trans Prostaglandin F2α (tromethamine salt) | 5 mg | 1834 |
| Cayman2015 | 162200 | HA Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16221 | Calcein | 1 g | 350 |
| Cayman2015 | 16221 | Calcein | 10 g | 1050 |
| Cayman2015 | 16221 | Calcein | 25 g | 1932 |
| Cayman2015 | 16221 | Calcein | 5 g | 616 |
| Cayman2015 | 16222 | Pimozide | 100 mg | 630 |
| Cayman2015 | 16222 | Pimozide | 250 mg | 1386 |
| Cayman2015 | 16222 | Pimozide | 50 mg | 350 |
| Cayman2015 | 16223 | L-Leucine 4-methoxy-β-naphthylamide (hydrochloride) | 1 g | 6048 |
| Cayman2015 | 16223 | L-Leucine 4-methoxy-β-naphthylamide (hydrochloride) | 100 mg | 756 |
| Cayman2015 | 16223 | L-Leucine 4-methoxy-β-naphthylamide (hydrochloride) | 250 mg | 1792 |
| Cayman2015 | 16224 | α-Phenyl-α-(2-pyridyl)acetonitrile | 1 g | 1750 |
| Cayman2015 | 16224 | α-Phenyl-α-(2-pyridyl)acetonitrile | 100 mg | 630 |
| Cayman2015 | 16224 | α-Phenyl-α-(2-pyridyl)acetonitrile | 50 mg | 350 |
| Cayman2015 | 16224 | α-Phenyl-α-(2-pyridyl)acetonitrile | 500 mg | 1050 |
| Cayman2015 | 16225 | 7,8,9,10-Tetrahydrobenzo[a]pyren-7-ol | 1 g | 1750 |
| Cayman2015 | 16225 | 7,8,9,10-Tetrahydrobenzo[a]pyren-7-ol | 250 mg | 546 |
| Cayman2015 | 16225 | 7,8,9,10-Tetrahydrobenzo[a]pyren-7-ol | 500 mg | 1036 |
| Cayman2015 | 16226 | NQDI-1 | 1 mg | 350 |
| Cayman2015 | 16226 | NQDI-1 | 10 mg | 1932 |
| Cayman2015 | 16226 | NQDI-1 | 25 mg | 4382 |
| Cayman2015 | 16226 | NQDI-1 | 5 mg | 1050 |
| Cayman2015 | 16227 | Nourseothricin (sulfate) | 1 mg | 350 |
| Cayman2015 | 16227 | Nourseothricin (sulfate) | 10 mg | 1232 |
| Cayman2015 | 16227 | Nourseothricin (sulfate) | 5 mg | 700 |
| Cayman2015 | 16227 | Nourseothricin (sulfate) | 50 mg | 5250 |
| Cayman2015 | 16228 | trans-Urocanic Acid | 1 g | 350 |
| Cayman2015 | 16228 | trans-Urocanic Acid | 5 g | 882 |
| Cayman2015 | 16230 | iPF2α-IV | 100 μg | 5488 |
| Cayman2015 | 16230 | iPF2α-IV | 25 μg | 1526 |
| Cayman2015 | 16230 | iPF2α-IV | 50 μg | 2898 |
| Cayman2015 | 16231 | AT-7519 (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 16231 | AT-7519 (hydrochloride) | 10 mg | 1932 |
| Cayman2015 | 16231 | AT-7519 (hydrochloride) | 25 mg | 4382 |
| Cayman2015 | 16231 | AT-7519 (hydrochloride) | 5 mg | 1316 |
| Cayman2015 | 16233 | ABT-199 | 1 mg | 1190 |
| Cayman2015 | 16233 | ABT-199 | 10 mg | 5950 |
| Cayman2015 | 16233 | ABT-199 | 25 mg | 11900 |
| Cayman2015 | 16233 | ABT-199 | 5 mg | 3150 |
| Cayman2015 | 16234 | ATB-346 | 1 mg | 686 |
| Cayman2015 | 16234 | ATB-346 | 10 mg | 3430 |
| Cayman2015 | 16234 | ATB-346 | 25 mg | 6860 |
| Cayman2015 | 16234 | ATB-346 | 5 mg | 2058 |
| Cayman2015 | 16235 | AWD 131-138 | 10 mg | 2268 |
| Cayman2015 | 16235 | AWD 131-138 | 25 mg | 5362 |
| Cayman2015 | 16235 | AWD 131-138 | 5 mg | 1190 |
| Cayman2015 | 16235 | AWD 131-138 | 50 mg | 9520 |
| Cayman2015 | 16237 | AZD 9291 | 1 mg | 350 |
| Cayman2015 | 16237 | AZD 9291 | 10 mg | 1750 |
| Cayman2015 | 16237 | AZD 9291 | 5 mg | 1316 |
| Cayman2015 | 16238 | BIX02188 | 1 mg | 490 |
| Cayman2015 | 16238 | BIX02188 | 10 mg | 3192 |
| Cayman2015 | 16238 | BIX02188 | 25 mg | 6734 |
| Cayman2015 | 16238 | BIX02188 | 5 mg | 1834 |
| Cayman2015 | 16239 | BMS 303141 | 10 mg | 2002 |
| Cayman2015 | 16239 | BMS 303141 | 25 mg | 4466 |
| Cayman2015 | 16239 | BMS 303141 | 5 mg | 1050 |
| Cayman2015 | 16239 | BMS 303141 | 50 mg | 8400 |
| Cayman2015 | 16240 | BMS 833923 | 10 mg | 1232 |
| Cayman2015 | 16240 | BMS 833923 | 25 mg | 2226 |
| Cayman2015 | 16240 | BMS 833923 | 5 mg | 686 |
| Cayman2015 | 16240 | BMS 833923 | 50 mg | 3640 |
| Cayman2015 | 16242 | CGK733 | 1 mg | 490 |
| Cayman2015 | 16242 | CGK733 | 10 mg | 1722 |
| Cayman2015 | 16242 | CGK733 | 5 mg | 1106 |
| Cayman2015 | 16242 | CGK733 | 50 mg | 6132 |
| Cayman2015 | 16243 | CK 636 | 10 mg | 1302 |
| Cayman2015 | 16243 | CK 636 | 25 mg | 3094 |
| Cayman2015 | 16243 | CK 636 | 5 mg | 686 |
| Cayman2015 | 16244 | CO 1686 | 1 mg | 770 |
| Cayman2015 | 16244 | CO 1686 | 10 mg | 3850 |
| Cayman2015 | 16244 | CO 1686 | 5 mg | 2310 |
| Cayman2015 | 16245 | CX-6258 | 1 mg | 546 |
| Cayman2015 | 16245 | CX-6258 | 10 mg | 2184 |
| Cayman2015 | 16245 | CX-6258 | 25 mg | 4102 |
| Cayman2015 | 16245 | CX-6258 | 5 mg | 1372 |
| Cayman2015 | 16246 | CYT 387 | 1 mg | 910 |
| Cayman2015 | 16246 | CYT 387 | 10 mg | 2100 |
| Cayman2015 | 16246 | CYT 387 | 5 mg | 1372 |
| Cayman2015 | 16246 | CYT 387 | 50 mg | 5922 |
| Cayman2015 | 16247 | Dapivirine | 1 mg | 490 |
| Cayman2015 | 16247 | Dapivirine | 10 mg | 3192 |
| Cayman2015 | 16247 | Dapivirine | 25 mg | 6132 |
| Cayman2015 | 16247 | Dapivirine | 5 mg | 1960 |
| Cayman2015 | 16249 | Foretinib | 1 mg | 1050 |
| Cayman2015 | 16249 | Foretinib | 10 mg | 3682 |
| Cayman2015 | 16249 | Foretinib | 25 mg | 6566 |
| Cayman2015 | 16249 | Foretinib | 5 mg | 2100 |
| Cayman2015 | 16250 | 5-trans Prostaglandin F2β | 1 mg | 1120 |
| Cayman2015 | 16250 | 5-trans Prostaglandin F2β | 10 mg | 8960 |
| Cayman2015 | 16250 | 5-trans Prostaglandin F2β | 5 mg | 5040 |
| Cayman2015 | 16252 | GNE 7915 | 10 mg | 1736 |
| Cayman2015 | 16252 | GNE 7915 | 5 mg | 910 |
| Cayman2015 | 16252 | GNE 7915 | 50 mg | 6370 |
| Cayman2015 | 16253 | GNF 2 | 1 mg | 1050 |
| Cayman2015 | 16253 | GNF 2 | 10 mg | 2632 |
| Cayman2015 | 16253 | GNF 2 | 5 mg | 1834 |
| Cayman2015 | 16253 | GNF 2 | 50 mg | 7350 |
| Cayman2015 | 16254 | GNF 5 | 10 mg | 672 |
| Cayman2015 | 16254 | GNF 5 | 25 mg | 1316 |
| Cayman2015 | 16254 | GNF 5 | 5 mg | 350 |
| Cayman2015 | 16254 | GNF 5 | 50 mg | 2450 |
| Cayman2015 | 16255 | GW 788388 | 1 mg | 630 |
| Cayman2015 | 16255 | GW 788388 | 10 mg | 1890 |
| Cayman2015 | 16255 | GW 788388 | 25 mg | 3626 |
| Cayman2015 | 16255 | GW 788388 | 5 mg | 1162 |
| Cayman2015 | 16256 | HPGDS Inhibitor I | 1 mg | 1330 |
| Cayman2015 | 16256 | HPGDS Inhibitor I | 10 mg | 5992 |
| Cayman2015 | 16256 | HPGDS Inhibitor I | 5 mg | 3332 |
| Cayman2015 | 16257 | ICG-001 | 1 mg | 770 |
| Cayman2015 | 16257 | ICG-001 | 10 mg | 2464 |
| Cayman2015 | 16257 | ICG-001 | 25 mg | 5586 |
| Cayman2015 | 16257 | ICG-001 | 5 mg | 1540 |
| Cayman2015 | 16258 | ISRIB | 10 mg | 1736 |
| Cayman2015 | 16258 | ISRIB | 25 mg | 4102 |
| Cayman2015 | 16258 | ISRIB | 5 mg | 910 |
| Cayman2015 | 16260 | JW 55 | 10 mg | 1302 |
| Cayman2015 | 16260 | JW 55 | 25 mg | 2058 |
| Cayman2015 | 16260 | JW 55 | 5 mg | 686 |
| Cayman2015 | 16260 | JW 55 | 50 mg | 3780 |
| Cayman2015 | 16261 | Kobe 0065 | 1 mg | 406 |
| Cayman2015 | 16261 | Kobe 0065 | 10 mg | 1834 |
| Cayman2015 | 16261 | Kobe 0065 | 25 mg | 4060 |
| Cayman2015 | 16261 | Kobe 0065 | 5 mg | 1022 |
| Cayman2015 | 16262 | Kobe 2602 | 10 mg | 350 |
| Cayman2015 | 16262 | Kobe 2602 | 100 mg | 1750 |
| Cayman2015 | 16262 | Kobe 2602 | 50 mg | 1050 |
| Cayman2015 | 16262 | Kobe 2602 | 500 mg | 6132 |
| Cayman2015 | 16263 | LDE225 (phosphate) | 1 mg | 490 |
| Cayman2015 | 16263 | LDE225 (phosphate) | 10 mg | 3682 |
| Cayman2015 | 16263 | LDE225 (phosphate) | 25 mg | 6132 |
| Cayman2015 | 16263 | LDE225 (phosphate) | 5 mg | 1960 |
| Cayman2015 | 16264 | LY2940680 | 1 mg | 770 |
| Cayman2015 | 16264 | LY2940680 | 10 mg | 5012 |
| Cayman2015 | 16264 | LY2940680 | 5 mg | 3472 |
| Cayman2015 | 16265 | MC 1568 | 1 mg | 350 |
| Cayman2015 | 16265 | MC 1568 | 10 mg | 1582 |
| Cayman2015 | 16265 | MC 1568 | 25 mg | 3500 |
| Cayman2015 | 16265 | MC 1568 | 5 mg | 1134 |
| Cayman2015 | 16266 | MDL 29951 | 1 mg | 1232 |
| Cayman2015 | 16266 | MDL 29951 | 10 mg | 4872 |
| Cayman2015 | 16266 | MDL 29951 | 5 mg | 2744 |
| Cayman2015 | 16266 | MDL 29951 | 500 μg | 686 |
| Cayman2015 | 16267 | Monomethylauristatin E | 1 mg | 1736 |
| Cayman2015 | 16267 | Monomethylauristatin E | 10 mg | 6370 |
| Cayman2015 | 16267 | Monomethylauristatin E | 5 mg | 4102 |
| Cayman2015 | 16267 | Monomethylauristatin E | 500 μg | 910 |
| Cayman2015 | 16268 | NSI-189 | 1 mg | 490 |
| Cayman2015 | 16268 | NSI-189 | 10 mg | 3920 |
| Cayman2015 | 16268 | NSI-189 | 5 mg | 2212 |
| Cayman2015 | 16269 | ONX 0912 | 1 mg | 686 |
| Cayman2015 | 16269 | ONX 0912 | 10 mg | 3430 |
| Cayman2015 | 16269 | ONX 0912 | 5 mg | 1890 |
| Cayman2015 | 16271 | ONX 0914 | 1 mg | 686 |
| Cayman2015 | 16271 | ONX 0914 | 10 mg | 3094 |
| Cayman2015 | 16271 | ONX 0914 | 25 mg | 6006 |
| Cayman2015 | 16271 | ONX 0914 | 5 mg | 1890 |
| Cayman2015 | 16272 | PBIT | 1 mg | 406 |
| Cayman2015 | 16272 | PBIT | 10 mg | 1834 |
| Cayman2015 | 16272 | PBIT | 25 mg | 4060 |
| Cayman2015 | 16272 | PBIT | 5 mg | 1022 |
| Cayman2015 | 16273 | PD 0332991 | 1 mg | 350 |
| Cayman2015 | 16273 | PD 0332991 | 10 mg | 1932 |
| Cayman2015 | 16273 | PD 0332991 | 25 mg | 3500 |
| Cayman2015 | 16273 | PD 0332991 | 5 mg | 1050 |
| Cayman2015 | 16274 | Ibrutinib | 1 mg | 686 |
| Cayman2015 | 16274 | Ibrutinib | 10 mg | 4116 |
| Cayman2015 | 16274 | Ibrutinib | 5 mg | 2226 |
| Cayman2015 | 16274 | Ibrutinib | 50 mg | 13384 |
| Cayman2015 | 16275 | PPQ-102 | 10 mg | 1946 |
| Cayman2015 | 16275 | PPQ-102 | 5 mg | 1022 |
| Cayman2015 | 16275 | PPQ-102 | 50 mg | 8176 |
| Cayman2015 | 16276 | PR-619 | 10 mg | 1078 |
| Cayman2015 | 16276 | PR-619 | 25 mg | 1540 |
| Cayman2015 | 16276 | PR-619 | 5 mg | 630 |
| Cayman2015 | 16276 | PR-619 | 50 mg | 2772 |
| Cayman2015 | 16277 | PTC-209 | 1 mg | 350 |
| Cayman2015 | 16277 | PTC-209 | 10 mg | 2450 |
| Cayman2015 | 16277 | PTC-209 | 5 mg | 1582 |
| Cayman2015 | 16277 | PTC-209 | 50 mg | 11382 |
| Cayman2015 | 16278 | RKI-1447 | 10 mg | 1736 |
| Cayman2015 | 16278 | RKI-1447 | 5 mg | 910 |
| Cayman2015 | 16278 | RKI-1447 | 50 mg | 7280 |
| Cayman2015 | 16279 | S1RA | 1 mg | 1736 |
| Cayman2015 | 16279 | S1RA | 10 mg | 8190 |
| Cayman2015 | 16279 | S1RA | 5 mg | 5012 |
| Cayman2015 | 16279 | S1RA | 500 μg | 910 |
| Cayman2015 | 16281 | SB 525334 | 1 mg | 350 |
| Cayman2015 | 16281 | SB 525334 | 10 mg | 1582 |
| Cayman2015 | 16281 | SB 525334 | 5 mg | 882 |
| Cayman2015 | 16281 | SB 525334 | 50 mg | 6132 |
| Cayman2015 | 16284 | SRPIN340 | 1 mg | 350 |
| Cayman2015 | 16284 | SRPIN340 | 10 mg | 1750 |
| Cayman2015 | 16284 | SRPIN340 | 25 mg | 3850 |
| Cayman2015 | 16284 | SRPIN340 | 5 mg | 966 |
| Cayman2015 | 16285 | TAK-632 | 1 mg | 350 |
| Cayman2015 | 16285 | TAK-632 | 10 mg | 1316 |
| Cayman2015 | 16285 | TAK-632 | 5 mg | 1932 |
| Cayman2015 | 16285 | TAK-632 | 50 mg | 8750 |
| Cayman2015 | 16286 | TCS PIM-1 1 | 10 mg | 1764 |
| Cayman2015 | 16286 | TCS PIM-1 1 | 100 mg | 7742 |
| Cayman2015 | 16286 | TCS PIM-1 1 | 5 mg | 1106 |
| Cayman2015 | 16286 | TCS PIM-1 1 | 50 mg | 4144 |
| Cayman2015 | 16287 | TDZD-8 | 1 mg | 350 |
| Cayman2015 | 16287 | TDZD-8 | 10 mg | 1232 |
| Cayman2015 | 16287 | TDZD-8 | 25 mg | 2632 |
| Cayman2015 | 16287 | TDZD-8 | 5 mg | 700 |
| Cayman2015 | 16288 | Tenovin-3 | 1 mg | 2100 |
| Cayman2015 | 16288 | Tenovin-3 | 10 mg | 10836 |
| Cayman2015 | 16288 | Tenovin-3 | 5 mg | 6090 |
| Cayman2015 | 16288 | Tenovin-3 | 500 μg | 1106 |
| Cayman2015 | 16289 | TG101348 | 1 mg | 630 |
| Cayman2015 | 16289 | TG101348 | 10 mg | 2142 |
| Cayman2015 | 16289 | TG101348 | 25 mg | 4886 |
| Cayman2015 | 16289 | TG101348 | 5 mg | 1330 |
| Cayman2015 | 16290 | 2,3-dinor-8-iso Prostaglandin F2α | 1 mg | 23912 |
| Cayman2015 | 16290 | 2,3-dinor-8-iso Prostaglandin F2α | 100 μg | 3080 |
| Cayman2015 | 16290 | 2,3-dinor-8-iso Prostaglandin F2α | 25 μg | 854 |
| Cayman2015 | 16290 | 2,3-dinor-8-iso Prostaglandin F2α | 50 μg | 1624 |
| Cayman2015 | 16291 | TGR5 Receptor Agonist | 1 mg | 350 |
| Cayman2015 | 16291 | TGR5 Receptor Agonist | 10 mg | 2282 |
| Cayman2015 | 16291 | TGR5 Receptor Agonist | 5 mg | 1582 |
| Cayman2015 | 16292 | Trametinib | 1 mg | 350 |
| Cayman2015 | 16292 | Trametinib | 10 mg | 2632 |
| Cayman2015 | 16292 | Trametinib | 5 mg | 1484 |
| Cayman2015 | 16292 | Trametinib | 50 mg | 8750 |
| Cayman2015 | 16293 | GIT 27 | 10 mg | 1232 |
| Cayman2015 | 16293 | GIT 27 | 25 mg | 2744 |
| Cayman2015 | 16293 | GIT 27 | 5 mg | 686 |
| Cayman2015 | 16293 | GIT 27 | 50 mg | 4802 |
| Cayman2015 | 16294 | VS-5584 | 1 mg | 350 |
| Cayman2015 | 16294 | VS-5584 | 10 mg | 2632 |
| Cayman2015 | 16294 | VS-5584 | 5 mg | 1582 |
| Cayman2015 | 16296 | VU0364439 | 1 mg | 350 |
| Cayman2015 | 16296 | VU0364439 | 10 mg | 1932 |
| Cayman2015 | 16296 | VU0364439 | 5 mg | 1232 |
| Cayman2015 | 16296 | VU0364439 | 50 mg | 6132 |
| Cayman2015 | 16297 | WZ4002 | 10 mg | 1610 |
| Cayman2015 | 16297 | WZ4002 | 100 mg | 7168 |
| Cayman2015 | 16297 | WZ4002 | 5 mg | 896 |
| Cayman2015 | 16297 | WZ4002 | 50 mg | 3808 |
| Cayman2015 | 16298 | XL 019 | 1 mg | 1050 |
| Cayman2015 | 16298 | XL 019 | 10 mg | 6832 |
| Cayman2015 | 16298 | XL 019 | 25 mg | 13132 |
| Cayman2015 | 16298 | XL 019 | 5 mg | 3934 |
| Cayman2015 | 16299 | XL 765 | 1 mg | 490 |
| Cayman2015 | 16299 | XL 765 | 10 mg | 4172 |
| Cayman2015 | 16299 | XL 765 | 5 mg | 2212 |
| Cayman2015 | 16299 | XL 765 | 50 mg | 13482 |
| Cayman2015 | 16300 | 5-iPF2α-VI | 10 μg | 644 |
| Cayman2015 | 16300 | 5-iPF2α-VI | 100 μg | 5152 |
| Cayman2015 | 16300 | 5-iPF2α-VI | 25 μg | 1526 |
| Cayman2015 | 16300 | 5-iPF2α-VI | 50 μg | 2898 |
| Cayman2015 | 16309 | XL888 | 1 mg | 546 |
| Cayman2015 | 16309 | XL888 | 10 mg | 3822 |
| Cayman2015 | 16309 | XL888 | 25 mg | 6832 |
| Cayman2015 | 16309 | XL888 | 5 mg | 2464 |
| Cayman2015 | 16314 | Y320 | 1 mg | 490 |
| Cayman2015 | 16314 | Y320 | 10 mg | 2940 |
| Cayman2015 | 16314 | Y320 | 25 mg | 6132 |
| Cayman2015 | 16314 | Y320 | 5 mg | 1722 |
| Cayman2015 | 16331 | Ezetimibe | 100 mg | 2310 |
| Cayman2015 | 16331 | Ezetimibe | 25 mg | 826 |
| Cayman2015 | 16331 | Ezetimibe | 250 mg | 5376 |
| Cayman2015 | 16331 | Ezetimibe | 50 mg | 1246 |
| Cayman2015 | 16332 | O6-Benzylguanine | 1 g | 8050 |
| Cayman2015 | 16332 | O6-Benzylguanine | 10 mg | 350 |
| Cayman2015 | 16332 | O6-Benzylguanine | 250 mg | 2632 |
| Cayman2015 | 16332 | O6-Benzylguanine | 50 mg | 616 |
| Cayman2015 | 16333 | β-Nicotyrine | 1 mg | 966 |
| Cayman2015 | 16333 | β-Nicotyrine | 10 mg | 3290 |
| Cayman2015 | 16333 | β-Nicotyrine | 25 mg | 5558 |
| Cayman2015 | 16333 | β-Nicotyrine | 5 mg | 1932 |
| Cayman2015 | 16335 | Cyclothiazide | 10 mg | 490 |
| Cayman2015 | 16335 | Cyclothiazide | 100 mg | 3920 |
| Cayman2015 | 16335 | Cyclothiazide | 25 mg | 1162 |
| Cayman2015 | 16335 | Cyclothiazide | 50 mg | 2212 |
| Cayman2015 | 16336 | Ku-55933 | 1 mg | 630 |
| Cayman2015 | 16336 | Ku-55933 | 10 mg | 1582 |
| Cayman2015 | 16336 | Ku-55933 | 5 mg | 910 |
| Cayman2015 | 16336 | Ku-55933 | 50 mg | 4732 |
| Cayman2015 | 16337 | SB-3CT | 1 mg | 686 |
| Cayman2015 | 16337 | SB-3CT | 5 mg | 3052 |
| Cayman2015 | 16337 | SB-3CT | 500 μg | 406 |
| Cayman2015 | 16339 | 7-keto Cholesterol | 10 mg | 1204 |
| Cayman2015 | 16339 | 7-keto Cholesterol | 100 mg | 8190 |
| Cayman2015 | 16339 | 7-keto Cholesterol | 5 mg | 630 |
| Cayman2015 | 16339 | 7-keto Cholesterol | 50 mg | 4732 |
| Cayman2015 | 16343 | Pregnenolone Carbonitrile | 100 mg | 1302 |
| Cayman2015 | 16343 | Pregnenolone Carbonitrile | 25 mg | 406 |
| Cayman2015 | 16343 | Pregnenolone Carbonitrile | 250 mg | 2646 |
| Cayman2015 | 16343 | Pregnenolone Carbonitrile | 50 mg | 686 |
| Cayman2015 | 16347 | 3-deoxy Glucosone | 1 mg | 686 |
| Cayman2015 | 16347 | 3-deoxy Glucosone | 10 mg | 4466 |
| Cayman2015 | 16347 | 3-deoxy Glucosone | 5 mg | 2576 |
| Cayman2015 | 16348 | DNA Base Excision Repair Pathway Inhibitor | 10 mg | 490 |
| Cayman2015 | 16348 | DNA Base Excision Repair Pathway Inhibitor | 100 mg | 1470 |
| Cayman2015 | 16348 | DNA Base Excision Repair Pathway Inhibitor | 25 mg | 770 |
| Cayman2015 | 16348 | DNA Base Excision Repair Pathway Inhibitor | 50 mg | 1106 |
| Cayman2015 | 16349 | PNU 74654 | 1 mg | 406 |
| Cayman2015 | 16349 | PNU 74654 | 10 mg | 1302 |
| Cayman2015 | 16349 | PNU 74654 | 5 mg | 756 |
| Cayman2015 | 16350 | 8-iso Prostaglandin F2α | 1 mg | 1526 |
| Cayman2015 | 16350 | 8-iso Prostaglandin F2α | 10 mg | 12208 |
| Cayman2015 | 16350 | 8-iso Prostaglandin F2α | 5 mg | 6874 |
| Cayman2015 | 16351 | AAL-993 | 1 mg | 826 |
| Cayman2015 | 16351 | AAL-993 | 5 mg | 1442 |
| Cayman2015 | 16352 | KB-R7943 (mesylate) | 1 mg | 490 |
| Cayman2015 | 16352 | KB-R7943 (mesylate) | 10 mg | 1918 |
| Cayman2015 | 16352 | KB-R7943 (mesylate) | 5 mg | 1176 |
| Cayman2015 | 16353 | TCID | 10 mg | 1316 |
| Cayman2015 | 16353 | TCID | 25 mg | 3010 |
| Cayman2015 | 16353 | TCID | 5 mg | 826 |
| Cayman2015 | 16354 | SU 1498 | 1 mg | 686 |
| Cayman2015 | 16354 | SU 1498 | 5 mg | 1834 |
| Cayman2015 | 16354 | SU 1498 | 500 μg | 406 |
| Cayman2015 | 16355 | Gaboxadol (hydrochloride) | 10 mg | 532 |
| Cayman2015 | 16355 | Gaboxadol (hydrochloride) | 100 mg | 2506 |
| Cayman2015 | 16355 | Gaboxadol (hydrochloride) | 25 mg | 966 |
| Cayman2015 | 16355 | Gaboxadol (hydrochloride) | 50 mg | 1540 |
| Cayman2015 | 16362 | Cannabigerol (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16363 | GPR41 (Internal) Polyclonal Antibody | 1 ea | 3206 |
| Cayman2015 | 16364 | B32B3 | 1 mg | 350 |
| Cayman2015 | 16364 | B32B3 | 10 mg | 1932 |
| Cayman2015 | 16364 | B32B3 | 5 mg | 1232 |
| Cayman2015 | 16364 | B32B3 | 50 mg | 8750 |
| Cayman2015 | 16370 | 8-iso Prostaglandin F2β | 1 mg | 826 |
| Cayman2015 | 16370 | 8-iso Prostaglandin F2β | 10 mg | 6608 |
| Cayman2015 | 16370 | 8-iso Prostaglandin F2β | 5 mg | 3724 |
| Cayman2015 | 16371 | Ataciguat | 1 mg | 910 |
| Cayman2015 | 16371 | Ataciguat | 10 mg | 7280 |
| Cayman2015 | 16371 | Ataciguat | 5 mg | 4102 |
| Cayman2015 | 16372 | Dihydrolipoic Acid | 100 mg | 980 |
| Cayman2015 | 16372 | Dihydrolipoic Acid | 25 mg | 350 |
| Cayman2015 | 16372 | Dihydrolipoic Acid | 50 mg | 630 |
| Cayman2015 | 16372 | Dihydrolipoic Acid | 500 mg | 3500 |
| Cayman2015 | 16373 | 4-Thiouridine | 100 mg | 4466 |
| Cayman2015 | 16373 | 4-Thiouridine | 25 mg | 1316 |
| Cayman2015 | 16373 | 4-Thiouridine | 250 mg | 9142 |
| Cayman2015 | 16373 | 4-Thiouridine | 5 mg | 406 |
| Cayman2015 | 16374 | α-Hydroxyglutaric Acid (sodium salt) | 10 mg | 350 |
| Cayman2015 | 16374 | α-Hydroxyglutaric Acid (sodium salt) | 100 mg | 1372 |
| Cayman2015 | 16374 | α-Hydroxyglutaric Acid (sodium salt) | 25 mg | 686 |
| Cayman2015 | 16374 | α-Hydroxyglutaric Acid (sodium salt) | 50 mg | 1050 |
| Cayman2015 | 16375 | Tin Protoporphyrin IX (chloride) | 10 mg | 1036 |
| Cayman2015 | 16375 | Tin Protoporphyrin IX (chloride) | 25 mg | 2464 |
| Cayman2015 | 16375 | Tin Protoporphyrin IX (chloride) | 5 mg | 546 |
| Cayman2015 | 16375 | Tin Protoporphyrin IX (chloride) | 50 mg | 4368 |
| Cayman2015 | 16376 | S-(5'-Adenosyl)-L-methionine (sulfate tosylate) | 100 mg | 1638 |
| Cayman2015 | 16376 | S-(5'-Adenosyl)-L-methionine (sulfate tosylate) | 50 mg | 910 |
| Cayman2015 | 16376 | S-(5'-Adenosyl)-L-methionine (sulfate tosylate) | 500 mg | 7280 |
| Cayman2015 | 16379 | Peracetylchitobiose | 10 mg | 546 |
| Cayman2015 | 16379 | Peracetylchitobiose | 100 mg | 3822 |
| Cayman2015 | 16379 | Peracetylchitobiose | 25 mg | 1232 |
| Cayman2015 | 16379 | Peracetylchitobiose | 50 mg | 2184 |
| Cayman2015 | 16380 | 8-iso-13,14-dihydro-15-keto Prostaglandin F2α | 1 mg | 12152 |
| Cayman2015 | 16380 | 8-iso-13,14-dihydro-15-keto Prostaglandin F2α | 100 μg | 1386 |
| Cayman2015 | 16380 | 8-iso-13,14-dihydro-15-keto Prostaglandin F2α | 50 μg | 868 |
| Cayman2015 | 16380 | 8-iso-13,14-dihydro-15-keto Prostaglandin F2α | 500 μg | 6510 |
| Cayman2015 | 16381 | 7-methyl-6-Thioguanosine (technical grade) | 10 mg | 2240 |
| Cayman2015 | 16381 | 7-methyl-6-Thioguanosine (technical grade) | 25 mg | 5292 |
| Cayman2015 | 16381 | 7-methyl-6-Thioguanosine (technical grade) | 5 mg | 1176 |
| Cayman2015 | 16382 | Sucrose octasulfate (potassium salt) | 1 g | 2142 |
| Cayman2015 | 16382 | Sucrose octasulfate (potassium salt) | 5 g | 9520 |
| Cayman2015 | 16382 | Sucrose octasulfate (potassium salt) | 500 mg | 1190 |
| Cayman2015 | 16383 | Fluorescein-5-maleimide | 10 mg | 675 |
| Cayman2015 | 16383 | Fluorescein-5-maleimide | 25 mg | 1410 |
| Cayman2015 | 16383 | Fluorescein-5-maleimide | 5 mg | 375 |
| Cayman2015 | 16383 | Fluorescein-5-maleimide | 50 mg | 2025 |
| Cayman2015 | 16385 | α-Bungarotoxin | 1 mg | 1372 |
| Cayman2015 | 16386 | Ponasterone A | 1 mg | 686 |
| Cayman2015 | 16386 | Ponasterone A | 10 mg | 4802 |
| Cayman2015 | 16386 | Ponasterone A | 25 mg | 10290 |
| Cayman2015 | 16386 | Ponasterone A | 5 mg | 2576 |
| Cayman2015 | 16389 | AB-CHMINACA metabolite M2 | 1 mg | 910 |
| Cayman2015 | 16389 | AB-CHMINACA metabolite M2 | 10 mg | 7280 |
| Cayman2015 | 16389 | AB-CHMINACA metabolite M2 | 5 mg | 4102 |
| Cayman2015 | 16390 | 8-iso-15-keto Prostaglandin F2α | 1 mg | 1932 |
| Cayman2015 | 16390 | 8-iso-15-keto Prostaglandin F2α | 100 μg | 350 |
| Cayman2015 | 16390 | 8-iso-15-keto Prostaglandin F2α | 500 μg | 1050 |
| Cayman2015 | 16391 | AB-CHMINACA metabolite M3A | 1 mg | 2268 |
| Cayman2015 | 16391 | AB-CHMINACA metabolite M3A | 5 mg | 9520 |
| Cayman2015 | 16391 | AB-CHMINACA metabolite M3A | 500 μg | 1190 |
| Cayman2015 | 16393 | AB-CHMINACA metabolite M4 | 1 mg | 910 |
| Cayman2015 | 16393 | AB-CHMINACA metabolite M4 | 10 mg | 7280 |
| Cayman2015 | 16393 | AB-CHMINACA metabolite M4 | 5 mg | 4102 |
| Cayman2015 | 16394 | AB-CHMINACA metabolite M | 1 mg | 910 |
| Cayman2015 | 16394 | AB-CHMINACA metabolite M | 10 mg | 7280 |
| Cayman2015 | 16394 | AB-CHMINACA metabolite M | 5 mg | 4102 |
| Cayman2015 | 16395 | 8-iso-15(R)-Prostaglandin F2α | 1 mg | 2800 |
| Cayman2015 | 16395 | 8-iso-15(R)-Prostaglandin F2α | 100 μg | 350 |
| Cayman2015 | 16395 | 8-iso-15(R)-Prostaglandin F2α | 5 mg | 12250 |
| Cayman2015 | 16395 | 8-iso-15(R)-Prostaglandin F2α | 500 μg | 1582 |
| Cayman2015 | 16397 | Tetrahydrocannabivarin (exempt preparation) | 1 mg | 2072 |
| Cayman2015 | 16398 | (±)-Cannabichromene (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16401 | UNC3230 | 1 mg | 406 |
| Cayman2015 | 16401 | UNC3230 | 10 mg | 3248 |
| Cayman2015 | 16401 | UNC3230 | 25 mg | 7112 |
| Cayman2015 | 16401 | UNC3230 | 5 mg | 1834 |
| Cayman2015 | 16403 | S-(4-Nitrobenzyl)-6-thioinosine | 100 mg | 1638 |
| Cayman2015 | 16403 | S-(4-Nitrobenzyl)-6-thioinosine | 25 mg | 630 |
| Cayman2015 | 16403 | S-(4-Nitrobenzyl)-6-thioinosine | 50 mg | 882 |
| Cayman2015 | 16404 | CMP-Sialic Acid (sodium salt) | 1 mg | 630 |
| Cayman2015 | 16404 | CMP-Sialic Acid (sodium salt) | 10 mg | 3780 |
| Cayman2015 | 16404 | CMP-Sialic Acid (sodium salt) | 25 mg | 8666 |
| Cayman2015 | 16404 | CMP-Sialic Acid (sodium salt) | 5 mg | 2044 |
| Cayman2015 | 16405 | 3,4,6-Tri-O-benzyl-β-D-Mannopyranose 1,2-(methyl orthoacetate) | 1 g | 2450 |
| Cayman2015 | 16405 | 3,4,6-Tri-O-benzyl-β-D-Mannopyranose 1,2-(methyl orthoacetate) | 100 mg | 350 |
| Cayman2015 | 16405 | 3,4,6-Tri-O-benzyl-β-D-Mannopyranose 1,2-(methyl orthoacetate) | 250 mg | 784 |
| Cayman2015 | 16405 | 3,4,6-Tri-O-benzyl-β-D-Mannopyranose 1,2-(methyl orthoacetate) | 500 mg | 1386 |
| Cayman2015 | 16406 | Kuromanin (chloride) | 1 mg | 1638 |
| Cayman2015 | 16406 | Kuromanin (chloride) | 5 mg | 7280 |
| Cayman2015 | 16406 | Kuromanin (chloride) | 500 μg | 910 |
| Cayman2015 | 16407 | (S)-Ketoprofen | 1 g | 1050 |
| Cayman2015 | 16407 | (S)-Ketoprofen | 100 mg | 350 |
| Cayman2015 | 16407 | (S)-Ketoprofen | 5 g | 3500 |
| Cayman2015 | 16407 | (S)-Ketoprofen | 500 mg | 700 |
| Cayman2015 | 16408 | 2'-Deoxyguanosine 5'-monophosphate (sodium salt hydrate) | 1 g | 616 |
| Cayman2015 | 16408 | 2'-Deoxyguanosine 5'-monophosphate (sodium salt hydrate) | 5 g | 2646 |
| Cayman2015 | 16408 | 2'-Deoxyguanosine 5'-monophosphate (sodium salt hydrate) | 500 mg | 406 |
| Cayman2015 | 16409 | Carprofen | 1 g | 784 |
| Cayman2015 | 16409 | Carprofen | 5 g | 2702 |
| Cayman2015 | 16409 | Carprofen | 500 mg | 490 |
| Cayman2015 | 16410 | Prostaglandin F2β | 1 mg | 938 |
| Cayman2015 | 16410 | Prostaglandin F2β | 10 mg | 7504 |
| Cayman2015 | 16410 | Prostaglandin F2β | 5 mg | 4228 |
| Cayman2015 | 16411 | β-Nicotinamide Mononucleotide | 10 mg | 490 |
| Cayman2015 | 16411 | β-Nicotinamide Mononucleotide | 100 mg | 3192 |
| Cayman2015 | 16411 | β-Nicotinamide Mononucleotide | 25 mg | 1036 |
| Cayman2015 | 16411 | β-Nicotinamide Mononucleotide | 50 mg | 1834 |
| Cayman2015 | 16412 | Hexanoyl Glycine | 10 mg | 490 |
| Cayman2015 | 16412 | Hexanoyl Glycine | 100 mg | 2058 |
| Cayman2015 | 16412 | Hexanoyl Glycine | 50 mg | 1232 |
| Cayman2015 | 16412 | Hexanoyl Glycine | 500 mg | 8330 |
| Cayman2015 | 16413 | (1'S,2'S)-Nicotine-1'-oxide | 100 mg | 3780 |
| Cayman2015 | 16413 | (1'S,2'S)-Nicotine-1'-oxide | 25 mg | 1050 |
| Cayman2015 | 16413 | (1'S,2'S)-Nicotine-1'-oxide | 50 mg | 2002 |
| Cayman2015 | 16415 | α-(difluoromethyl)-DL-Arginine | 1 mg | 350 |
| Cayman2015 | 16415 | α-(difluoromethyl)-DL-Arginine | 10 mg | 1750 |
| Cayman2015 | 16415 | α-(difluoromethyl)-DL-Arginine | 25 mg | 3332 |
| Cayman2015 | 16415 | α-(difluoromethyl)-DL-Arginine | 5 mg | 1050 |
| Cayman2015 | 16419 | LEI-106 | 1 mg | 504 |
| Cayman2015 | 16419 | LEI-106 | 10 mg | 2688 |
| Cayman2015 | 16419 | LEI-106 | 25 mg | 5880 |
| Cayman2015 | 16419 | LEI-106 | 5 mg | 1512 |
| Cayman2015 | 16420 | Prostaglandin F2β (tromethamine salt) | 1 mg | 714 |
| Cayman2015 | 16420 | Prostaglandin F2β (tromethamine salt) | 10 mg | 5712 |
| Cayman2015 | 16420 | Prostaglandin F2β (tromethamine salt) | 5 mg | 3220 |
| Cayman2015 | 16421 | MA-CHMINACA | 1 mg | 490 |
| Cayman2015 | 16421 | MA-CHMINACA | 10 mg | 3920 |
| Cayman2015 | 16421 | MA-CHMINACA | 5 mg | 2212 |
| Cayman2015 | 16423 | SGI-1776 | 1 mg | 350 |
| Cayman2015 | 16423 | SGI-1776 | 10 mg | 2450 |
| Cayman2015 | 16423 | SGI-1776 | 5 mg | 1582 |
| Cayman2015 | 16423 | SGI-1776 | 50 mg | 8750 |
| Cayman2015 | 16424 | RVX-208 | 1 mg | 490 |
| Cayman2015 | 16424 | RVX-208 | 10 mg | 2212 |
| Cayman2015 | 16424 | RVX-208 | 25 mg | 4662 |
| Cayman2015 | 16424 | RVX-208 | 5 mg | 1232 |
| Cayman2015 | 16425 | PF-04620110 | 10 mg | 1764 |
| Cayman2015 | 16425 | PF-04620110 | 25 mg | 4144 |
| Cayman2015 | 16425 | PF-04620110 | 5 mg | 1036 |
| Cayman2015 | 16426 | CUDC-101 | 10 mg | 1568 |
| Cayman2015 | 16426 | CUDC-101 | 25 mg | 3724 |
| Cayman2015 | 16426 | CUDC-101 | 5 mg | 826 |
| Cayman2015 | 16426 | CUDC-101 | 50 mg | 6202 |
| Cayman2015 | 16427 | LAQ824 | 1 mg | 546 |
| Cayman2015 | 16427 | LAQ824 | 10 mg | 4102 |
| Cayman2015 | 16427 | LAQ824 | 5 mg | 2464 |
| Cayman2015 | 16428 | LB 42708 | 1 mg | 490 |
| Cayman2015 | 16428 | LB 42708 | 10 mg | 2212 |
| Cayman2015 | 16428 | LB 42708 | 5 mg | 1344 |
| Cayman2015 | 16429 | Darapladib | 1 mg | 546 |
| Cayman2015 | 16429 | Darapladib | 10 mg | 3556 |
| Cayman2015 | 16429 | Darapladib | 25 mg | 8050 |
| Cayman2015 | 16429 | Darapladib | 5 mg | 1918 |
| Cayman2015 | 16432 | RHC-80267 | 10 mg | 784 |
| Cayman2015 | 16432 | RHC-80267 | 25 mg | 1834 |
| Cayman2015 | 16432 | RHC-80267 | 5 mg | 490 |
| Cayman2015 | 16432 | RHC-80267 | 50 mg | 3192 |
| Cayman2015 | 16433 | Nullscript | 1 mg | 756 |
| Cayman2015 | 16433 | Nullscript | 10 mg | 6020 |
| Cayman2015 | 16433 | Nullscript | 5 mg | 3402 |
| Cayman2015 | 16434 | PX 2 | 1 mg | 910 |
| Cayman2015 | 16434 | PX 2 | 10 mg | 7280 |
| Cayman2015 | 16434 | PX 2 | 5 mg | 4102 |
| Cayman2015 | 16436 | 4-Chloromethcathinone (hydrochloride) | 10 mg | 1302 |
| Cayman2015 | 16436 | 4-Chloromethcathinone (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 16436 | 4-Chloromethcathinone (hydrochloride) | 50 mg | 5488 |
| Cayman2015 | 16439 | GSK-LSD1 (hydrochloride) | 1 mg | 350 |
| Cayman2015 | 16439 | GSK-LSD1 (hydrochloride) | 10 mg | 1750 |
| Cayman2015 | 16439 | GSK-LSD1 (hydrochloride) | 25 mg | 3934 |
| Cayman2015 | 16439 | GSK-LSD1 (hydrochloride) | 5 mg | 966 |
| Cayman2015 | 16440 | U-44069 | 1 mg | 1750 |
| Cayman2015 | 16440 | U-44069 | 10 mg | 14000 |
| Cayman2015 | 16440 | U-44069 | 5 mg | 7882 |
| Cayman2015 | 16442 | 5-trans U-44069 | 1 mg | 938 |
| Cayman2015 | 16442 | 5-trans U-44069 | 10 mg | 7504 |
| Cayman2015 | 16442 | 5-trans U-44069 | 5 mg | 4228 |
| Cayman2015 | 16443 | CBL-018 | 1 mg | 910 |
| Cayman2015 | 16443 | CBL-018 | 10 mg | 7280 |
| Cayman2015 | 16443 | CBL-018 | 5 mg | 4102 |
| Cayman2015 | 16444 | Phenylacetone (exempt preparation) | 1 mg | 686 |
| Cayman2015 | 16449 | TNP-470 | 10 mg | 2002 |
| Cayman2015 | 16449 | TNP-470 | 25 mg | 4732 |
| Cayman2015 | 16449 | TNP-470 | 5 mg | 1050 |
| Cayman2015 | 16450 | U-46619 | 1 mg | 980 |
| Cayman2015 | 16450 | U-46619 | 10 mg | 7840 |
| Cayman2015 | 16450 | U-46619 | 5 mg | 4410 |
| Cayman2015 | 16452 | 5-trans U-46619 | 1 mg | 1092 |
| Cayman2015 | 16452 | 5-trans U-46619 | 10 mg | 8736 |
| Cayman2015 | 16452 | 5-trans U-46619 | 5 mg | 4914 |
| Cayman2015 | 16453 | AB-CHMINACA metabolite M6 | 1 mg | 2534 |
| Cayman2015 | 16453 | AB-CHMINACA metabolite M6 | 5 mg | 10640 |
| Cayman2015 | 16453 | AB-CHMINACA metabolite M6 | 500 μg | 1330 |
| Cayman2015 | 16454 | Medetomidine (hydrochloride) | 10 mg | 1092 |
| Cayman2015 | 16454 | Medetomidine (hydrochloride) | 5 mg | 686 |
| Cayman2015 | 16454 | Medetomidine (hydrochloride) | 50 mg | 4466 |
| Cayman2015 | 16456 | 1-methyl-D-Tryptophan | 1 g | 1302 |
| Cayman2015 | 16456 | 1-methyl-D-Tryptophan | 250 mg | 406 |
| Cayman2015 | 16456 | 1-methyl-D-Tryptophan | 5 g | 5446 |
| Cayman2015 | 16456 | 1-methyl-D-Tryptophan | 500 mg | 728 |
| Cayman2015 | 16457 | L-Ascorbic Acid 2-phosphate (magnesium salt) | 10 g | 1302 |
| Cayman2015 | 16457 | L-Ascorbic Acid 2-phosphate (magnesium salt) | 5 g | 686 |
| Cayman2015 | 16457 | L-Ascorbic Acid 2-phosphate (magnesium salt) | 50 g | 5488 |
| Cayman2015 | 16458 | Picaridin | 1 mg | 350 |
| Cayman2015 | 16458 | Picaridin | 10 mg | 2450 |
| Cayman2015 | 16458 | Picaridin | 5 mg | 1316 |
| Cayman2015 | 16458 | Picaridin | 50 mg | 4900 |
| Cayman2015 | 16459 | Biotin-HPDP | 10 mg | 672 |
| Cayman2015 | 16459 | Biotin-HPDP | 5 mg | 350 |
| Cayman2015 | 16459 | Biotin-HPDP | 50 mg | 2632 |
| Cayman2015 | 16460 | Δ17-U-46619 | 1 mg | 10780 |
| Cayman2015 | 16460 | Δ17-U-46619 | 100 μg | 1470 |
| Cayman2015 | 16460 | Δ17-U-46619 | 50 μg | 770 |
| Cayman2015 | 16460 | Δ17-U-46619 | 500 μg | 6160 |
| Cayman2015 | 16461 | 3-[2-N-(Biotinyl)aminoethyldithio]propanoic Acid | 10 mg | 546 |
| Cayman2015 | 16461 | 3-[2-N-(Biotinyl)aminoethyldithio]propanoic Acid | 100 mg | 3556 |
| Cayman2015 | 16461 | 3-[2-N-(Biotinyl)aminoethyldithio]propanoic Acid | 25 mg | 1232 |
| Cayman2015 | 16461 | 3-[2-N-(Biotinyl)aminoethyldithio]propanoic Acid | 50 mg | 2184 |
| Cayman2015 | 16462 | Azumolene (sodium salt) | 1 mg | 406 |
| Cayman2015 | 16462 | Azumolene (sodium salt) | 10 mg | 3248 |
| Cayman2015 | 16462 | Azumolene (sodium salt) | 5 mg | 1834 |
| Cayman2015 | 16463 | MTSSL | 10 mg | 885 |
| Cayman2015 | 16463 | MTSSL | 50 mg | 3765 |
| Cayman2015 | 16465 | U-51605 | 1 mg | 3808 |
| Cayman2015 | 16465 | U-51605 | 100 μg | 476 |
| Cayman2015 | 16465 | U-51605 | 5 mg | 16660 |
| Cayman2015 | 16465 | U-51605 | 500 μg | 2142 |
| Cayman2015 | 16468 | Rifabutin | 10 mg | 406 |
| Cayman2015 | 16468 | Rifabutin | 100 mg | 1624 |
| Cayman2015 | 16468 | Rifabutin | 25 mg | 910 |
| Cayman2015 | 16468 | Rifabutin | 500 mg | 6104 |
| Cayman2015 | 16470 | 16,16-dimethyl Prostaglandin F2β | 1 mg | 924 |
| Cayman2015 | 16470 | 16,16-dimethyl Prostaglandin F2β | 10 mg | 7392 |
| Cayman2015 | 16470 | 16,16-dimethyl Prostaglandin F2β | 5 mg | 4158 |
| Cayman2015 | 16471 | Danazol | 100 mg | 616 |
| Cayman2015 | 16471 | Danazol | 250 mg | 1386 |
| Cayman2015 | 16471 | Danazol | 50 mg | 406 |
| Cayman2015 | 16471 | Danazol | 500 mg | 2646 |
| Cayman2015 | 16472 | Pyrimethamine? | 10 mg | 350 |
| Cayman2015 | 16472 | Pyrimethamine? | 100 mg | 1232 |
| Cayman2015 | 16472 | Pyrimethamine? | 50 mg | 700 |
| Cayman2015 | 16472 | Pyrimethamine? | 500 mg | 3500 |
| Cayman2015 | 16473 | Trimethoprim | 10 g | 840 |
| Cayman2015 | 16473 | Trimethoprim | 25 g | 1344 |
| Cayman2015 | 16473 | Trimethoprim | 5 g | 490 |
| Cayman2015 | 16473 | Trimethoprim | 50 g | 2450 |
| Cayman2015 | 16474 | ?Reserpine | 1 g | 322 |
| Cayman2015 | 16474 | ?Reserpine | 5 g | 1134 |
| Cayman2015 | 16476 | Biochanin A | 1 g | 2100 |
| Cayman2015 | 16476 | Biochanin A | 100 mg | 350 |
| Cayman2015 | 16476 | Biochanin A | 250 mg | 700 |
| Cayman2015 | 16478 | Promethazine (hydrochloride) | 10 g | 350 |
| Cayman2015 | 16478 | Promethazine (hydrochloride) | 25 g | 574 |
| Cayman2015 | 16478 | Promethazine (hydrochloride) | 50 g | 1050 |
| Cayman2015 | 16479 | L-(?)-Fucose | 1 g | 406 |
| Cayman2015 | 16479 | L-(?)-Fucose | 10 g | 2436 |
| Cayman2015 | 16479 | L-(?)-Fucose | 5 g | 1316 |
| Cayman2015 | 16480 | Blonanserin? | 10 mg | 686 |
| Cayman2015 | 16480 | Blonanserin? | 100 mg | 3430 |
| Cayman2015 | 16480 | Blonanserin? | 25 mg | 1596 |
| Cayman2015 | 16480 | Blonanserin? | 5 mg | 490 |
| Cayman2015 | 16481 | 1,3-Dilinoleoyl-rac-glycerol | 100 mg | 532 |
| Cayman2015 | 16481 | 1,3-Dilinoleoyl-rac-glycerol | 50 mg | 350 |
| Cayman2015 | 16481 | 1,3-Dilinoleoyl-rac-glycerol | 500 mg | 2450 |
| Cayman2015 | 16482 | Epothilone A | 1 mg | 490 |
| Cayman2015 | 16482 | Epothilone A | 10 mg | 2450 |
| Cayman2015 | 16482 | Epothilone A | 5 mg | 1344 |
| Cayman2015 | 16483 | Nε-?(1-Carboxymethyl)-L-?lysine | 1 mg | 490 |
| Cayman2015 | 16483 | Nε-?(1-Carboxymethyl)-L-?lysine | 10 mg | 3430 |
| Cayman2015 | 16483 | Nε-?(1-Carboxymethyl)-L-?lysine | 25 mg | 7350 |
| Cayman2015 | 16483 | Nε-?(1-Carboxymethyl)-L-?lysine | 5 mg | 1960 |
| Cayman2015 | 16484 | Zilpaterol? | 1 mg | 490 |
| Cayman2015 | 16484 | Zilpaterol? | 10 mg | 3920 |
| Cayman2015 | 16484 | Zilpaterol? | 5 mg | 2086 |
| Cayman2015 | 16485 | 1-thio-β-D-Glucose (sodium salt) | 1 g | 1456 |
| Cayman2015 | 16485 | 1-thio-β-D-Glucose (sodium salt) | 250 mg | 406 |
| Cayman2015 | 16485 | 1-thio-β-D-Glucose (sodium salt) | 500 mg | 770 |
| Cayman2015 | 16486 | Erythromycin? | 10 g | 882 |
| Cayman2015 | 16486 | Erythromycin? | 100 g | 5390 |
| Cayman2015 | 16486 | Erythromycin? | 25 g | 1596 |
| Cayman2015 | 16486 | Erythromycin? | 5 g | 490 |
| Cayman2015 | 16488 | Monensin (sodium? salt) | 1 g | 560 |
| Cayman2015 | 16488 | Monensin (sodium? salt) | 10 g | 4900 |
| Cayman2015 | 16488 | Monensin (sodium? salt) | 5 g | 2632 |
| Cayman2015 | 16488 | Monensin (sodium? salt) | 500 mg | 350 |
| Cayman2015 | 16489 | Glyceryl Triheptadecanoate | 1 g | 2100 |
| Cayman2015 | 16489 | Glyceryl Triheptadecanoate | 100 mg | 560 |
| Cayman2015 | 16489 | Glyceryl Triheptadecanoate | 50 mg | 350 |
| Cayman2015 | 16489 | Glyceryl Triheptadecanoate | 500 mg | 1232 |
| Cayman2015 | 16490 | 1,2-O-Dihexadecyl-rac-glycerol | 100 mg | 910 |
| Cayman2015 | 16490 | 1,2-O-Dihexadecyl-rac-glycerol | 250 mg | 2156 |
| Cayman2015 | 16490 | 1,2-O-Dihexadecyl-rac-glycerol | 500 mg | 4102 |
| Cayman2015 | 16491 | 1,2-O-Dioctadecyl-rac-glycerol | 1 g | 2464 |
| Cayman2015 | 16491 | 1,2-O-Dioctadecyl-rac-glycerol | 250 mg | 686 |
| Cayman2015 | 16491 | 1,2-O-Dioctadecyl-rac-glycerol | 500 mg | 1302 |
| Cayman2015 | 16494 | n-Dodecyl-β-D-maltoside | 1 g | 1092 |
| Cayman2015 | 16494 | n-Dodecyl-β-D-maltoside | 5 g | 2744 |
| Cayman2015 | 16494 | n-Dodecyl-β-D-maltoside | 500 mg | 686 |
| Cayman2015 | 16495 | X-Gal? | 1 g | 462 |
| Cayman2015 | 16495 | X-Gal? | 5 g | 1694 |
| Cayman2015 | 16495 | X-Gal? | 500 mg | 308 |
| Cayman2015 | 16496 | Isorhamnetin | 1 mg | 686 |
| Cayman2015 | 16496 | Isorhamnetin | 10 mg | 2058 |
| Cayman2015 | 16496 | Isorhamnetin | 25 mg | 4284 |
| Cayman2015 | 16496 | Isorhamnetin | 5 mg | 1204 |
| Cayman2015 | 16497 | Palmitic Acid-d31 | 1 g | 4956 |
| Cayman2015 | 16497 | Palmitic Acid-d31 | 100 mg | 826 |
| Cayman2015 | 16497 | Palmitic Acid-d31 | 500 mg | 3304 |
| Cayman2015 | 16499 | A-443654 | 1 mg | 2268 |
| Cayman2015 | 16499 | A-443654 | 5 mg | 9520 |
| Cayman2015 | 16499 | A-443654 | 500 μg | 1190 |
| Cayman2015 | 16500 | 11-deoxy Prostaglandin F2α | 1 mg | 714 |
| Cayman2015 | 16500 | 11-deoxy Prostaglandin F2α | 10 mg | 5712 |
| Cayman2015 | 16500 | 11-deoxy Prostaglandin F2α | 5 mg | 3220 |
| Cayman2015 | 16501 | Ac-Calpastatin (184-210) | 1 mg | 5152 |
| Cayman2015 | 16501 | Ac-Calpastatin (184-210) | 100 μg | 644 |
| Cayman2015 | 16501 | Ac-Calpastatin (184-210) | 500 μg | 2744 |
| Cayman2015 | 16502 | Peptide YY (3-36) | 1 mg | 4396 |
| Cayman2015 | 16502 | Peptide YY (3-36) | 100 μg | 770 |
| Cayman2015 | 16502 | Peptide YY (3-36) | 500 μg | 2310 |
| Cayman2015 | 16503 | SR 1078 | 1 mg | 350 |
| Cayman2015 | 16503 | SR 1078 | 10 mg | 1750 |
| Cayman2015 | 16503 | SR 1078 | 5 mg | 1232 |
| Cayman2015 | 16510 | 11-deoxy Prostaglandin F2β | 1 mg | 714 |
| Cayman2015 | 16510 | 11-deoxy Prostaglandin F2β | 10 mg | 5712 |
| Cayman2015 | 16510 | 11-deoxy Prostaglandin F2β | 5 mg | 3220 |
| Cayman2015 | 16516 | BRD32048 | 1 mg | 938 |
| Cayman2015 | 16516 | BRD32048 | 5 mg | 3920 |
| Cayman2015 | 16516 | BRD32048 | 500 μg | 490 |
| Cayman2015 | 16517 | 5-Azidopentanoic Acid | 100 mg | 1232 |
| Cayman2015 | 16517 | 5-Azidopentanoic Acid | 250 mg | 2772 |
| Cayman2015 | 16517 | 5-Azidopentanoic Acid | 500 mg | 5236 |
| Cayman2015 | 16518 | 6-Azidohexanoic Acid | 1 g | 2632 |
| Cayman2015 | 16518 | 6-Azidohexanoic Acid | 100 mg | 350 |
| Cayman2015 | 16518 | 6-Azidohexanoic Acid | 250 mg | 826 |
| Cayman2015 | 16519 | (R)-Ketamine (hydrochloride) | 10 mg | 644 |
| Cayman2015 | 16519 | (R)-Ketamine (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 16519 | (R)-Ketamine (hydrochloride) | 50 mg | 1372 |
| Cayman2015 | 16520 | 11β-Prostaglandin F2α | 1 mg | 1596 |
| Cayman2015 | 16520 | 11β-Prostaglandin F2α | 10 mg | 12768 |
| Cayman2015 | 16520 | 11β-Prostaglandin F2α | 5 mg | 7182 |
| Cayman2015 | 16521 | Cellulose triacetate | 10 g | 882 |
| Cayman2015 | 16521 | Cellulose triacetate | 25 g | 1960 |
| Cayman2015 | 16521 | Cellulose triacetate | 5 g | 490 |
| Cayman2015 | 16521 | Cellulose triacetate | 50 g | 3430 |
| Cayman2015 | 16522 | 11β-Prostaglandin F2α Ethanolamide | 1 mg | 1246 |
| Cayman2015 | 16522 | 11β-Prostaglandin F2α Ethanolamide | 10 mg | 9968 |
| Cayman2015 | 16522 | 11β-Prostaglandin F2α Ethanolamide | 5 mg | 5544 |
| Cayman2015 | 16523 | AhR (human) Assay Kit | 384 Well | 24696 |
| Cayman2015 | 16523 | AhR (human) Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 16523 | AhR (human) Assay Kit | 96 Well | 9114 |
| Cayman2015 | 16524 | ERRγ (human) Reporter Assay Kit | 384 Well | 24696 |
| Cayman2015 | 16524 | ERRγ (human) Reporter Assay Kit | 3x32 Well | 9268 |
| Cayman2015 | 16524 | ERRγ (human) Reporter Assay Kit | 96 Well | 9114 |
| Cayman2015 | 16525 | Gimeracil? | 10 mg | 840 |
| Cayman2015 | 16525 | Gimeracil? | 25 mg | 1596 |
| Cayman2015 | 16525 | Gimeracil? | 5 mg | 490 |
| Cayman2015 | 16525 | Gimeracil? | 50 mg | 2702 |
| Cayman2015 | 16526 | L-138,037 | 1 mg | 686 |
| Cayman2015 | 16526 | L-138,037 | 10 mg | 5488 |
| Cayman2015 | 16526 | L-138,037 | 5 mg | 3094 |
| Cayman2015 | 16527 | 2-Chloro-4-nitrophenyl-α-D-glucopyranoside | 10 mg | 490 |
| Cayman2015 | 16527 | 2-Chloro-4-nitrophenyl-α-D-glucopyranoside | 100 mg | 3682 |
| Cayman2015 | 16527 | 2-Chloro-4-nitrophenyl-α-D-glucopyranoside | 50 mg | 2086 |
| Cayman2015 | 16528 | Spinosyn A? | 1 mg | 3150 |
| Cayman2015 | 16528 | Spinosyn A? | 5 mg | 11186 |
| Cayman2015 | 16529 | MTSES | 100 mg | 1666 |
| Cayman2015 | 16529 | MTSES | 25 mg | 490 |
| Cayman2015 | 16529 | MTSES | 250 mg | 3682 |
| Cayman2015 | 16529 | MTSES | 50 mg | 938 |
| Cayman2015 | 16530 | 2,3-dinor-11β-Prostaglandin F2α | 100 μg | 4788 |
| Cayman2015 | 16530 | 2,3-dinor-11β-Prostaglandin F2α | 25 μg | 1330 |
| Cayman2015 | 16530 | 2,3-dinor-11β-Prostaglandin F2α | 50 μg | 2534 |
| Cayman2015 | 16531 | 6-IATR | 1 mg | 980 |
| Cayman2015 | 16531 | 6-IATR | 5 mg | 3164 |
| Cayman2015 | 16531 | 6-IATR | 500 μg | 546 |
| Cayman2015 | 16532 | Nisin A | 1 g | 560 |
| Cayman2015 | 16532 | Nisin A | 10 g | 2450 |
| Cayman2015 | 16532 | Nisin A | 5 g | 1582 |
| Cayman2015 | 16532 | Nisin A | 500 mg | 350 |
| Cayman2015 | 16534 | NOC-5 | 1 mg | 490 |
| Cayman2015 | 16534 | NOC-5 | 10 mg | 1666 |
| Cayman2015 | 16534 | NOC-5 | 25 mg | 3682 |
| Cayman2015 | 16534 | NOC-5 | 5 mg | 980 |
| Cayman2015 | 16535 | (±)-Nicotine | 100 mg | 1148 |
| Cayman2015 | 16535 | (±)-Nicotine | 250 mg | 2730 |
| Cayman2015 | 16535 | (±)-Nicotine | 500 mg | 4018 |
| Cayman2015 | 16536 | Dilaurin? | 1 g | 3822 |
| Cayman2015 | 16536 | Dilaurin? | 100 mg | 546 |
| Cayman2015 | 16536 | Dilaurin? | 250 mg | 1302 |
| Cayman2015 | 16538 | Pladienolide B? | 2.5 mg | 11158 |
| Cayman2015 | 16538 | Pladienolide B? | 500 μg | 3192 |
| Cayman2015 | 16539 | Mouse Anti-6HIS IgG:Unconjugated | 1 mg | 8400 |
| Cayman2015 | 16539 | Mouse Anti-6HIS IgG:Unconjugated | 100 μg | 4396 |
| Cayman2015 | 16540 | 11β-13,14-dihydro-15-keto Prostaglandin F2α | 100 μg | 1204 |
| Cayman2015 | 16540 | 11β-13,14-dihydro-15-keto Prostaglandin F2α | 50 μg | 630 |
| Cayman2015 | 16540 | 11β-13,14-dihydro-15-keto Prostaglandin F2α | 500 μg | 5040 |
| Cayman2015 | 16545 | Streptavidin:Alkaline Phosphatase | 1 ea | 1560 |
| Cayman2015 | 16548 | D-Mannoheptulose? | 10 mg | 1036 |
| Cayman2015 | 16548 | D-Mannoheptulose? | 25 mg | 2464 |
| Cayman2015 | 16548 | D-Mannoheptulose? | 5 mg | 546 |
| Cayman2015 | 16548 | D-Mannoheptulose? | 50 mg | 4368 |
| Cayman2015 | 16549 | α-Zearalenol? | 1 mg | 770 |
| Cayman2015 | 16549 | α-Zearalenol? | 10 mg | 6160 |
| Cayman2015 | 16549 | α-Zearalenol? | 5 mg | 3276 |
| Cayman2015 | 16552 | Oleandomycin? | 25 mg | 4368 |
| Cayman2015 | 16552 | Oleandomycin? | 5 mg | 1246 |
| Cayman2015 | 16553 | CHIR124? | 1 mg | 490 |
| Cayman2015 | 16553 | CHIR124? | 10 mg | 2702 |
| Cayman2015 | 16553 | CHIR124? | 25 mg | 4900 |
| Cayman2015 | 16553 | CHIR124? | 5 mg | 1596 |
| Cayman2015 | 16554 | Ferutinin? | 1 mg | 435 |
| Cayman2015 | 16554 | Ferutinin? | 10 mg | 2175 |
| Cayman2015 | 16554 | Ferutinin? | 5 mg | 1305 |
| Cayman2015 | 16555 | MBDB-d3 (hydrochloride) | 1 mg | 1736 |
| Cayman2015 | 16555 | MBDB-d3 (hydrochloride) | 500 μg | 910 |
| Cayman2015 | 16556 | cis,cis-Octadeca-9,12-dienol | 1 g | 2632 |
| Cayman2015 | 16556 | cis,cis-Octadeca-9,12-dienol | 100 mg | 350 |
| Cayman2015 | 16556 | cis,cis-Octadeca-9,12-dienol | 250 mg | 784 |
| Cayman2015 | 16556 | cis,cis-Octadeca-9,12-dienol | 500 mg | 1386 |
| Cayman2015 | 16557 | Mouse Anti-6HIS IgG:Biotin | 100 μg | 4710 |
| Cayman2015 | 16562 | Rabbit Anti-T7 IgG:DyLight? 650 | 100 μg | 4710 |
| Cayman2015 | 16563 | Activated SureLight? Peridinin-Chlorophyll Protein Complex (PerCP) | 1 mg | 1200 |
| Cayman2015 | 16572 | Goat Anti-Mouse IgG:Eu-W1024 | 1 mg | 88500 |
| Cayman2015 | 16572 | Goat Anti-Mouse IgG:Eu-W1024 | 20 μg | 4125 |
| Cayman2015 | 16572 | Goat Anti-Mouse IgG:Eu-W1024 | 50 μg | 10125 |
| Cayman2015 | 16573 | Goat Anti-Rabbit IgG:Eu-W1024 | 1 mg | 88500 |
| Cayman2015 | 16573 | Goat Anti-Rabbit IgG:Eu-W1024 | 20 μg | 4125 |
| Cayman2015 | 16573 | Goat Anti-Rabbit IgG:Eu-W1024 | 50 μg | 10125 |
| Cayman2015 | 16575 | Mouse Anti-GST IgG:Eu-W1024 | 1 mg | 101625 |
| Cayman2015 | 16575 | Mouse Anti-GST IgG:Eu-W1024 | 20 μg | 4125 |
| Cayman2015 | 16575 | Mouse Anti-GST IgG:Eu-W1024 | 50 μg | 10125 |
| Cayman2015 | 16576 | Mouse Anti-6HIS IgG:Eu-W1024 | 1 mg | 108000 |
| Cayman2015 | 16576 | Mouse Anti-6HIS IgG:Eu-W1024 | 20 μg | 4575 |
| Cayman2015 | 16576 | Mouse Anti-6HIS IgG:Eu-W1024 | 50 μg | 10875 |
| Cayman2015 | 16577 | Mouse Anti-c-myc IgG:Eu-W1024 | 1 mg | 139200 |
| Cayman2015 | 16577 | Mouse Anti-c-myc IgG:Eu-W1024 | 20 μg | 4575 |
| Cayman2015 | 16577 | Mouse Anti-c-myc IgG:Eu-W1024 | 50 μg | 11400 |
| Cayman2015 | 16578 | Mouse Anti-DYKDDDDK IgG:Eu-W1024 | 1 mg | 108000 |
| Cayman2015 | 16578 | Mouse Anti-DYKDDDDK IgG:Eu-W1024 | 20 μg | 4575 |
| Cayman2015 | 16578 | Mouse Anti-DYKDDDDK IgG:Eu-W1024 | 50 μg | 10875 |
| Cayman2015 | 16579 | Mouse Anti-HA IgG:Eu-W1024 | 1 mg | 108000 |
| Cayman2015 | 16579 | Mouse Anti-HA IgG:Eu-W1024 | 20 μg | 5130 |
| Cayman2015 | 16579 | Mouse Anti-HA IgG:Eu-W1024 | 50 μg | 10875 |
| Cayman2015 | 16581 | Streptavidin:Eu-W1024 | 1 mg | 88500 |
| Cayman2015 | 16581 | Streptavidin:Eu-W1024 | 20 μg | 4125 |
| Cayman2015 | 16581 | Streptavidin:Eu-W1024 | 50 μg | 10125 |
| Cayman2015 | 16583 | SureLight? Allophycocyanin (APC) | 1 mg | 750 |
| Cayman2015 | 16584 | Goat Anti-Human IgA:SureLight? APC | 100 μg | 2835 |
| Cayman2015 | 16585 | Goat Anti-Human IgE:SureLight? APC | 100 μg | 4710 |
| Cayman2015 | 16586 | Goat Anti-Human IgM:SureLight? APC | 100 μg | 2835 |
| Cayman2015 | 16587 | Goat Anti-Mouse IgG:SureLight? APC | 1 mg | 4575 |
| Cayman2015 | 16588 | Goat Anti-Mouse IgE:SureLight? APC | 100 μg | 2835 |
| Cayman2015 | 16589 | Goat F(Ab')2 Anti-Mouse IgG (H+L):SureLight? APC | 100 μg | 2835 |
| Cayman2015 | 16590 | Goat F(Ab')2 Anti-Mouse IgG Fc-Spec:SureLight? APC | 100 μg | 2835 |
| Cayman2015 | 16591 | Goat Anti-Mouse IgG Fc-Spec:SureLight? APC | 100 μg | 1425 |
| Cayman2015 | 16592 | Goat Anti-Mouse IgM:SureLight? APC | 100 μg | 1425 |
| Cayman2015 | 16593 | Goat Anti-Rat IgG:SureLight? APC | 100 μg | 1425 |
| Cayman2015 | 16594 | Goat F(Ab')2 Anti-Rat IgG:SureLight? APC | 100 μg | 2835 |
| Cayman2015 | 16595 | Goat Anti-Rat IgG Fc-Spec:SureLight? APC | 100 μg | 1425 |
| Cayman2015 | 16596 | Goat Anti-Rabbit IgG:SureLight? APC | 1 mg | 4575 |
| Cayman2015 | 16596 | Goat Anti-Rabbit IgG:SureLight? APC | 100 μg | 1425 |
| Cayman2015 | 16598 | Goat Anti-GST IgG:SureLight? APC | 1 mg | 6465 |
| Cayman2015 | 16598 | Goat Anti-GST IgG:SureLight? APC | 100 μg | 4710 |
| Cayman2015 | 16599 | Mouse IgG2A Isotype Control:SureLight? APC | 100 μg | 2835 |
| Cayman2015 | 16600 | Mouse IgG2B Isotype Control:SureLight? APC | 100 μg | 2835 |
| Cayman2015 | 16601 | Mouse Anti-6HIS IgG:SureLight? APC | 1 mg | 6465 |
| Cayman2015 | 16601 | Mouse Anti-6HIS IgG:SureLight? APC | 100 μg | 4710 |
| Cayman2015 | 16602 | Mouse Anti-c-myc IgG:SureLight? APC | 1 mg | 6465 |
| Cayman2015 | 16602 | Mouse Anti-c-myc IgG:SureLight? APC | 100 μg | 4710 |
| Cayman2015 | 16603 | 5-fluoro ADB | 1 mg | 910 |
| Cayman2015 | 16603 | 5-fluoro ADB | 10 mg | 7280 |
| Cayman2015 | 16603 | 5-fluoro ADB | 5 mg | 4102 |
| Cayman2015 | 16605 | Actinonin? | 25 mg | 4760 |
| Cayman2015 | 16605 | Actinonin? | 5 mg | 1190 |
| Cayman2015 | 16606 | Tropicamide? | 1 g | 350 |
| Cayman2015 | 16606 | Tropicamide? | 5 g | 1582 |
| Cayman2015 | 16608 | BIBR 1532? | 1 mg | 350 |
| Cayman2015 | 16608 | BIBR 1532? | 10 mg | 1372 |
| Cayman2015 | 16608 | BIBR 1532? | 5 mg | 882 |
| Cayman2015 | 16608 | BIBR 1532? | 50 mg | 5950 |
| Cayman2015 | 16610 | Mouse Anti-HA IgG:SureLight? APC | 1 mg | 6465 |
| Cayman2015 | 16610 | Mouse Anti-HA IgG:SureLight? APC | 100 μg | 4710 |
| Cayman2015 | 16611 | Anti-Cytokeratin (CloneC11):SureLight? APC | 100 μg | 4710 |
| Cayman2015 | 16612 | Rabbit Anti-V5 tag IgG:SureLight? APC | 100 μg | 4710 |
| Cayman2015 | 16615 | BVT 948 | 1 mg | 350 |
| Cayman2015 | 16615 | BVT 948 | 10 mg | 1232 |
| Cayman2015 | 16615 | BVT 948 | 5 mg | 784 |
| Cayman2015 | 16616 | MAB-CHMINACA | 1 mg | 490 |
| Cayman2015 | 16616 | MAB-CHMINACA | 10 mg | 3920 |
| Cayman2015 | 16616 | MAB-CHMINACA | 5 mg | 2212 |
| Cayman2015 | 16617 | ?3'-Sialyllactose (sodium salt?) | 10 mg | 490 |
| Cayman2015 | 16617 | ?3'-Sialyllactose (sodium salt?) | 100 mg | 3920 |
| Cayman2015 | 16617 | ?3'-Sialyllactose (sodium salt?) | 25 mg | 1106 |
| Cayman2015 | 16617 | ?3'-Sialyllactose (sodium salt?) | 50 mg | 2086 |
| Cayman2015 | 16618 | Bupivacaine | 1 g | 560 |
| Cayman2015 | 16618 | Bupivacaine | 25 g | 2450 |
| Cayman2015 | 16618 | Bupivacaine | 5 g | 770 |
| Cayman2015 | 16618 | Bupivacaine | 500 mg | 350 |
| Cayman2015 | 16619 | SD 208 | 1 mg | 406 |
| Cayman2015 | 16619 | SD 208 | 10 mg | 2030 |
| Cayman2015 | 16619 | SD 208 | 25 mg | 4564 |
| Cayman2015 | 16619 | SD 208 | 5 mg | 1218 |
| Cayman2015 | 16620 | ?4-Methylumbelliferyl-N-acetyl-α-D-neuraminic Acid (sodium salt?) | 1 mg | 490 |
| Cayman2015 | 16620 | ?4-Methylumbelliferyl-N-acetyl-α-D-neuraminic Acid (sodium salt?) | 10 mg | 1820 |
| Cayman2015 | 16620 | ?4-Methylumbelliferyl-N-acetyl-α-D-neuraminic Acid (sodium salt?) | 25 mg | 3920 |
| Cayman2015 | 16620 | ?4-Methylumbelliferyl-N-acetyl-α-D-neuraminic Acid (sodium salt?) | 5 mg | 1106 |
| Cayman2015 | 16621 | Mito-TEMPO (hydrate) | 1 mg | 350 |
| Cayman2015 | 16621 | Mito-TEMPO (hydrate) | 10 mg | 1372 |
| Cayman2015 | 16621 | Mito-TEMPO (hydrate) | 25 mg | 3066 |
| Cayman2015 | 16621 | Mito-TEMPO (hydrate) | 5 mg | 784 |
| Cayman2015 | 16622 | Cyproterone Acetate? | 1 g | 3920 |
| Cayman2015 | 16622 | Cyproterone Acetate? | 100 mg | 490 |
| Cayman2015 | 16622 | Cyproterone Acetate? | 250 mg | 1162 |
| Cayman2015 | 16623 | Kanosamine (hydrochloride)? | 1 mg | 490 |
| Cayman2015 | 16623 | Kanosamine (hydrochloride)? | 10 mg | 3920 |
| Cayman2015 | 16623 | Kanosamine (hydrochloride)? | 25 mg | 8638 |
| Cayman2015 | 16623 | Kanosamine (hydrochloride)? | 5 mg | 2212 |
| Cayman2015 | 16625 | Anti-EP4 Receptor (C-Term):SureLight? APC | 100 μg | 4710 |
| Cayman2015 | 16630 | Streptavidin:SureLight? APC | 1 mg | 4575 |
| Cayman2015 | 16631 | Streptavidin:SureLight? APC Protein Assay Format | 1 mg | 4575 |
| Cayman2015 | 16632 | SureLight? B-Phycoerythrin (B-PE) | 1 mg | 375 |
| Cayman2015 | 16633 | Streptavidin:SureLight? B-PE | 1 mg | 3390 |
| Cayman2015 | 16637 | SureLight? R-Phycoerythrin (R-PE) | 1 mg | 150 |
| Cayman2015 | 16638 | Goat Anti-Human IgG:SureLight? R-PE | 1 mg | 4575 |
| Cayman2015 | 16638 | Goat Anti-Human IgG:SureLight? R-PE | 100 μg | 1425 |
| Cayman2015 | 16639 | Goat Anti-Human IgA:SureLight? R-PE | 100 μg | 1425 |
| Cayman2015 | 16640 | Goat Anti-Human IgE:SureLight? R-PE | 100 μg | 4710 |
| Cayman2015 | 16641 | Goat Anti-Human IgG Fcγ:SureLight? R-PE | 1 mg | 4575 |
| Cayman2015 | 16641 | Goat Anti-Human IgG Fcγ:SureLight? R-PE | 100 μg | 1425 |
| Cayman2015 | 16642 | Goat Anti-Mouse (H+L):SureLight? R-PE | 1 mg | 4575 |
| Cayman2015 | 16642 | Goat Anti-Mouse (H+L):SureLight? R-PE | 100 μg | 1425 |
| Cayman2015 | 16643 | SB 590885 | 1 mg | 546 |
| Cayman2015 | 16643 | SB 590885 | 10 mg | 2184 |
| Cayman2015 | 16643 | SB 590885 | 25 mg | 4774 |
| Cayman2015 | 16643 | SB 590885 | 5 mg | 1372 |
| Cayman2015 | 16644 | Wnt-C59 | 1 mg | 490 |
| Cayman2015 | 16644 | Wnt-C59 | 10 mg | 1960 |
| Cayman2015 | 16644 | Wnt-C59 | 5 mg | 1232 |
| Cayman2015 | 16644 | Wnt-C59 | 50 mg | 8330 |
| Cayman2015 | 16646 | Goat Anti-Mouse IgE:SureLight? R-PE | 100 μg | 2835 |
| Cayman2015 | 16647 | Goat F(Ab')2 Anti-Mouse IgG (H+L):SureLight? R-PE | 100 μg | 2835 |
| Cayman2015 | 16648 | Goat F(Ab')2 Anti-Mouse IgG Fc-Spec:SureLight? R-PE | 100 μg | 2835 |
| Cayman2015 | 16649 | Goat Anti-Mouse IgG Fc-Spec:SureLight? R-PE | 100 μg | 1425 |
| Cayman2015 | 16651 | Goat Anti-Mouse IgM:SureLight? R-PE | 100 μg | 2835 |
| Cayman2015 | 16652 | Goat Anti-Rat IgG:SureLight? R-PE | 100 μg | 1425 |
| Cayman2015 | 16653 | Goat F(Ab')2 Anti-Rat IgG:SureLight? R-PE | 100 μg | 2835 |
| Cayman2015 | 16654 | Goat Anti-Rat IgG Fc-Spec:SureLight? R-PE | 100 μg | 1425 |
| Cayman2015 | 16655 | Goat Anti-Rabbit IgG:SureLight? R-PE | 1 mg | 4575 |
| Cayman2015 | 16655 | Goat Anti-Rabbit IgG:SureLight? R-PE | 100 μg | 1425 |
| Cayman2015 | 16656 | Rabbit Anti-Goat IgG:SureLight? R-PE | 1 mg | 4575 |
| Cayman2015 | 16657 | Mouse IgG2A Isotype Control:SureLight? R-PE | 100 μg | 2835 |
| Cayman2015 | 16658 | Mouse IgG2B Isotype Control:SureLight? R-PE | 100 μg | 2835 |
| Cayman2015 | 16659 | Anti-Cytokeratin (Clone C11):SureLight? R-PE | 100 μg | 4710 |
| Cayman2015 | 16660 | 13,14-dihydro Prostaglandin F2α | 1 mg | 546 |
| Cayman2015 | 16660 | 13,14-dihydro Prostaglandin F2α | 10 mg | 4368 |
| Cayman2015 | 16660 | 13,14-dihydro Prostaglandin F2α | 5 mg | 2464 |
| Cayman2015 | 16662 | Anti-Acetyl Lysine (Clone 7F8):SureLight? R-PE | 100 μg | 4710 |
| Cayman2015 | 16663 | ?4-epi-Chlortetracycline (hydrochloride?) | 1 mg | 1680 |
| Cayman2015 | 16663 | ?4-epi-Chlortetracycline (hydrochloride?) | 5 mg | 6300 |
| Cayman2015 | 16663 | ?4-epi-Chlortetracycline (hydrochloride?) | 500 μg | 1050 |
| Cayman2015 | 16664 | Mozavaptan (hydrochloride) | 10 mg | 784 |
| Cayman2015 | 16664 | Mozavaptan (hydrochloride) | 100 mg | 6370 |
| Cayman2015 | 16664 | Mozavaptan (hydrochloride) | 5 mg | 490 |
| Cayman2015 | 16664 | Mozavaptan (hydrochloride) | 50 mg | 3430 |
| Cayman2015 | 16665 | Melphalan? | 100 mg | 1638 |
| Cayman2015 | 16665 | Melphalan? | 250 mg | 2954 |
| Cayman2015 | 16665 | Melphalan? | 50 mg | 910 |
| Cayman2015 | 16665 | Melphalan? | 500 mg | 4550 |
| Cayman2015 | 16666 | Monocrotaline? | 10 mg | 882 |
| Cayman2015 | 16666 | Monocrotaline? | 100 mg | 2450 |
| Cayman2015 | 16666 | Monocrotaline? | 5 mg | 490 |
| Cayman2015 | 16666 | Monocrotaline? | 50 mg | 1568 |
| Cayman2015 | 16667 | BMS 345541? (trifluoroacetate salt) | 1 mg | 476 |
| Cayman2015 | 16667 | BMS 345541? (trifluoroacetate salt) | 10 mg | 3570 |
| Cayman2015 | 16667 | BMS 345541? (trifluoroacetate salt) | 25 mg | 6552 |
| Cayman2015 | 16667 | BMS 345541? (trifluoroacetate salt) | 5 mg | 1904 |
| Cayman2015 | 16669 | 2-Amino-5-fluorobenzoic Acid | 1 g | 616 |
| Cayman2015 | 16669 | 2-Amino-5-fluorobenzoic Acid | 10 g | 4928 |
| Cayman2015 | 16669 | 2-Amino-5-fluorobenzoic Acid | 5 g | 2618 |
| Cayman2015 | 16670 | 13,14-dihydro-15-keto Prostaglandin F2α | 1 mg | 882 |
| Cayman2015 | 16670 | 13,14-dihydro-15-keto Prostaglandin F2α | 10 mg | 7056 |
| Cayman2015 | 16670 | 13,14-dihydro-15-keto Prostaglandin F2α | 5 mg | 3976 |
| Cayman2015 | 16671 | 13,14-dihydro-15-keto Prostaglandin F2α isopropyl ester | 1 mg | 714 |
| Cayman2015 | 16671 | 13,14-dihydro-15-keto Prostaglandin F2α isopropyl ester | 10 mg | 5712 |
| Cayman2015 | 16671 | 13,14-dihydro-15-keto Prostaglandin F2α isopropyl ester | 5 mg | 3220 |
| Cayman2015 | 16674 | Flupirtine (maleate?) | 100 mg | 1456 |
| Cayman2015 | 16674 | Flupirtine (maleate?) | 25 mg | 406 |
| Cayman2015 | 16674 | Flupirtine (maleate?) | 50 mg | 770 |
| Cayman2015 | 16675 | ?Glufosinate (ammonium salt) | 1 g | 3500 |
| Cayman2015 | 16675 | ?Glufosinate (ammonium salt) | 100 mg | 532 |
| Cayman2015 | 16675 | ?Glufosinate (ammonium salt) | 250 mg | 1134 |
| Cayman2015 | 16675 | ?Glufosinate (ammonium salt) | 50 mg | 350 |
| Cayman2015 | 16676 | AZD 1080? | 1 mg | 686 |
| Cayman2015 | 16676 | AZD 1080? | 10 mg | 5488 |
| Cayman2015 | 16676 | AZD 1080? | 25 mg | 12012 |
| Cayman2015 | 16676 | AZD 1080? | 5 mg | 3094 |
| Cayman2015 | 16677 | Astragaloside A? | 1 mg | 630 |
| Cayman2015 | 16677 | Astragaloside A? | 10 mg | 4732 |
| Cayman2015 | 16677 | Astragaloside A? | 5 mg | 2674 |
| Cayman2015 | 16677 | Astragaloside A? | 50 mg | 12600 |
| Cayman2015 | 16678 | K02288? | 1 mg | 406 |
| Cayman2015 | 16678 | K02288? | 10 mg | 2646 |
| Cayman2015 | 16678 | K02288? | 5 mg | 1526 |
| Cayman2015 | 16678 | K02288? | 50 mg | 9142 |
| Cayman2015 | 16680 | Unoprostone | 1 mg | 672 |
| Cayman2015 | 16680 | Unoprostone | 10 mg | 5376 |
| Cayman2015 | 16680 | Unoprostone | 5 mg | 3024 |
| Cayman2015 | 16680 | Unoprostone | 50 mg | 21504 |
| Cayman2015 | 16681 | Unoprostone isopropyl ester | 1 mg | 672 |
| Cayman2015 | 16681 | Unoprostone isopropyl ester | 10 mg | 5376 |
| Cayman2015 | 16681 | Unoprostone isopropyl ester | 5 mg | 3024 |
| Cayman2015 | 16681 | Unoprostone isopropyl ester | 50 mg | 21504 |
| Cayman2015 | 16682 | P7C3? | 10 mg | 2002 |
| Cayman2015 | 16682 | P7C3? | 25 mg | 4704 |
| Cayman2015 | 16682 | P7C3? | 5 mg | 1176 |
| Cayman2015 | 16682 | P7C3? | 50 mg | 7644 |
| Cayman2015 | 16683 | Anti-CB1 Receptor (C-term.):SureLight? R-PE | 100 μg | 4710 |
| Cayman2015 | 16684 | Anti-EP2 Receptor:SureLight? R-PE | 100 μg | 4710 |
| Cayman2015 | 16685 | Lumula | 1 mg | 784 |
| Cayman2015 | 16685 | Lumula | 10 mg | 6272 |
| Cayman2015 | 16685 | Lumula | 5 mg | 3528 |
| Cayman2015 | 16686 | Anti-15-Hydroxy PGDH:SureLight? R-PE | 100 μg | 4710 |
| Cayman2015 | 16687 | Anti-EP4 Receptor (C-Term):SureLight? R-PE | 100 μg | 4710 |
| Cayman2015 | 16690 | Anti-PGI Synthase:SureLight? R-PE | 100 μg | 4710 |
| Cayman2015 | 16691 | Mouse Anti-Fluorescein IgG:SureLight? PE | 100 μg | 4710 |
| Cayman2015 | 16692 | Mouse Anti-HRP IgG:SureLight? PE | 100 μg | 4710 |
| Cayman2015 | 16693 | Mouse Anti-Alkaline Phosphatase IgG:SureLight? PE | 100 μg | 4710 |
| Cayman2015 | 16694 | Mouse Anti-Biotin IgG:SureLight? PE | 100 μg | 4710 |
| Cayman2015 | 16695 | SureLight? P3 | 5 mg | 4200 |
| Cayman2015 | 16697 | Goat Anti-Rabbit IgG:SureLight? P3 | 1 mg | 4575 |
| Cayman2015 | 16703 | Goat Anti-Human (H+L):HRP | 1 mg | 2130 |
| Cayman2015 | 16705 | LY2784544? | 1 mg | 966 |
| Cayman2015 | 16705 | LY2784544? | 10 mg | 3570 |
| Cayman2015 | 16705 | LY2784544? | 25 mg | 6762 |
| Cayman2015 | 16705 | LY2784544? | 5 mg | 2170 |
| Cayman2015 | 16706 | MK 0752 | 1 mg | 770 |
| Cayman2015 | 16706 | MK 0752 | 10 mg | 5012 |
| Cayman2015 | 16706 | MK 0752 | 5 mg | 3472 |
| Cayman2015 | 16707 | Baricitinib | 1 mg | 546 |
| Cayman2015 | 16707 | Baricitinib | 10 mg | 4102 |
| Cayman2015 | 16707 | Baricitinib | 25 mg | 8190 |
| Cayman2015 | 16707 | Baricitinib | 5 mg | 2464 |
| Cayman2015 | 16708 | SR 3677 | 1 mg | 490 |
| Cayman2015 | 16708 | SR 3677 | 10 mg | 2450 |
| Cayman2015 | 16708 | SR 3677 | 25 mg | 5516 |
| Cayman2015 | 16708 | SR 3677 | 5 mg | 1344 |
| Cayman2015 | 16709 | Pacritinib? | 1 mg | 938 |
| Cayman2015 | 16709 | Pacritinib? | 5 mg | 3920 |
| Cayman2015 | 16709 | Pacritinib? | 500 μg | 490 |
| Cayman2015 | 16710 | 15-cyclohexyl pentanor Prostaglandin F2α | 1 mg | 714 |
| Cayman2015 | 16710 | 15-cyclohexyl pentanor Prostaglandin F2α | 10 mg | 5712 |
| Cayman2015 | 16710 | 15-cyclohexyl pentanor Prostaglandin F2α | 5 mg | 3220 |
| Cayman2015 | 16711 | Avagacestat | 1 mg | 490 |
| Cayman2015 | 16711 | Avagacestat | 10 mg | 3920 |
| Cayman2015 | 16711 | Avagacestat | 5 mg | 2212 |
| Cayman2015 | 16712 | LY2811376? | 1 mg | 490 |
| Cayman2015 | 16712 | LY2811376? | 10 mg | 3920 |
| Cayman2015 | 16712 | LY2811376? | 5 mg | 2212 |
| Cayman2015 | 16712 | LY2811376? | 50 mg | 12250 |
| Cayman2015 | 16713 | Semagacestat? | 1 mg | 490 |
| Cayman2015 | 16713 | Semagacestat? | 10 mg | 3920 |
| Cayman2015 | 16713 | Semagacestat? | 5 mg | 2212 |
| Cayman2015 | 16714 | ?NVP-BSK805 (hydrochloride) | 1 mg | 770 |
| Cayman2015 | 16714 | ?NVP-BSK805 (hydrochloride) | 10 mg | 4620 |
| Cayman2015 | 16714 | ?NVP-BSK805 (hydrochloride) | 5 mg | 3276 |
| Cayman2015 | 16715 | Celiprolol (hydrochloride??) | 1 mg | 490 |
| Cayman2015 | 16715 | Celiprolol (hydrochloride??) | 10 mg | 2058 |
| Cayman2015 | 16715 | Celiprolol (hydrochloride??) | 25 mg | 4536 |
| Cayman2015 | 16715 | Celiprolol (hydrochloride??) | 5 mg | 1344 |
| Cayman2015 | 16716 | NSC 348884? | 1 mg | 490 |
| Cayman2015 | 16716 | NSC 348884? | 10 mg | 2450 |
| Cayman2015 | 16716 | NSC 348884? | 25 mg | 5516 |
| Cayman2015 | 16716 | NSC 348884? | 5 mg | 1344 |
| Cayman2015 | 16718 | CZC-8004 | 1 mg | 1638 |
| Cayman2015 | 16718 | CZC-8004 | 10 mg | 7280 |
| Cayman2015 | 16718 | CZC-8004 | 5 mg | 4550 |
| Cayman2015 | 16718 | CZC-8004 | 500 μg | 910 |
| Cayman2015 | 16719 | Amastatin (hydrochloride?) | 1 mg | 630 |
| Cayman2015 | 16719 | Amastatin (hydrochloride?) | 10 mg | 3850 |
| Cayman2015 | 16719 | Amastatin (hydrochloride?) | 5 mg | 2100 |
| Cayman2015 | 16719 | Amastatin (hydrochloride?) | 500 μg | 350 |
| Cayman2015 | 16720 | 15-keto Prostaglandin F2α | 1 mg | 742 |
| Cayman2015 | 16720 | 15-keto Prostaglandin F2α | 10 mg | 5936 |
| Cayman2015 | 16720 | 15-keto Prostaglandin F2α | 5 mg | 3346 |
| Cayman2015 | 16722 | Fudosteine | 10 mg | 350 |
| Cayman2015 | 16722 | Fudosteine | 100 mg | 2282 |
| Cayman2015 | 16722 | Fudosteine | 25 mg | 700 |
| Cayman2015 | 16722 | Fudosteine | 50 mg | 1232 |
| Cayman2015 | 16723 | ?SLIGRL-NH2? | 1 mg | 630 |
| Cayman2015 | 16723 | ?SLIGRL-NH2? | 10 mg | 4830 |
| Cayman2015 | 16723 | ?SLIGRL-NH2? | 5 mg | 2772 |
| Cayman2015 | 16723 | ?SLIGRL-NH2? | 500 μg | 350 |
| Cayman2015 | 16724 | Phenylacetyl L-Glutamine | 10 mg | 546 |
| Cayman2015 | 16724 | Phenylacetyl L-Glutamine | 100 mg | 3822 |
| Cayman2015 | 16724 | Phenylacetyl L-Glutamine | 25 mg | 1232 |
| Cayman2015 | 16724 | Phenylacetyl L-Glutamine | 50 mg | 2184 |
| Cayman2015 | 16725 | ?3-Guanidinopropionic Acid? | 1 g | 560 |
| Cayman2015 | 16725 | ?3-Guanidinopropionic Acid? | 10 g | 3500 |
| Cayman2015 | 16725 | ?3-Guanidinopropionic Acid? | 5 g | 2030 |
| Cayman2015 | 16725 | ?3-Guanidinopropionic Acid? | 500 mg | 350 |
| Cayman2015 | 16726 | Sotrastaurin? | 1 mg | 546 |
| Cayman2015 | 16726 | Sotrastaurin? | 10 mg | 4102 |
| Cayman2015 | 16726 | Sotrastaurin? | 5 mg | 2324 |
| Cayman2015 | 16727 | Tideglusib? | 10 mg | 672 |
| Cayman2015 | 16727 | Tideglusib? | 5 mg | 350 |
| Cayman2015 | 16727 | Tideglusib? | 50 mg | 2282 |
| Cayman2015 | 16728 | AZD 2858? | 1 mg | 350 |
| Cayman2015 | 16728 | AZD 2858? | 10 mg | 1932 |
| Cayman2015 | 16728 | AZD 2858? | 5 mg | 1316 |
| Cayman2015 | 16729 | ZM 39923 (hydrochloride?) | 1 mg | 490 |
| Cayman2015 | 16729 | ZM 39923 (hydrochloride?) | 10 mg | 1960 |
| Cayman2015 | 16729 | ZM 39923 (hydrochloride?) | 5 mg | 1232 |
| Cayman2015 | 16730 | 15(R)-15-methyl Prostaglandin F2α | 1 mg | 714 |
| Cayman2015 | 16730 | 15(R)-15-methyl Prostaglandin F2α | 10 mg | 5712 |
| Cayman2015 | 16730 | 15(R)-15-methyl Prostaglandin F2α | 5 mg | 3220 |
| Cayman2015 | 16731 | AZ 960 | 1 mg | 1330 |
| Cayman2015 | 16731 | AZ 960 | 10 mg | 7322 |
| Cayman2015 | 16731 | AZ 960 | 5 mg | 4662 |
| Cayman2015 | 16732 | CEP-33779? | 1 mg | 1386 |
| Cayman2015 | 16732 | CEP-33779? | 5 mg | 3626 |
| Cayman2015 | 16732 | CEP-33779? | 500 μg | 770 |
| Cayman2015 | 16733 | 1-Azakenpaullone? | 1 mg | 1185 |
| Cayman2015 | 16733 | 1-Azakenpaullone? | 5 mg | 5040 |
| Cayman2015 | 16734 | 15(R)-15-methyl Prostaglandin F2α methyl ester | 1 mg | 588 |
| Cayman2015 | 16734 | 15(R)-15-methyl Prostaglandin F2α methyl ester | 10 mg | 4704 |
| Cayman2015 | 16734 | 15(R)-15-methyl Prostaglandin F2α methyl ester | 5 mg | 2646 |
| Cayman2015 | 16735 | AL 8810 | 1 mg | 1176 |
| Cayman2015 | 16735 | AL 8810 | 10 mg | 9408 |
| Cayman2015 | 16735 | AL 8810 | 25 mg | 20580 |
| Cayman2015 | 16735 | AL 8810 | 5 mg | 5292 |
| Cayman2015 | 16736 | Histone (calf thymus)? | 100 mg | 770 |
| Cayman2015 | 16736 | Histone (calf thymus)? | 25 mg | 350 |
| Cayman2015 | 16736 | Histone (calf thymus)? | 50 mg | 532 |
| Cayman2015 | 16737 | Goat Anti-Human IgG Fc-Spec:HRP | 1 mg | 2130 |
| Cayman2015 | 16738 | Goat Anti-Mouse (H+L):HRP | 1 mg | 2130 |
| Cayman2015 | 16740 | 15(R)-Prostaglandin F2α | 1 mg | 1078 |
| Cayman2015 | 16740 | 15(R)-Prostaglandin F2α | 10 mg | 8820 |
| Cayman2015 | 16740 | 15(R)-Prostaglandin F2α | 5 mg | 5040 |
| Cayman2015 | 16740 | 15(R)-Prostaglandin F2α | 500 μg | 630 |
| Cayman2015 | 16741 | Goat Anti-Rabbit (H+L):HRP | 1 mg | 2130 |
| Cayman2015 | 16742 | Goat Anti-Rabbit IgG Fc-Spec:HRP | 1 mg | 2130 |
| Cayman2015 | 16743 | 15(S)-15-methyl Prostaglandin F2α | 1 mg | 1568 |
| Cayman2015 | 16743 | 15(S)-15-methyl Prostaglandin F2α | 10 mg | 12544 |
| Cayman2015 | 16743 | 15(S)-15-methyl Prostaglandin F2α | 5 mg | 7056 |
| Cayman2015 | 16744 | 15(S)-15-methyl Prostaglandin F2α methyl ester | 1 mg | 588 |
| Cayman2015 | 16744 | 15(S)-15-methyl Prostaglandin F2α methyl ester | 10 mg | 4704 |
| Cayman2015 | 16744 | 15(S)-15-methyl Prostaglandin F2α methyl ester | 5 mg | 2646 |
| Cayman2015 | 16745 | Mouse Anti-6HIS IgG:HRP | 100 μg | 4710 |
| Cayman2015 | 16746 | Mouse Anti-HA IgG:HRP | 100 μg | 4710 |
| Cayman2015 | 16747 | Streptavidin:HRP | 1 mg | 2250 |
| Cayman2015 | 16748 | 3,3'-Diiodo-L-thyronine | 1 mg | 1386 |
| Cayman2015 | 16748 | 3,3'-Diiodo-L-thyronine | 10 mg | 10780 |
| Cayman2015 | 16748 | 3,3'-Diiodo-L-thyronine | 5 mg | 6160 |
| Cayman2015 | 16748 | 3,3'-Diiodo-L-thyronine | 500 μg | 770 |
| Cayman2015 | 16749 | D-Carnitine | 1 g | 5390 |
| Cayman2015 | 16749 | D-Carnitine | 100 mg | 882 |
| Cayman2015 | 16749 | D-Carnitine | 50 mg | 490 |
| Cayman2015 | 16749 | D-Carnitine | 500 mg | 3430 |
| Cayman2015 | 16750 | 16,16-dimethyl Prostaglandin F2α | 1 mg | 924 |
| Cayman2015 | 16750 | 16,16-dimethyl Prostaglandin F2α | 10 mg | 7392 |
| Cayman2015 | 16750 | 16,16-dimethyl Prostaglandin F2α | 5 mg | 4158 |
| Cayman2015 | 16751 | Biocytin? | 10 mg | 406 |
| Cayman2015 | 16751 | Biocytin? | 100 mg | 1946 |
| Cayman2015 | 16751 | Biocytin? | 25 mg | 812 |
| Cayman2015 | 16751 | Biocytin? | 50 mg | 1120 |
| Cayman2015 | 16752 | Palonosetron (hydrochloride?) | 10 mg | 1484 |
| Cayman2015 | 16752 | Palonosetron (hydrochloride?) | 5 mg | 826 |
| Cayman2015 | 16752 | Palonosetron (hydrochloride?) | 50 mg | 4130 |
| Cayman2015 | 16753 | Deferasirox? | 1 mg | 406 |
| Cayman2015 | 16753 | Deferasirox? | 10 mg | 2646 |
| Cayman2015 | 16753 | Deferasirox? | 25 mg | 6090 |
| Cayman2015 | 16753 | Deferasirox? | 5 mg | 1386 |
| Cayman2015 | 16754 | Bialaphos (sodium salt?) | 10 mg | 350 |
| Cayman2015 | 16754 | Bialaphos (sodium salt?) | 100 mg | 1932 |
| Cayman2015 | 16754 | Bialaphos (sodium salt?) | 50 mg | 1316 |
| Cayman2015 | 16755 | ?4-Nitrophenyl-N-acetyl-α-D-galactosaminide? | 1 mg | 490 |
| Cayman2015 | 16755 | ?4-Nitrophenyl-N-acetyl-α-D-galactosaminide? | 10 mg | 1960 |
| Cayman2015 | 16755 | ?4-Nitrophenyl-N-acetyl-α-D-galactosaminide? | 25 mg | 4172 |
| Cayman2015 | 16755 | ?4-Nitrophenyl-N-acetyl-α-D-galactosaminide? | 5 mg | 1232 |
| Cayman2015 | 16758 | PTC-124? | 10 mg | 980 |
| Cayman2015 | 16758 | PTC-124? | 25 mg | 2184 |
| Cayman2015 | 16758 | PTC-124? | 5 mg | 546 |
| Cayman2015 | 16758 | PTC-124? | 50 mg | 3556 |
| Cayman2015 | 16760 | 16-phenoxy tetranor Prostaglandin F2α | 1 mg | 714 |
| Cayman2015 | 16760 | 16-phenoxy tetranor Prostaglandin F2α | 10 mg | 5712 |
| Cayman2015 | 16760 | 16-phenoxy tetranor Prostaglandin F2α | 5 mg | 3220 |
| Cayman2015 | 16763 | Creatinine-d3? | 1 mg | 882 |
| Cayman2015 | 16763 | Creatinine-d3? | 10 mg | 4900 |
| Cayman2015 | 16763 | Creatinine-d3? | 5 mg | 3430 |
| Cayman2015 | 16763 | Creatinine-d3? | 500 μg | 490 |
| Cayman2015 | 16764 | Cloprostenol (sodium salt) | 1 mg | 518 |
| Cayman2015 | 16764 | Cloprostenol (sodium salt) | 10 mg | 3374 |
| Cayman2015 | 16764 | Cloprostenol (sodium salt) | 5 mg | 2338 |
| Cayman2015 | 16765 | (+)-Cloprostenol | 1 mg | 686 |
| Cayman2015 | 16765 | (+)-Cloprostenol | 10 mg | 5488 |
| Cayman2015 | 16765 | (+)-Cloprostenol | 5 mg | 3094 |
| Cayman2015 | 16766 | (+)-Cloprostenol (sodium salt) | 1 mg | 686 |
| Cayman2015 | 16766 | (+)-Cloprostenol (sodium salt) | 10 mg | 5488 |
| Cayman2015 | 16766 | (+)-Cloprostenol (sodium salt) | 5 mg | 3094 |
| Cayman2015 | 16768 | Fluprostenol | 1 mg | 714 |
| Cayman2015 | 16768 | Fluprostenol | 10 mg | 5712 |
| Cayman2015 | 16768 | Fluprostenol | 25 mg | 12502 |
| Cayman2015 | 16768 | Fluprostenol | 5 mg | 3220 |
| Cayman2015 | 16769 | Fluprostenol isopropyl ester | 1 mg | 784 |
| Cayman2015 | 16769 | Fluprostenol isopropyl ester | 10 mg | 6272 |
| Cayman2015 | 16769 | Fluprostenol isopropyl ester | 5 mg | 3528 |
| Cayman2015 | 16770 | 16-phenyl tetranor Prostaglandin F2α | 1 mg | 714 |
| Cayman2015 | 16770 | 16-phenyl tetranor Prostaglandin F2α | 10 mg | 5712 |
| Cayman2015 | 16770 | 16-phenyl tetranor Prostaglandin F2α | 5 mg | 3220 |
| Cayman2015 | 16771 | ?CBFβ Inhibitor? | 10 mg | 1540 |
| Cayman2015 | 16771 | ?CBFβ Inhibitor? | 25 mg | 3458 |
| Cayman2015 | 16771 | ?CBFβ Inhibitor? | 5 mg | 812 |
| Cayman2015 | 16772 | R-59-022 | 1 mg | 406 |
| Cayman2015 | 16772 | R-59-022 | 10 mg | 1792 |
| Cayman2015 | 16772 | R-59-022 | 5 mg | 1022 |
| Cayman2015 | 16772 | R-59-022 | 50 mg | 7714 |
| Cayman2015 | 16773 | ?D-(+)-Raffinose (hydrate) | 10 g | 336 |
| Cayman2015 | 16773 | ?D-(+)-Raffinose (hydrate) | 100 g | 1848 |
| Cayman2015 | 16773 | ?D-(+)-Raffinose (hydrate) | 25 g | 546 |
| Cayman2015 | 16773 | ?D-(+)-Raffinose (hydrate) | 50 g | 1008 |
| Cayman2015 | 16774 | ?Uridine-3'-monophosphate (sodium salt) | 10 mg | 1316 |
| Cayman2015 | 16774 | ?Uridine-3'-monophosphate (sodium salt) | 25 mg | 2884 |
| Cayman2015 | 16774 | ?Uridine-3'-monophosphate (sodium salt) | 5 mg | 770 |
| Cayman2015 | 16774 | ?Uridine-3'-monophosphate (sodium salt) | 50 mg | 5012 |
| Cayman2015 | 16775 | β-D-Glucose? | 10 g | 350 |
| Cayman2015 | 16775 | β-D-Glucose? | 100 g | 1582 |
| Cayman2015 | 16775 | β-D-Glucose? | 25 g | 476 |
| Cayman2015 | 16775 | β-D-Glucose? | 50 g | 882 |
| Cayman2015 | 16776 | 5-trans Fluprostenol | 1 mg | 980 |
| Cayman2015 | 16776 | 5-trans Fluprostenol | 10 mg | 7840 |
| Cayman2015 | 16776 | 5-trans Fluprostenol | 5 mg | 4410 |
| Cayman2015 | 16777 | 5-trans Fluprostenol isopropyl ester | 1 mg | 994 |
| Cayman2015 | 16777 | 5-trans Fluprostenol isopropyl ester | 10 mg | 7952 |
| Cayman2015 | 16777 | 5-trans Fluprostenol isopropyl ester | 5 mg | 4480 |
| Cayman2015 | 16777 | 5-trans Fluprostenol isopropyl ester | 50 mg | 31808 |
| Cayman2015 | 16779 | CX-4945? | 1 mg | 1232 |
| Cayman2015 | 16779 | CX-4945? | 10 mg | 3976 |
| Cayman2015 | 16779 | CX-4945? | 5 mg | 2338 |
| Cayman2015 | 16779 | CX-4945? | 500 μg | 686 |
| Cayman2015 | 16780 | 2,3-dinor Fluprostenol | 100 μg | 4788 |
| Cayman2015 | 16780 | 2,3-dinor Fluprostenol | 25 μg | 1330 |
| Cayman2015 | 16780 | 2,3-dinor Fluprostenol | 50 μg | 2534 |
| Cayman2015 | 16781 | 9-keto Fluprostenol | 1 mg | 812 |
| Cayman2015 | 16781 | 9-keto Fluprostenol | 10 mg | 6496 |
| Cayman2015 | 16781 | 9-keto Fluprostenol | 5 mg | 3654 |
| Cayman2015 | 16782 | 9-keto Fluprostenol isopropyl ester | 1 mg | 994 |
| Cayman2015 | 16782 | 9-keto Fluprostenol isopropyl ester | 10 mg | 7952 |
| Cayman2015 | 16782 | 9-keto Fluprostenol isopropyl ester | 5 mg | 4480 |
| Cayman2015 | 16783 | 11-keto Fluprostenol | 1 mg | 812 |
| Cayman2015 | 16783 | 11-keto Fluprostenol | 10 mg | 6496 |
| Cayman2015 | 16783 | 11-keto Fluprostenol | 5 mg | 3654 |
| Cayman2015 | 16785 | 15-keto Fluprostenol | 1 mg | 686 |
| Cayman2015 | 16785 | 15-keto Fluprostenol | 10 mg | 5488 |
| Cayman2015 | 16785 | 15-keto Fluprostenol | 5 mg | 3094 |
| Cayman2015 | 16786 | 15-keto Fluprostenol isopropyl ester | 1 mg | 994 |
| Cayman2015 | 16786 | 15-keto Fluprostenol isopropyl ester | 10 mg | 7952 |
| Cayman2015 | 16786 | 15-keto Fluprostenol isopropyl ester | 25 mg | 17402 |
| Cayman2015 | 16786 | 15-keto Fluprostenol isopropyl ester | 5 mg | 4480 |
| Cayman2015 | 16787 | 15(S)-Fluprostenol | 1 mg | 770 |
| Cayman2015 | 16787 | 15(S)-Fluprostenol | 10 mg | 6160 |
| Cayman2015 | 16787 | 15(S)-Fluprostenol | 5 mg | 3472 |
| Cayman2015 | 16788 | 15(S)-Fluprostenol isopropyl ester | 1 mg | 952 |
| Cayman2015 | 16788 | 15(S)-Fluprostenol isopropyl ester | 10 mg | 7616 |
| Cayman2015 | 16788 | 15(S)-Fluprostenol isopropyl ester | 5 mg | 4284 |
| Cayman2015 | 16789 | Oxolinic ?Acid | 1 g | 350 |
| Cayman2015 | 16789 | Oxolinic ?Acid | 10 g | 1582 |
| Cayman2015 | 16789 | Oxolinic ?Acid | 25 g | 3500 |
| Cayman2015 | 16789 | Oxolinic ?Acid | 5 g | 882 |
| Cayman2015 | 16791 | Tesaglitazar | 1 mg | 406 |
| Cayman2015 | 16791 | Tesaglitazar | 10 mg | 2240 |
| Cayman2015 | 16791 | Tesaglitazar | 5 mg | 1316 |
| Cayman2015 | 16791 | Tesaglitazar | 50 mg | 10150 |
| Cayman2015 | 16792 | Kynurenic Acid? | 1 g | 406 |
| Cayman2015 | 16792 | Kynurenic Acid? | 5 g | 1470 |
| Cayman2015 | 16792 | Kynurenic Acid? | 500 mg | 266 |
| Cayman2015 | 16793 | (S)-Ibuprofen | 1 g | 476 |
| Cayman2015 | 16793 | (S)-Ibuprofen | 10 g | 2394 |
| Cayman2015 | 16793 | (S)-Ibuprofen | 5 g | 1330 |
| Cayman2015 | 16793 | (S)-Ibuprofen | 500 mg | 266 |
| Cayman2015 | 16794 | ?(R)-Ibuprofen? | 100 mg | 868 |
| Cayman2015 | 16794 | ?(R)-Ibuprofen? | 250 mg | 2016 |
| Cayman2015 | 16794 | ?(R)-Ibuprofen? | 500 mg | 3822 |
| Cayman2015 | 16795 | 3-chloro-5-hydroxy BA | 100 mg | 1260 |
| Cayman2015 | 16795 | 3-chloro-5-hydroxy BA | 25 mg | 392 |
| Cayman2015 | 16795 | 3-chloro-5-hydroxy BA | 50 mg | 672 |
| Cayman2015 | 16795 | 3-chloro-5-hydroxy BA | 500 mg | 5488 |
| Cayman2015 | 16801 | 3-deoxy Galactosone | 1 mg | 770 |
| Cayman2015 | 16801 | 3-deoxy Galactosone | 10 mg | 6160 |
| Cayman2015 | 16801 | 3-deoxy Galactosone | 5 mg | 3472 |
| Cayman2015 | 16803 | Luminol | 10 g | 882 |
| Cayman2015 | 16803 | Luminol | 25 g | 1960 |
| Cayman2015 | 16803 | Luminol | 5 g | 490 |
| Cayman2015 | 16803 | Luminol | 50 g | 3430 |
| Cayman2015 | 16804 | Brassinazole? | 1 mg | 826 |
| Cayman2015 | 16804 | Brassinazole? | 10 mg | 3962 |
| Cayman2015 | 16804 | Brassinazole? | 5 mg | 2478 |
| Cayman2015 | 16805 | Sulindac sulfone | 1 mg | 350 |
| Cayman2015 | 16805 | Sulindac sulfone | 10 mg | 1330 |
| Cayman2015 | 16805 | Sulindac sulfone | 25 mg | 2534 |
| Cayman2015 | 16805 | Sulindac sulfone | 5 mg | 784 |
| Cayman2015 | 16806 | ?4α-Phorbol 12-myristate 13-acetate? | 1 mg | 825 |
| Cayman2015 | 16807 | (S)-(+)-Methoprene? | 1 g | 2450 |
| Cayman2015 | 16807 | (S)-(+)-Methoprene? | 100 mg | 350 |
| Cayman2015 | 16807 | (S)-(+)-Methoprene? | 250 mg | 784 |
| Cayman2015 | 16807 | (S)-(+)-Methoprene? | 500 mg | 1316 |
| Cayman2015 | 16808 | ?Dibenzylfluorescein? | 1 mg | 490 |
| Cayman2015 | 16808 | ?Dibenzylfluorescein? | 10 mg | 3682 |
| Cayman2015 | 16808 | ?Dibenzylfluorescein? | 25 mg | 7966 |
| Cayman2015 | 16808 | ?Dibenzylfluorescein? | 5 mg | 1960 |
| Cayman2015 | 16810 | 17-phenyl trinor Prostaglandin F2α | 1 mg | 644 |
| Cayman2015 | 16810 | 17-phenyl trinor Prostaglandin F2α | 10 mg | 5152 |
| Cayman2015 | 16810 | 17-phenyl trinor Prostaglandin F2α | 25 mg | 11270 |
| Cayman2015 | 16810 | 17-phenyl trinor Prostaglandin F2α | 5 mg | 2898 |
| Cayman2015 | 16811 | Latanoprost (free acid) | 1 mg | 770 |
| Cayman2015 | 16811 | Latanoprost (free acid) | 10 mg | 6160 |
| Cayman2015 | 16811 | Latanoprost (free acid) | 5 mg | 3472 |
| Cayman2015 | 16811 | Latanoprost (free acid) | 50 mg | 26950 |
| Cayman2015 | 16812 | Latanoprost | 1 mg | 630 |
| Cayman2015 | 16812 | Latanoprost | 10 mg | 2520 |
| Cayman2015 | 16812 | Latanoprost | 5 mg | 1890 |
| Cayman2015 | 16812 | Latanoprost | 50 mg | 10080 |
| Cayman2015 | 16813 | 5-trans Latanoprost | 1 mg | 826 |
| Cayman2015 | 16813 | 5-trans Latanoprost | 10 mg | 6608 |
| Cayman2015 | 16813 | 5-trans Latanoprost | 5 mg | 3724 |
| Cayman2015 | 16813 | 5-trans Latanoprost | 50 mg | 28910 |
| Cayman2015 | 16814 | 15(R)-17-phenyl trinor Prostaglandin F2α | 1 mg | 714 |
| Cayman2015 | 16814 | 15(R)-17-phenyl trinor Prostaglandin F2α | 10 mg | 5712 |
| Cayman2015 | 16814 | 15(R)-17-phenyl trinor Prostaglandin F2α | 5 mg | 3220 |
| Cayman2015 | 16815 | 15-keto Latanoprost (free acid) | 1 mg | 672 |
| Cayman2015 | 16815 | 15-keto Latanoprost (free acid) | 10 mg | 5376 |
| Cayman2015 | 16815 | 15-keto Latanoprost (free acid) | 5 mg | 3024 |
| Cayman2015 | 16816 | 15-keto Latanoprost | 1 mg | 672 |
| Cayman2015 | 16816 | 15-keto Latanoprost | 10 mg | 5376 |
| Cayman2015 | 16816 | 15-keto Latanoprost | 5 mg | 3024 |
| Cayman2015 | 16817 | 15-keto-17-phenyl trinor Prostaglandin F2α | 1 mg | 714 |
| Cayman2015 | 16817 | 15-keto-17-phenyl trinor Prostaglandin F2α | 10 mg | 5712 |
| Cayman2015 | 16817 | 15-keto-17-phenyl trinor Prostaglandin F2α | 5 mg | 3220 |
| Cayman2015 | 16818 | 15(S)-Latanoprost | 1 mg | 798 |
| Cayman2015 | 16818 | 15(S)-Latanoprost | 10 mg | 6384 |
| Cayman2015 | 16818 | 15(S)-Latanoprost | 5 mg | 3598 |
| Cayman2015 | 16818 | 15(S)-Latanoprost | 50 mg | 27930 |
| Cayman2015 | 16820 | 17-phenyl trinor Prostaglandin F2α ethyl amide | 1 mg | 630 |
| Cayman2015 | 16820 | 17-phenyl trinor Prostaglandin F2α ethyl amide | 10 mg | 4102 |
| Cayman2015 | 16820 | 17-phenyl trinor Prostaglandin F2α ethyl amide | 5 mg | 2842 |
| Cayman2015 | 16820 | 17-phenyl trinor Prostaglandin F2α ethyl amide | 50 mg | 10234 |
| Cayman2015 | 16821 | 17-phenyl trinor Prostaglandin F2α amide | 1 mg | 714 |
| Cayman2015 | 16821 | 17-phenyl trinor Prostaglandin F2α amide | 10 mg | 5712 |
| Cayman2015 | 16821 | 17-phenyl trinor Prostaglandin F2α amide | 5 mg | 3220 |
| Cayman2015 | 16822 | Latanoprost ethyl amide | 1 mg | 742 |
| Cayman2015 | 16822 | Latanoprost ethyl amide | 10 mg | 5936 |
| Cayman2015 | 16822 | Latanoprost ethyl amide | 5 mg | 3346 |
| Cayman2015 | 16823 | 17-phenyl trinor Prostaglandin F2α diethyl amide | 1 mg | 798 |
| Cayman2015 | 16823 | 17-phenyl trinor Prostaglandin F2α diethyl amide | 10 mg | 6384 |
| Cayman2015 | 16823 | 17-phenyl trinor Prostaglandin F2α diethyl amide | 5 mg | 3598 |
| Cayman2015 | 16824 | 17-phenyl trinor Prostaglandin F2α isopropyl ester | 1 mg | 826 |
| Cayman2015 | 16824 | 17-phenyl trinor Prostaglandin F2α isopropyl ester | 10 mg | 6608 |
| Cayman2015 | 16824 | 17-phenyl trinor Prostaglandin F2α isopropyl ester | 5 mg | 3724 |
| Cayman2015 | 16825 | 15(R)-17-phenyl trinor Prostaglandin F2α isopropyl ester | 1 mg | 826 |
| Cayman2015 | 16825 | 15(R)-17-phenyl trinor Prostaglandin F2α isopropyl ester | 10 mg | 6608 |
| Cayman2015 | 16825 | 15(R)-17-phenyl trinor Prostaglandin F2α isopropyl ester | 5 mg | 3724 |
| Cayman2015 | 16825 | 15(R)-17-phenyl trinor Prostaglandin F2α isopropyl ester | 50 mg | 28910 |
| Cayman2015 | 16827 | N-undecanoyl-L-Homoserine lactone | 10 mg | 798 |
| Cayman2015 | 16827 | N-undecanoyl-L-Homoserine lactone | 25 mg | 1890 |
| Cayman2015 | 16827 | N-undecanoyl-L-Homoserine lactone | 5 mg | 420 |
| Cayman2015 | 16827 | N-undecanoyl-L-Homoserine lactone | 50 mg | 3360 |
| Cayman2015 | 16831 | Cicaprost | 1 mg | 4872 |
| Cayman2015 | 16831 | Cicaprost | 5 mg | 20496 |
| Cayman2015 | 16831 | Cicaprost | 500 μg | 2562 |
| Cayman2015 | 16833 | Lisinopril | 1 g | 784 |
| Cayman2015 | 16833 | Lisinopril | 100 mg | 98 |
| Cayman2015 | 16833 | Lisinopril | 5 g | 3430 |
| Cayman2015 | 16833 | Lisinopril | 500 mg | 448 |
| Cayman2015 | 16834 | Hexadecanal-d5 | 1 mg | 1624 |
| Cayman2015 | 16834 | Hexadecanal-d5 | 5 mg | 6832 |
| Cayman2015 | 16834 | Hexadecanal-d5 | 500 μg | 854 |
| Cayman2015 | 16835 | CAY10580 | 1 mg | 1512 |
| Cayman2015 | 16835 | CAY10580 | 10 mg | 11172 |
| Cayman2015 | 16835 | CAY10580 | 5 mg | 6384 |
| Cayman2015 | 16835 | CAY10580 | 500 μg | 798 |
| Cayman2015 | 16837 | β-Carotene | 10 g | 560 |
| Cayman2015 | 16837 | β-Carotene | 25 g | 1330 |
| Cayman2015 | 16837 | β-Carotene | 5 g | 294 |
| Cayman2015 | 16837 | β-Carotene | 50 g | 2352 |
| Cayman2015 | 16838 | CAY10581 | 1 mg | 406 |
| Cayman2015 | 16838 | CAY10581 | 10 mg | 3248 |
| Cayman2015 | 16838 | CAY10581 | 25 mg | 7112 |
| Cayman2015 | 16838 | CAY10581 | 5 mg | 1834 |
| Cayman2015 | 16840 | tetranor-PGFM | 100 μg | 5446 |
| Cayman2015 | 16840 | tetranor-PGFM | 25 μg | 1512 |
| Cayman2015 | 16840 | tetranor-PGFM | 50 μg | 2870 |
| Cayman2015 | 16841 | NBD-FTY720 phenoxy (hydrochloride) | 1 mg | 2912 |
| Cayman2015 | 16841 | NBD-FTY720 phenoxy (hydrochloride) | 100 μg | 364 |
| Cayman2015 | 16841 | NBD-FTY720 phenoxy (hydrochloride) | 5 mg | 12740 |
| Cayman2015 | 16841 | NBD-FTY720 phenoxy (hydrochloride) | 500 μg | 1638 |
| Cayman2015 | 16844 | LED209 | 1 mg | 154 |
| Cayman2015 | 16844 | LED209 | 10 mg | 1232 |
| Cayman2015 | 16844 | LED209 | 5 mg | 700 |
| Cayman2015 | 16844 | LED209 | 50 mg | 5390 |
| Cayman2015 | 16851 | (±)-CP 47,497 (exempt preparation) | 10 mg | 1582 |
| Cayman2015 | 16851 | (±)-CP 47,497 (exempt preparation) | 25 mg | 3570 |
| Cayman2015 | 16851 | (±)-CP 47,497 (exempt preparation) | 5 mg | 882 |
| Cayman2015 | 16853 | 13,14-dihydro-15-keto-tetranor Prostaglandin F1β | 10 μg | 448 |
| Cayman2015 | 16853 | 13,14-dihydro-15-keto-tetranor Prostaglandin F1β | 100 μg | 3584 |
| Cayman2015 | 16853 | 13,14-dihydro-15-keto-tetranor Prostaglandin F1β | 25 μg | 1064 |
| Cayman2015 | 16853 | 13,14-dihydro-15-keto-tetranor Prostaglandin F1β | 50 μg | 2016 |
| Cayman2015 | 16854 | 8(Z),14(Z)-Eicosadienoic Acid | 1 mg | 7616 |
| Cayman2015 | 16854 | 8(Z),14(Z)-Eicosadienoic Acid | 100 μg | 952 |
| Cayman2015 | 16854 | 8(Z),14(Z)-Eicosadienoic Acid | 500 μg | 4284 |
| Cayman2015 | 16860 | Swainsonine | 1 mg | 1148 |
| Cayman2015 | 16860 | Swainsonine | 10 mg | 8428 |
| Cayman2015 | 16860 | Swainsonine | 5 mg | 4816 |
| Cayman2015 | 16860 | Swainsonine | 500 μg | 602 |
| Cayman2015 | 16862 | Ximelagatran? | 1 mg | 1736 |
| Cayman2015 | 16862 | Ximelagatran? | 5 mg | 7280 |
| Cayman2015 | 16862 | Ximelagatran? | 500 μg | 910 |
| Cayman2015 | 16866 | Coenzyme Q9 | 1 mg | 770 |
| Cayman2015 | 16866 | Coenzyme Q9 | 10 mg | 5684 |
| Cayman2015 | 16866 | Coenzyme Q9 | 5 mg | 3248 |
| Cayman2015 | 16866 | Coenzyme Q9 | 500 μg | 406 |
| Cayman2015 | 16868 | N-nonanoyl-L-Homoserine lactone | 10 mg | 686 |
| Cayman2015 | 16868 | N-nonanoyl-L-Homoserine lactone | 25 mg | 1638 |
| Cayman2015 | 16868 | N-nonanoyl-L-Homoserine lactone | 5 mg | 364 |
| Cayman2015 | 16868 | N-nonanoyl-L-Homoserine lactone | 50 mg | 2912 |
| Cayman2015 | 16871 | ?(R)-3-hydroxy Myristic Acid? | 10 mg | 490 |
| Cayman2015 | 16871 | ?(R)-3-hydroxy Myristic Acid? | 100 mg | 3192 |
| Cayman2015 | 16871 | ?(R)-3-hydroxy Myristic Acid? | 25 mg | 1106 |
| Cayman2015 | 16871 | ?(R)-3-hydroxy Myristic Acid? | 50 mg | 1960 |
| Cayman2015 | 16873 | OTSSP167 (hydrochloride) | 1 mg | 686 |
| Cayman2015 | 16873 | OTSSP167 (hydrochloride) | 10 mg | 5488 |
| Cayman2015 | 16873 | OTSSP167 (hydrochloride) | 5 mg | 3094 |
| Cayman2015 | 16874 | Nexturastat A? | 1 mg | 1232 |
| Cayman2015 | 16874 | Nexturastat A? | 10 mg | 9604 |
| Cayman2015 | 16874 | Nexturastat A? | 5 mg | 5488 |
| Cayman2015 | 16874 | Nexturastat A? | 500 μg | 686 |
| Cayman2015 | 16875 | AZ 505 | 1 mg | 980 |
| Cayman2015 | 16875 | AZ 505 | 10 mg | 5460 |
| Cayman2015 | 16875 | AZ 505 | 5 mg | 3822 |
| Cayman2015 | 16875 | AZ 505 | 500 μg | 546 |
| Cayman2015 | 16876 | AZD 2461? | 1 mg | 490 |
| Cayman2015 | 16876 | AZD 2461? | 10 mg | 3920 |
| Cayman2015 | 16876 | AZD 2461? | 25 mg | 7350 |
| Cayman2015 | 16876 | AZD 2461? | 5 mg | 2086 |
| Cayman2015 | 16877 | ?(4-Chloro-3,5-dimethylphenoxy)acetic Acid? | 100 mg | 980 |
| Cayman2015 | 16877 | ?(4-Chloro-3,5-dimethylphenoxy)acetic Acid? | 250 mg | 2184 |
| Cayman2015 | 16877 | ?(4-Chloro-3,5-dimethylphenoxy)acetic Acid? | 50 mg | 546 |
| Cayman2015 | 16877 | ?(4-Chloro-3,5-dimethylphenoxy)acetic Acid? | 500 mg | 3822 |
| Cayman2015 | 16880 | Guanylyl Imidodiphosphate | 1 mg | 490 |
| Cayman2015 | 16880 | Guanylyl Imidodiphosphate | 10 mg | 2450 |
| Cayman2015 | 16880 | Guanylyl Imidodiphosphate | 25 mg | 4900 |
| Cayman2015 | 16880 | Guanylyl Imidodiphosphate | 5 mg | 1344 |
| Cayman2015 | 16881 | Polyinosinic-polycytidylic Acid (potassium salt?) | 50 mg | 6510 |
| Cayman2015 | 16882 | Clozapine N-oxide? | 1 mg | 392 |
| Cayman2015 | 16882 | Clozapine N-oxide? | 10 mg | 1568 |
| Cayman2015 | 16882 | Clozapine N-oxide? | 25 mg | 3430 |
| Cayman2015 | 16882 | Clozapine N-oxide? | 5 mg | 1176 |
| Cayman2015 | 16885 | (+)-Evodiamine | 1 g | 4872 |
| Cayman2015 | 16885 | (+)-Evodiamine | 100 mg | 728 |
| Cayman2015 | 16885 | (+)-Evodiamine | 250 mg | 1386 |
| Cayman2015 | 16885 | (+)-Evodiamine | 50 mg | 406 |
| Cayman2015 | 16886 | NNGH? | 1 mg | 350 |
| Cayman2015 | 16886 | NNGH? | 10 mg | 1162 |
| Cayman2015 | 16886 | NNGH? | 25 mg | 2632 |
| Cayman2015 | 16886 | NNGH? | 5 mg | 630 |
| Cayman2015 | 16889 | ?DL-α-Difluoromethylornithine (hydrochloride hydrate)? | 100 mg | 910 |
| Cayman2015 | 16889 | ?DL-α-Difluoromethylornithine (hydrochloride hydrate)? | 25 mg | 350 |
| Cayman2015 | 16889 | ?DL-α-Difluoromethylornithine (hydrochloride hydrate)? | 50 mg | 630 |
| Cayman2015 | 16889 | ?DL-α-Difluoromethylornithine (hydrochloride hydrate)? | 500 mg | 3850 |
| Cayman2015 | 16890 | 17-trifluoromethylphenyl trinor Prostaglandin F2α | 1 mg | 686 |
| Cayman2015 | 16890 | 17-trifluoromethylphenyl trinor Prostaglandin F2α | 10 mg | 5488 |
| Cayman2015 | 16890 | 17-trifluoromethylphenyl trinor Prostaglandin F2α | 5 mg | 3094 |
| Cayman2015 | 16891 | GSK 690693 (hydrochloride) | 1 mg | 546 |
| Cayman2015 | 16891 | GSK 690693 (hydrochloride) | 10 mg | 2184 |
| Cayman2015 | 16891 | GSK 690693 (hydrochloride) | 25 mg | 4774 |
| Cayman2015 | 16891 | GSK 690693 (hydrochloride) | 5 mg | 1372 |
| Cayman2015 | 16893 | ?NSC 632839? | 1 mg | 406 |
| Cayman2015 | 16893 | ?NSC 632839? | 10 mg | 1218 |
| Cayman2015 | 16893 | ?NSC 632839? | 25 mg | 2534 |
| Cayman2015 | 16893 | ?NSC 632839? | 5 mg | 812 |
| Cayman2015 | 16894 | Coelenterazine h | 1 mg | 3962 |
| Cayman2015 | 16894 | Coelenterazine h | 500 μg | 2086 |
| Cayman2015 | 16895 | 17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α | 1 mg | 784 |
| Cayman2015 | 16895 | 17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α | 10 mg | 6272 |
| Cayman2015 | 16895 | 17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2α | 5 mg | 3528 |
| Cayman2015 | 16898 | JX-401 | 1 mg | 630 |
| Cayman2015 | 16898 | JX-401 | 10 mg | 2212 |
| Cayman2015 | 16898 | JX-401 | 5 mg | 1260 |
| Cayman2015 | 16898 | JX-401 | 50 mg | 9450 |
| Cayman2015 | 16899 | BRL 50481 | 10 mg | 882 |
| Cayman2015 | 16899 | BRL 50481 | 25 mg | 1960 |
| Cayman2015 | 16899 | BRL 50481 | 5 mg | 490 |
| Cayman2015 | 16899 | BRL 50481 | 50 mg | 3430 |
| Cayman2015 | 16910 | 19(R)-hydroxy Prostaglandin F2α | 100 μg | 1148 |
| Cayman2015 | 16910 | 19(R)-hydroxy Prostaglandin F2α | 50 μg | 602 |
| Cayman2015 | 16910 | 19(R)-hydroxy Prostaglandin F2α | 500 μg | 4816 |
| Cayman2015 | 16915 | GW 441756 | 1 mg | 525 |
| Cayman2015 | 16915 | GW 441756 | 10 mg | 1575 |
| Cayman2015 | 16915 | GW 441756 | 5 mg | 1050 |
| Cayman2015 | 16917 | RGFP 966 | 1 mg | 350 |
| Cayman2015 | 16917 | RGFP 966 | 10 mg | 2100 |
| Cayman2015 | 16917 | RGFP 966 | 5 mg | 1316 |
| Cayman2015 | 16919 | BRD73954 | 10 mg | 7280 |
| Cayman2015 | 16919 | BRD73954 | 5 mg | 4102 |
| Cayman2015 | 16920 | 15(R),19(R)-hydroxy Prostaglandin F2α | 100 μg | 826 |
| Cayman2015 | 16920 | 15(R),19(R)-hydroxy Prostaglandin F2α | 50 μg | 434 |
| Cayman2015 | 16920 | 15(R),19(R)-hydroxy Prostaglandin F2α | 500 μg | 3472 |
| Cayman2015 | 16921 | ?Metformin-d6 (hydrochloride?) | 1 mg | 1386 |
| Cayman2015 | 16921 | ?Metformin-d6 (hydrochloride?) | 5 mg | 5390 |
| Cayman2015 | 16921 | ?Metformin-d6 (hydrochloride?) | 500 μg | 770 |
| Cayman2015 | 16923 | Clinafloxacin (hydrochloride) | 1 g | 5250 |
| Cayman2015 | 16923 | Clinafloxacin (hydrochloride) | 100 mg | 1050 |
| Cayman2015 | 16923 | Clinafloxacin (hydrochloride) | 250 mg | 2100 |
| Cayman2015 | 16923 | Clinafloxacin (hydrochloride) | 500 mg | 3360 |
| Cayman2015 | 16924 | α-Naphthoflavone | 1 g | 350 |
| Cayman2015 | 16924 | α-Naphthoflavone | 10 g | 1750 |
| Cayman2015 | 16924 | α-Naphthoflavone | 25 g | 3500 |
| Cayman2015 | 16924 | α-Naphthoflavone | 5 g | 966 |
| Cayman2015 | 16928 | CL-82198 | 10 mg | 1302 |
| Cayman2015 | 16928 | CL-82198 | 25 mg | 3094 |
| Cayman2015 | 16928 | CL-82198 | 5 mg | 686 |
| Cayman2015 | 16928 | CL-82198 | 50 mg | 5488 |
| Cayman2015 | 16929 | WSP-5 | 1 mg | 490 |
| Cayman2015 | 16929 | WSP-5 | 10 mg | 3920 |
| Cayman2015 | 16929 | WSP-5 | 5 mg | 2212 |
| Cayman2015 | 16930 | ?Allopregnanolone? | 1 mg | 350 |
| Cayman2015 | 16930 | ?Allopregnanolone? | 10 mg | 1932 |
| Cayman2015 | 16930 | ?Allopregnanolone? | 5 mg | 1316 |
| Cayman2015 | 16931 | Desloratadine | 1 g | 6552 |
| Cayman2015 | 16931 | Desloratadine | 100 mg | 1036 |
| Cayman2015 | 16931 | Desloratadine | 50 mg | 546 |
| Cayman2015 | 16931 | Desloratadine | 500 mg | 4102 |
| Cayman2015 | 16932 | Limonin? | 1 g | 8190 |
| Cayman2015 | 16932 | Limonin? | 100 mg | 1204 |
| Cayman2015 | 16932 | Limonin? | 50 mg | 630 |
| Cayman2015 | 16932 | Limonin? | 500 mg | 5040 |
| Cayman2015 | 16933 | Arbidol (hydrochloride) | 10 mg | 980 |
| Cayman2015 | 16933 | Arbidol (hydrochloride) | 100 mg | 4802 |
| Cayman2015 | 16933 | Arbidol (hydrochloride) | 5 mg | 546 |
| Cayman2015 | 16933 | Arbidol (hydrochloride) | 50 mg | 2674 |
| Cayman2015 | 16934 | Doripenem? | 10 mg | 686 |
| Cayman2015 | 16934 | Doripenem? | 100 mg | 4802 |
| Cayman2015 | 16934 | Doripenem? | 25 mg | 1624 |
| Cayman2015 | 16934 | Doripenem? | 50 mg | 3094 |
| Cayman2015 | 16935 | Cariporide | 10 mg | 1232 |
| Cayman2015 | 16935 | Cariporide | 100 mg | 9604 |
| Cayman2015 | 16935 | Cariporide | 5 mg | 686 |
| Cayman2015 | 16935 | Cariporide | 50 mg | 5488 |
| Cayman2015 | 16936 | 2'-O-Methyladenosine | 10 mg | 630 |
| Cayman2015 | 16936 | 2'-O-Methyladenosine | 100 mg | 2240 |
| Cayman2015 | 16936 | 2'-O-Methyladenosine | 5 mg | 350 |
| Cayman2015 | 16936 | 2'-O-Methyladenosine | 50 mg | 1302 |
| Cayman2015 | 16938 | Tomatidine (hydrochloride?) | 10 mg | 350 |
| Cayman2015 | 16938 | Tomatidine (hydrochloride?) | 100 mg | 2282 |
| Cayman2015 | 16938 | Tomatidine (hydrochloride?) | 25 mg | 658 |
| Cayman2015 | 16938 | Tomatidine (hydrochloride?) | 50 mg | 1232 |
| Cayman2015 | 16939 | Ranitidine? (hydrochloride) | 1 g | 350 |
| Cayman2015 | 16939 | Ranitidine? (hydrochloride) | 5 g | 616 |
| Cayman2015 | 16940 | 20-ethyl Prostaglandin F2α | 1 mg | 714 |
| Cayman2015 | 16940 | 20-ethyl Prostaglandin F2α | 10 mg | 5712 |
| Cayman2015 | 16940 | 20-ethyl Prostaglandin F2α | 5 mg | 3220 |
| Cayman2015 | 16942 | ?Glycochenodeoxycholic Acid (sodium salt?) | 100 mg | 630 |
| Cayman2015 | 16942 | ?Glycochenodeoxycholic Acid (sodium salt?) | 25 mg | 350 |
| Cayman2015 | 16942 | ?Glycochenodeoxycholic Acid (sodium salt?) | 50 mg | 532 |
| Cayman2015 | 16942 | ?Glycochenodeoxycholic Acid (sodium salt?) | 500 mg | 2100 |
| Cayman2015 | 16944 | (-)-Gallocatechin? | 1 mg | 350 |
| Cayman2015 | 16944 | (-)-Gallocatechin? | 10 mg | 1932 |
| Cayman2015 | 16944 | (-)-Gallocatechin? | 25 mg | 3934 |
| Cayman2015 | 16944 | (-)-Gallocatechin? | 5 mg | 1050 |
| Cayman2015 | 16945 | SCH 202676? (hydrobromide) | 10 mg | 1302 |
| Cayman2015 | 16945 | SCH 202676? (hydrobromide) | 25 mg | 3094 |
| Cayman2015 | 16945 | SCH 202676? (hydrobromide) | 5 mg | 686 |
| Cayman2015 | 16945 | SCH 202676? (hydrobromide) | 50 mg | 5488 |
| Cayman2015 | 16946 | ?7,8-Dihydroxyflavone? | 1 g | 1092 |
| Cayman2015 | 16946 | ?7,8-Dihydroxyflavone? | 100 mg | 546 |
| Cayman2015 | 16948 | L-Acetylcarnitine (chloride) | 1 g | 350 |
| Cayman2015 | 16948 | L-Acetylcarnitine (chloride) | 10 g | 1372 |
| Cayman2015 | 16948 | L-Acetylcarnitine (chloride) | 25 g | 2632 |
| Cayman2015 | 16948 | L-Acetylcarnitine (chloride) | 5 g | 784 |
| Cayman2015 | 16949 | 1,3,7-Trimethyluric Acid | 100 mg | 2464 |
| Cayman2015 | 16949 | 1,3,7-Trimethyluric Acid | 25 mg | 686 |
| Cayman2015 | 16949 | 1,3,7-Trimethyluric Acid | 250 mg | 5488 |
| Cayman2015 | 16949 | 1,3,7-Trimethyluric Acid | 50 mg | 1302 |
| Cayman2015 | 16950 | 20-hydroxy Prostaglandin F2α | 100 μg | 3220 |
| Cayman2015 | 16950 | 20-hydroxy Prostaglandin F2α | 50 μg | 714 |
| Cayman2015 | 16950 | 20-hydroxy Prostaglandin F2α | 500 μg | 5712 |
| Cayman2015 | 16951 | ?Sanguinarine (chloride)? | 1 mg | 350 |
| Cayman2015 | 16951 | ?Sanguinarine (chloride)? | 10 mg | 1750 |
| Cayman2015 | 16951 | ?Sanguinarine (chloride)? | 25 mg | 3934 |
| Cayman2015 | 16951 | ?Sanguinarine (chloride)? | 5 mg | 1050 |
| Cayman2015 | 16953 | Sulforhodamine 101 | 100 mg | 882 |
| Cayman2015 | 16953 | Sulforhodamine 101 | 250 mg | 2086 |
| Cayman2015 | 16953 | Sulforhodamine 101 | 50 mg | 490 |
| Cayman2015 | 16953 | Sulforhodamine 101 | 500 mg | 3430 |
| Cayman2015 | 16954 | Indole-3-Acetic Acid (sodium salt) | 1 g | 350 |
| Cayman2015 | 16954 | Indole-3-Acetic Acid (sodium salt) | 10 g | 2800 |
| Cayman2015 | 16954 | Indole-3-Acetic Acid (sodium salt) | 25 g | 6132 |
| Cayman2015 | 16954 | Indole-3-Acetic Acid (sodium salt) | 5 g | 1582 |
| Cayman2015 | 16956 | Enoxacin | 1 g | 784 |
| Cayman2015 | 16956 | Enoxacin | 5 g | 2450 |
| Cayman2015 | 16956 | Enoxacin | 500 mg | 476 |
| Cayman2015 | 16966 | MDMB-FUBINACA? | 1 mg | 910 |
| Cayman2015 | 16966 | MDMB-FUBINACA? | 10 mg | 7280 |
| Cayman2015 | 16966 | MDMB-FUBINACA? | 5 mg | 4102 |
| Cayman2015 | 16967 | Astemizole | 10 mg | 350 |
| Cayman2015 | 16967 | Astemizole | 100 mg | 1582 |
| Cayman2015 | 16967 | Astemizole | 50 mg | 882 |
| Cayman2015 | 16985 | Rp-Cyclic AMPS (triethylammonium salt) | 1 mg | 1554 |
| Cayman2015 | 16985 | Rp-Cyclic AMPS (triethylammonium salt) | 5 mg | 6832 |
| Cayman2015 | 16985 | Rp-Cyclic AMPS (triethylammonium salt) | 500 μg | 910 |
| Cayman2015 | 16990 | Prostaglandin F3α | 1 mg | 11564 |
| Cayman2015 | 16990 | Prostaglandin F3α | 100 μg | 1568 |
| Cayman2015 | 16990 | Prostaglandin F3α | 50 μg | 826 |
| Cayman2015 | 16990 | Prostaglandin F3α | 500 μg | 6608 |
| Cayman2015 | 16992 | 8-iso Prostaglandin F3α | 100 μg | 5292 |
| Cayman2015 | 16992 | 8-iso Prostaglandin F3α | 50 μg | 2786 |
| Cayman2015 | 16992 | 8-iso Prostaglandin F3α | 500 μg | 22288 |
| Cayman2015 | 16995 | 17-trans Prostaglandin F3α | 100 μg | 1568 |
| Cayman2015 | 16995 | 17-trans Prostaglandin F3α | 25 μg | 490 |
| Cayman2015 | 16995 | 17-trans Prostaglandin F3α | 50 μg | 826 |
| Cayman2015 | 17010 | Prostaglandin G2 | 100 μg | 3626 |
| Cayman2015 | 17010 | Prostaglandin G2 | 25 μg | 1008 |
| Cayman2015 | 17010 | Prostaglandin G2 | 50 μg | 1918 |
| Cayman2015 | 17010 | Prostaglandin G2 | 500 μg | 16128 |
| Cayman2015 | 170100 | Vilogenin (sheepshead minnow) Monoclonal Antibody (ND-5C9) | 100 μL | 5180 |
| Cayman2015 | 170100 | Vilogenin (sheepshead minnow) Monoclonal Antibody (ND-5C9) | 500 μL | 23320 |
| Cayman2015 | 170101 | Vilogenin (brown bullhead) Monoclonal Antibody (ND-1D12) | 100 μL | 5180 |
| Cayman2015 | 170101 | Vilogenin (brown bullhead) Monoclonal Antibody (ND-1D12) | 500 μL | 23320 |
| Cayman2015 | 170105 | Vilogenin (striped bass) Monoclonal Antibody (ND-1C8) | 100 μL | 5180 |
| Cayman2015 | 170105 | Vilogenin (striped bass) Monoclonal Antibody (ND-1C8) | 500 μL | 23320 |
| Cayman2015 | 170107 | Vilogenin (striped bass) Monoclonal Antibody (ND-3G2) | 100 μL | 5180 |
| Cayman2015 | 170107 | Vilogenin (striped bass) Monoclonal Antibody (ND-3G2) | 500 μL | 23320 |
| Cayman2015 | 170115 | Vilogenin (carp) Monoclonal Antibody (ND-2D3) | 100 μL | 5180 |
| Cayman2015 | 170115 | Vilogenin (carp) Monoclonal Antibody (ND-2D3) | 500 μL | 23320 |
| Cayman2015 | 170120 | Vilogenin (Arctic char) Polyclonal Antibody (PO-1) | 100 μL | 4540 |
| Cayman2015 | 170120 | Vilogenin (Arctic char) Polyclonal Antibody (PO-1) | 500 μL | 20440 |
| Cayman2015 | 170130 | Vilogenin (cod) Polyclonal Antibody (CS-1) | 100 μL | 4840 |
| Cayman2015 | 170130 | Vilogenin (cod) Polyclonal Antibody (CS-1) | 500 μL | 21780 |
| Cayman2015 | 170140 | Vilogenin (salmon) Polyclonal Antibody (AA-1) | 100 μL | 4580 |
| Cayman2015 | 170140 | Vilogenin (salmon) Polyclonal Antibody (AA-1) | 500 μL | 20620 |
| Cayman2015 | 170145 | Vilogenin (salmon) Monoclonal Antibody (BN-5) | 100 μL | 5900 |
| Cayman2015 | 170145 | Vilogenin (salmon) Monoclonal Antibody (BN-5) | 500 μL | 26560 |
| Cayman2015 | 170147 | Vilogenin (salmon) Monoclonal Antibody (KB-1) | 100 μL | 4580 |
| Cayman2015 | 170147 | Vilogenin (salmon) Monoclonal Antibody (KB-1) | 500 μL | 20620 |
| Cayman2015 | 17015 | Prostaglandin H1 | 100 μg | 2268 |
| Cayman2015 | 17015 | Prostaglandin H1 | 25 μg | 630 |
| Cayman2015 | 17015 | Prostaglandin H1 | 50 μg | 1204 |
| Cayman2015 | 17015 | Prostaglandin H1 | 500 μg | 10080 |
| Cayman2015 | 170150 | Vilogenin (sea bream) Polyclonal Antibody (PO-2) | 100 μL | 4580 |
| Cayman2015 | 170150 | Vilogenin (sea bream) Polyclonal Antibody (PO-2) | 500 μL | 20620 |
| Cayman2015 | 170165 | Vilogenin (zebrafish) Monoclonal Antibody (JE-2A6) | 100 μL | 5180 |
| Cayman2015 | 170165 | Vilogenin (zebrafish) Monoclonal Antibody (JE-2A6) | 500 μL | 23320 |
| Cayman2015 | 170166 | Vilogenin (zebrafish) Monoclonal Antibody (JE-8D6) | 100 μL | 5180 |
| Cayman2015 | 170166 | Vilogenin (zebrafish) Monoclonal Antibody (JE-8D6) | 500 μL | 23320 |
| Cayman2015 | 170167 | Vilogenin (zebrafish) Monoclonal Antibody (JE-10D4) | 100 μL | 4840 |
| Cayman2015 | 170167 | Vilogenin (zebrafish) Monoclonal Antibody (JE-10D4) | 500 μL | 21780 |
| Cayman2015 | 170170 | Vilogenin (turbot) Polyclonal Antibody (CS-2) | 100 μL | 4840 |
| Cayman2015 | 170170 | Vilogenin (turbot) Polyclonal Antibody (CS-2) | 500 μL | 21780 |
| Cayman2015 | 170180 | Vilogenin (wolffish) Polyclonal Antibody (CS-3) | 100 μL | 4840 |
| Cayman2015 | 170180 | Vilogenin (wolffish) Polyclonal Antibody (CS-3) | 500 μL | 21780 |
| Cayman2015 | 170195 | Vilogenin (killifish) Monoclonal Antibody (ND-5F8) | 100 μL | 5180 |
| Cayman2015 | 170195 | Vilogenin (killifish) Monoclonal Antibody (ND-5F8) | 500 μL | 23320 |
| Cayman2015 | 17020 | Prostaglandin H2 | 100 μg | 1302 |
| Cayman2015 | 17020 | Prostaglandin H2 | 25 μg | 406 |
| Cayman2015 | 17020 | Prostaglandin H2 | 50 μg | 728 |
| Cayman2015 | 17020 | Prostaglandin H2 | 500 μg | 5684 |
| Cayman2015 | 170265 | Vilogenin (sturgeon) Monoclonal Antibody (ND-1H2) | 100 μL | 5180 |
| Cayman2015 | 170265 | Vilogenin (sturgeon) Monoclonal Antibody (ND-1H2) | 500 μL | 23320 |
| Cayman2015 | 17084 | AB-CHMINACA metabolite M7 | 1 mg | 2534 |
| Cayman2015 | 17084 | AB-CHMINACA metabolite M7 | 5 mg | 10640 |
| Cayman2015 | 17084 | AB-CHMINACA metabolite M7 | 500 μg | 1330 |
| Cayman2015 | 171142 | Zona Radiata (salmon) Polyclonal Antibody (O-146) | 100 μL | 4580 |
| Cayman2015 | 171142 | Zona Radiata (salmon) Polyclonal Antibody (O-146) | 500 μL | 20620 |
| Cayman2015 | 172130 | Metallothionein (cod) Polyclonal Antibody (KH-1) | 100 μL | 4580 |
| Cayman2015 | 172130 | Metallothionein (cod) Polyclonal Antibody (KH-1) | 500 μL | 20620 |
| Cayman2015 | 173125 | CYP1A (cod) Monoclonal Antibody (NP-7) | 100 μL | 4580 |
| Cayman2015 | 173125 | CYP1A (cod) Monoclonal Antibody (NP-7) | 500 μL | 20620 |
| Cayman2015 | 173132 | CYP1A (fish) Monoclonal Antibody (C10-7) | 100 μL | 4580 |
| Cayman2015 | 173132 | CYP1A (fish) Monoclonal Antibody (C10-7) | 500 μL | 20620 |
| Cayman2015 | 173135 | CYP1A (fish) Polyclonal Antibody (CP-226) | 100 μL | 4580 |
| Cayman2015 | 173135 | CYP1A (fish) Polyclonal Antibody (CP-226) | 500 μL | 20620 |
| Cayman2015 | 18110 | 6α-Prostaglandin I1 | 1 mg | 714 |
| Cayman2015 | 18110 | 6α-Prostaglandin I1 | 10 mg | 5712 |
| Cayman2015 | 18110 | 6α-Prostaglandin I1 | 5 mg | 3220 |
| Cayman2015 | 18112 | 8,9-EE-14(Z)-E | 100 μg | 2170 |
| Cayman2015 | 18112 | 8,9-EE-14(Z)-E | 25 μg | 602 |
| Cayman2015 | 18112 | 8,9-EE-14(Z)-E | 50 μg | 1148 |
| Cayman2015 | 18112 | 8,9-EE-14(Z)-E | 500 μg | 9758 |
| Cayman2015 | 18113 | YM-53601 | 1 mg | 4466 |
| Cayman2015 | 18113 | YM-53601 | 5 mg | 18816 |
| Cayman2015 | 18113 | YM-53601 | 500 μg | 2352 |
| Cayman2015 | 18120 | 6β-Prostaglandin I1 | 1 mg | 714 |
| Cayman2015 | 18120 | 6β-Prostaglandin I1 | 10 mg | 5712 |
| Cayman2015 | 18120 | 6β-Prostaglandin I1 | 5 mg | 3220 |
| Cayman2015 | 18210 | Carbaprostacyclin | 1 mg | 2002 |
| Cayman2015 | 18210 | Carbaprostacyclin | 5 mg | 8400 |
| Cayman2015 | 18210 | Carbaprostacyclin | 500 μg | 1050 |
| Cayman2015 | 18211 | 5-cis Carbaprostacyclin | 1 mg | 1652 |
| Cayman2015 | 18211 | 5-cis Carbaprostacyclin | 5 mg | 7812 |
| Cayman2015 | 18211 | 5-cis Carbaprostacyclin | 500 μg | 868 |
| Cayman2015 | 18212 | 13,14-dehydro-15-cyclohexyl Carbaprostacyclin | 100 μg | 1302 |
| Cayman2015 | 18212 | 13,14-dehydro-15-cyclohexyl Carbaprostacyclin | 50 μg | 686 |
| Cayman2015 | 18212 | 13,14-dehydro-15-cyclohexyl Carbaprostacyclin | 500 μg | 5488 |
| Cayman2015 | 18213 | Carbaprostacyclin-biotin | 1 mg | 5530 |
| Cayman2015 | 18213 | Carbaprostacyclin-biotin | 100 μg | 1148 |
| Cayman2015 | 18213 | Carbaprostacyclin-biotin | 500 μg | 3360 |
| Cayman2015 | 18215 | Iloprost | 1 mg | 2744 |
| Cayman2015 | 18215 | Iloprost | 10 mg | 20188 |
| Cayman2015 | 18215 | Iloprost | 5 mg | 11536 |
| Cayman2015 | 18215 | Iloprost | 500 μg | 1442 |
| Cayman2015 | 18216 | Ciprostene (calcium salt) | 1 mg | 1736 |
| Cayman2015 | 18216 | Ciprostene (calcium salt) | 10 mg | 13888 |
| Cayman2015 | 18216 | Ciprostene (calcium salt) | 5 mg | 7812 |
| Cayman2015 | 18218 | CAY10572 | 1 mg | 560 |
| Cayman2015 | 18218 | CAY10572 | 10 mg | 4480 |
| Cayman2015 | 18218 | CAY10572 | 5 mg | 2520 |
| Cayman2015 | 18218 | CAY10572 | 50 mg | 19600 |
| Cayman2015 | 18219 | Prostaglandin E Synthase (cytosolic) Monoclonal Antibody (Clone JJ6) | 100 μg | 4840 |
| Cayman2015 | 18219 | Prostaglandin E Synthase (cytosolic) Monoclonal Antibody (Clone JJ6) | 25 μg | 2160 |
| Cayman2015 | 18220 | Prostaglandin I2 (sodium salt) | 1 mg | 770 |
| Cayman2015 | 18220 | Prostaglandin I2 (sodium salt) | 10 mg | 5698 |
| Cayman2015 | 18220 | Prostaglandin I2 (sodium salt) | 25 mg | 13482 |
| Cayman2015 | 18220 | Prostaglandin I2 (sodium salt) | 5 mg | 3472 |
| Cayman2015 | 18228 | Piriprost (potassium salt) | 1 mg | 574 |
| Cayman2015 | 18228 | Piriprost (potassium salt) | 10 mg | 4592 |
| Cayman2015 | 18228 | Piriprost (potassium salt) | 5 mg | 2590 |
| Cayman2015 | 18228 | Piriprost (potassium salt) | 50 mg | 20090 |
| Cayman2015 | 18230 | Beraprost (sodium salt) | 1 mg | 1652 |
| Cayman2015 | 18230 | Beraprost (sodium salt) | 10 mg | 13216 |
| Cayman2015 | 18230 | Beraprost (sodium salt) | 5 mg | 7434 |
| Cayman2015 | 18300 | Prostaglandin I3 (sodium salt) | 1 mg | 20020 |
| Cayman2015 | 18300 | Prostaglandin I3 (sodium salt) | 100 μg | 3094 |
| Cayman2015 | 18300 | Prostaglandin I3 (sodium salt) | 50 μg | 1820 |
| Cayman2015 | 18300 | Prostaglandin I3 (sodium salt) | 500 μg | 11830 |
| Cayman2015 | 18500 | Prostaglandin J2 | 1 mg | 1736 |
| Cayman2015 | 18500 | Prostaglandin J2 | 10 mg | 12740 |
| Cayman2015 | 18500 | Prostaglandin J2 | 5 mg | 7280 |
| Cayman2015 | 18500 | Prostaglandin J2 | 500 μg | 910 |
| Cayman2015 | 18550 | Δ12-Prostaglandin J2 | 1 mg | 3584 |
| Cayman2015 | 18550 | Δ12-Prostaglandin J2 | 100 μg | 448 |
| Cayman2015 | 18550 | Δ12-Prostaglandin J2 | 500 μg | 2016 |
| Cayman2015 | 18570 | 15-deoxy-Δ12,14-Prostaglandin J2 | 1 mg | 1372 |
| Cayman2015 | 18570 | 15-deoxy-Δ12,14-Prostaglandin J2 | 100 μg | 350 |
| Cayman2015 | 18570 | 15-deoxy-Δ12,14-Prostaglandin J2 | 5 mg | 5250 |
| Cayman2015 | 18570 | 15-deoxy-Δ12,14-Prostaglandin J2 | 500 μg | 952 |
| Cayman2015 | 18570.1 | 15-deoxy-Δ12,14-Prostaglandin J2 | 1 mg | 826 |
| Cayman2015 | 18570.1 | 15-deoxy-Δ12,14-Prostaglandin J2 | 10 mg | 6608 |
| Cayman2015 | 18570.1 | 15-deoxy-Δ12,14-Prostaglandin J2 | 5 mg | 3724 |
| Cayman2015 | 18580 | 15-deoxy-Δ12,14-Prostaglandin J2 Glutathione | 100 μg | 2548 |
| Cayman2015 | 18580 | 15-deoxy-Δ12,14-Prostaglandin J2 Glutathione | 50 μg | 1344 |
| Cayman2015 | 18580 | 15-deoxy-Δ12,14-Prostaglandin J2 Glutathione | 500 μg | 10752 |
| Cayman2015 | 18585 | (-)-Nutlin-3 | 1 mg | 1050 |
| Cayman2015 | 18585 | (-)-Nutlin-3 | 10 mg | 4732 |
| Cayman2015 | 18585 | (-)-Nutlin-3 | 25 mg | 10500 |
| Cayman2015 | 18585 | (-)-Nutlin-3 | 5 mg | 2632 |
| Cayman2015 | 18590 | CAY10410 | 1 mg | 1862 |
| Cayman2015 | 18590 | CAY10410 | 10 mg | 13720 |
| Cayman2015 | 18590 | CAY10410 | 5 mg | 7840 |
| Cayman2015 | 18590 | CAY10410 | 500 μg | 980 |
| Cayman2015 | 18800 | Prostaglandin K1 | 1 mg | 4256 |
| Cayman2015 | 18800 | Prostaglandin K1 | 100 μg | 532 |
| Cayman2015 | 18800 | Prostaglandin K1 | 5 mg | 18620 |
| Cayman2015 | 18800 | Prostaglandin K1 | 500 μg | 2394 |
| Cayman2015 | 188150 | CD36 Monoclonal Antibody (Clone JC63.1) | 1 ea | 3010 |
| Cayman2015 | 188150 | CD36 Monoclonal Antibody (Clone JC63.1) | 5 ea | 9030 |
| Cayman2015 | 18900 | Prostaglandin K2 | 1 mg | 4256 |
| Cayman2015 | 18900 | Prostaglandin K2 | 100 μg | 532 |
| Cayman2015 | 18900 | Prostaglandin K2 | 5 mg | 18620 |
| Cayman2015 | 18900 | Prostaglandin K2 | 500 μg | 2394 |
| Cayman2015 | 189542 | Nitrotyrosine Monoclonal Antibody | 200 μg | 4060 |
| Cayman2015 | 189542 | Nitrotyrosine Monoclonal Antibody | 50 μg | 1190 |
| Cayman2015 | 189710 | Prion Protein Monoclonal Antibody (Clone 12F10) | 1 ea | 5900 |
| Cayman2015 | 189720 | Prion Protein Monoclonal Antibody (Clone SAF 32) | 1 ea | 5900 |
| Cayman2015 | 189730 | Prion Protein Monoclonal Antibody (Clone SAF 53) | 1 ea | 5900 |
| Cayman2015 | 189740 | Prion Protein Monoclonal Antibody (Clone SAF 54) | 1 ea | 5900 |
| Cayman2015 | 189750 | Prion Protein Monoclonal Antibody (Clone Pri 308) | 1 ea | 5900 |
| Cayman2015 | 189755 | Prion Protein Monoclonal Antibody (Clone SAF 61) | 1 ea | 5900 |
| Cayman2015 | 189760 | Prion Protein Monoclonal Antibody (Clone 8G8) | 1 ea | 5900 |
| Cayman2015 | 189765 | Prion Protein Monoclonal Antibody (Clone SAF 83) | 1 ea | 5900 |
| Cayman2015 | 189770 | Prion Protein Monoclonal Antibody (SAF-70) | 1 ea | 5900 |
| Cayman2015 | 189775 | Prion Protein Monoclonal Antibody (Clone SAF 84) | 1 ea | 5900 |
| Cayman2015 | 19010 | Carbocyclic Thromboxane A2 | 1 mg | 3024 |
| Cayman2015 | 19010 | Carbocyclic Thromboxane A2 | 100 μg | 378 |
| Cayman2015 | 19010 | Carbocyclic Thromboxane A2 | 5 mg | 13230 |
| Cayman2015 | 19010 | Carbocyclic Thromboxane A2 | 500 μg | 1708 |
| Cayman2015 | 19020 | Pinane Thromboxane A2 | 1 mg | 1148 |
| Cayman2015 | 19020 | Pinane Thromboxane A2 | 10 mg | 8428 |
| Cayman2015 | 19020 | Pinane Thromboxane A2 | 5 mg | 4816 |
| Cayman2015 | 19020 | Pinane Thromboxane A2 | 500 μg | 602 |
| Cayman2015 | 19021 | I-SAP | 1 mg | 6608 |
| Cayman2015 | 19021 | I-SAP | 100 μg | 826 |
| Cayman2015 | 19021 | I-SAP | 500 μg | 3724 |
| Cayman2015 | 19023 | AH 23848 (calcium salt) | 1 mg | 910 |
| Cayman2015 | 19023 | AH 23848 (calcium salt) | 10 mg | 7280 |
| Cayman2015 | 19023 | AH 23848 (calcium salt) | 5 mg | 4102 |
| Cayman2015 | 19025 | SQ 29,548 | 1 mg | 910 |
| Cayman2015 | 19025 | SQ 29,548 | 10 mg | 7280 |
| Cayman2015 | 19025 | SQ 29,548 | 5 mg | 4102 |
| Cayman2015 | 19030 | Thromboxane B2 | 1 mg | 770 |
| Cayman2015 | 19030 | Thromboxane B2 | 10 mg | 6160 |
| Cayman2015 | 19030 | Thromboxane B2 | 5 mg | 3472 |
| Cayman2015 | 19030 | Thromboxane B2 | 50 mg | 26950 |
| Cayman2015 | 19380 | HDAC8 (human recombinant) | 100 μg | 7714 |
| Cayman2015 | 19380 | HDAC8 (human recombinant) | 25 μg | 2142 |
| Cayman2015 | 19380 | HDAC8 (human recombinant) | 50 μg | 4074 |
| Cayman2015 | 19600 | I-BOP | 1 mg | 6944 |
| Cayman2015 | 19600 | I-BOP | 100 μg | 938 |
| Cayman2015 | 19600 | I-BOP | 500 μg | 4228 |
| Cayman2015 | 19612 | Hsp90β Polyclonal Antibody | 100 μL | 4920 |
| Cayman2015 | 19612 | Hsp90β Polyclonal Antibody | 25 μL | 2240 |
| Cayman2015 | 19990 | Thromboxane B3 | 1 mg | 9016 |
| Cayman2015 | 19990 | Thromboxane B3 | 100 μg | 1218 |
| Cayman2015 | 19990 | Thromboxane B3 | 50 μg | 644 |
| Cayman2015 | 19990 | Thromboxane B3 | 500 μg | 5152 |
| Cayman2015 | 19995 | 11-dehydro Thromboxane B3 | 1 mg | 9016 |
| Cayman2015 | 19995 | 11-dehydro Thromboxane B3 | 100 μg | 1218 |
| Cayman2015 | 19995 | 11-dehydro Thromboxane B3 | 50 μg | 644 |
| Cayman2015 | 19995 | 11-dehydro Thromboxane B3 | 500 μg | 5152 |
| Cayman2015 | 20001 | Cysteinyl Leukotriene HPLC Mixture I | 1 ea | 2198 |
| Cayman2015 | 20002 | Cysteinyl Leukotriene HPLC Mixture II | 1 ea | 2198 |
| Cayman2015 | 20009 | Leukotriene A3 methyl ester | 100 μg | 3836 |
| Cayman2015 | 20009 | Leukotriene A3 methyl ester | 25 μg | 1064 |
| Cayman2015 | 20009 | Leukotriene A3 methyl ester | 50 μg | 2016 |
| Cayman2015 | 20010 | Leukotriene A4 methyl ester | 100 μg | 4186 |
| Cayman2015 | 20010 | Leukotriene A4 methyl ester | 25 μg | 1162 |
| Cayman2015 | 20010 | Leukotriene A4 methyl ester | 50 μg | 2212 |
| Cayman2015 | 20010 | Leukotriene A4 methyl ester | 500 μg | 18592 |
| Cayman2015 | 200200 | Acridinium NHS ester | 1 mg | 910 |
| Cayman2015 | 200200 | Acridinium NHS ester | 10 mg | 6370 |
| Cayman2015 | 200200 | Acridinium NHS ester | 5 mg | 3416 |
| Cayman2015 | 200200 | Acridinium NHS ester | 50 mg | 13650 |
| Cayman2015 | 200201 | Acridinium Protein Labeling Kit | 1 ea | 1778 |
| Cayman2015 | 200202 | Acridinium Purification Buffer (10X) | 50 mL | 238 |
| Cayman2015 | 200203 | Acridinium Quench Solution | 2 mL | 84 |
| Cayman2015 | 200204 | Acridinium Labeling Buffer | 5 mL | 84 |
| Cayman2015 | 200205 | Acridinium Trigger Solution I | 1 ea | 84 |
| Cayman2015 | 200206 | Acridinium Trigger Solution II | 1 ea | 84 |
| Cayman2015 | 200207 | Acridinium Desalting Column | 1 ea | 168 |
| Cayman2015 | 200280 | DISBAC10 | 1 mg | 756 |
| Cayman2015 | 200280 | DISBAC10 | 10 mg | 6048 |
| Cayman2015 | 200280 | DISBAC10 | 5 mg | 3402 |
| Cayman2015 | 20109 | Leukotriene B3 | 100 μg | 5950 |
| Cayman2015 | 20109 | Leukotriene B3 | 25 μg | 1652 |
| Cayman2015 | 20109 | Leukotriene B3 | 50 μg | 3136 |
| Cayman2015 | 20110 | Leukotriene B4 | 100 μg | 5796 |
| Cayman2015 | 20110 | Leukotriene B4 | 25 μg | 1610 |
| Cayman2015 | 20110 | Leukotriene B4 | 50 μg | 3066 |
| Cayman2015 | 20110 | Leukotriene B4 | 500 μg | 23184 |
| Cayman2015 | 20112 | Leukotriene B4 Ethanolamide | 100 μg | 5642 |
| Cayman2015 | 20112 | Leukotriene B4 Ethanolamide | 25 μg | 1568 |
| Cayman2015 | 20112 | Leukotriene B4 Ethanolamide | 50 μg | 2982 |
| Cayman2015 | 20114 | Leukotriene B4-3-aminopropylamide | 100 μg | 5642 |
| Cayman2015 | 20114 | Leukotriene B4-3-aminopropylamide | 25 μg | 1568 |
| Cayman2015 | 20114 | Leukotriene B4-3-aminopropylamide | 50 μg | 2982 |
| Cayman2015 | 20115 | Leukotriene B4 dimethyl amide | 100 μg | 7112 |
| Cayman2015 | 20115 | Leukotriene B4 dimethyl amide | 25 μg | 1974 |
| Cayman2015 | 20115 | Leukotriene B4 dimethyl amide | 50 μg | 3752 |
| Cayman2015 | 20134 | 12-epi Leukotriene B3 | 100 μg | 6748 |
| Cayman2015 | 20134 | 12-epi Leukotriene B3 | 25 μg | 1876 |
| Cayman2015 | 20134 | 12-epi Leukotriene B3 | 50 μg | 3570 |
| Cayman2015 | 20135 | 12-epi Leukotriene B4 | 100 μg | 6748 |
| Cayman2015 | 20135 | 12-epi Leukotriene B4 | 25 μg | 1876 |
| Cayman2015 | 20135 | 12-epi Leukotriene B4 | 50 μg | 3570 |
| Cayman2015 | 20140 | 12-oxo Leukotriene B4 | 100 μg | 6748 |
| Cayman2015 | 20140 | 12-oxo Leukotriene B4 | 25 μg | 1876 |
| Cayman2015 | 20140 | 12-oxo Leukotriene B4 | 50 μg | 3570 |
| Cayman2015 | 20150 | 14,15-dehydro Leukotriene B4 | 100 μg | 5642 |
| Cayman2015 | 20150 | 14,15-dehydro Leukotriene B4 | 25 μg | 1568 |
| Cayman2015 | 20150 | 14,15-dehydro Leukotriene B4 | 50 μg | 2982 |
| Cayman2015 | 20170 | 18-carboxy dinor Leukotriene B4 | 100 μg | 7112 |
| Cayman2015 | 20170 | 18-carboxy dinor Leukotriene B4 | 25 μg | 1974 |
| Cayman2015 | 20170 | 18-carboxy dinor Leukotriene B4 | 50 μg | 3752 |
| Cayman2015 | 20180 | 20-carboxy Leukotriene B4 | 100 μg | 7112 |
| Cayman2015 | 20180 | 20-carboxy Leukotriene B4 | 25 μg | 1974 |
| Cayman2015 | 20180 | 20-carboxy Leukotriene B4 | 50 μg | 3752 |
| Cayman2015 | 20190 | 20-hydroxy Leukotriene B4 | 100 μg | 6748 |
| Cayman2015 | 20190 | 20-hydroxy Leukotriene B4 | 25 μg | 1876 |
| Cayman2015 | 20190 | 20-hydroxy Leukotriene B4 | 50 μg | 3570 |
| Cayman2015 | 20195 | 20-trifluoro Leukotriene B4 | 100 μg | 6748 |
| Cayman2015 | 20195 | 20-trifluoro Leukotriene B4 | 25 μg | 1876 |
| Cayman2015 | 20195 | 20-trifluoro Leukotriene B4 | 50 μg | 3570 |
| Cayman2015 | 20210 | Leukotriene C4 | 100 μg | 5488 |
| Cayman2015 | 20210 | Leukotriene C4 | 25 μg | 1526 |
| Cayman2015 | 20210 | Leukotriene C4 | 50 μg | 2898 |
| Cayman2015 | 20230 | 11-trans Leukotriene C4 | 100 μg | 6748 |
| Cayman2015 | 20230 | 11-trans Leukotriene C4 | 25 μg | 1876 |
| Cayman2015 | 20230 | 11-trans Leukotriene C4 | 50 μg | 3570 |
| Cayman2015 | 20310 | Leukotriene D4 | 100 μg | 5488 |
| Cayman2015 | 20310 | Leukotriene D4 | 25 μg | 1526 |
| Cayman2015 | 20310 | Leukotriene D4 | 50 μg | 2898 |
| Cayman2015 | 20330 | 11-trans Leukotriene D4 | 100 μg | 6748 |
| Cayman2015 | 20330 | 11-trans Leukotriene D4 | 25 μg | 1876 |
| Cayman2015 | 20330 | 11-trans Leukotriene D4 | 50 μg | 3570 |
| Cayman2015 | 20410 | Leukotriene E4 | 100 μg | 3626 |
| Cayman2015 | 20410 | Leukotriene E4 | 25 μg | 1008 |
| Cayman2015 | 20410 | Leukotriene E4 | 50 μg | 1918 |
| Cayman2015 | 20420 | N-acetyl Leukotriene E4 | 100 μg | 4480 |
| Cayman2015 | 20420 | N-acetyl Leukotriene E4 | 25 μg | 1246 |
| Cayman2015 | 20420 | N-acetyl Leukotriene E4 | 50 μg | 2366 |
| Cayman2015 | 20430 | 11-trans Leukotriene E4 | 100 μg | 4480 |
| Cayman2015 | 20430 | 11-trans Leukotriene E4 | 25 μg | 1246 |
| Cayman2015 | 20430 | 11-trans Leukotriene E4 | 50 μg | 2366 |
| Cayman2015 | 20520 | Leukotriene F4 | 100 μg | 5446 |
| Cayman2015 | 20520 | Leukotriene F4 | 25 μg | 1512 |
| Cayman2015 | 20520 | Leukotriene F4 | 50 μg | 2870 |
| Cayman2015 | 300000 | Optineurin (C-Term) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 300002 | Optineurin (INT) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 300003 | HIF-1α (C-Term) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 300011 | CD36 Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 300012 | Prostaglandin E Synthase-2 (microsomal) Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 300013 | β-Catenin Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 300014 | Monoacylglycerol Lipase Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 300830 | Caveolin 1/3 Blocking Peptide | 200 μg | 1498 |
| Cayman2015 | 301500 | CB1 Receptor Blocking Peptide | 200 μg | 1498 |
| Cayman2015 | 301550 | CB2 Receptor Blocking Peptide | 200 μg | 1498 |
| Cayman2015 | 301600 | Fatty Acid Amide Hydrolase Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 301640 | DP1 Receptor Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 301700 | PPARγ Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 301710 | PPARα Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 301740 | EP1 Receptor Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 301750 | EP2 Receptor Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 301760 | EP3 Receptor Blocking Peptide | 1 ea | 1498 |
| Cayman2015 | 301775 | EP4 Receptor (C-Term) Blocking Peptide | 1 ea | 1498 |
我们公司zui大优势是强大的采购，
1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，
2： 货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，
3：提供加急服务，一般1-2周到货，超过时限加急费全免
4：价格公道，绝大部分价格有优势，当然不能保证100%产品都是,因为意味着没有服务.
5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大 交大 复旦，中山等100多所大学，ROCHE，阿斯利康，国药 ，fisher等500多家公司
6：我们还是santa,Advanced Biotechnologies Inc;Athens Research & Technology, bangs, BBInternational, crystalchem, dianova, FD Neurotechnologies, Inc. FormuMax Scientific, Inc; Genebridege; Glycotope Biotechnology GmbH; iduron; Innovative Research of America； Ludger ； neuroprobe; omicronbio; Polysciences; prospecbi; QA-BIO；quickzyme；RESEARCH DIETS, INC；sterlitech；sysy；TriLink BioTechnologies, Inc；worthington-biochem;zyagen;......几十家国外公司授权代理
7：我们还从事invitrogen，qiagen; abcam ;sigma;neb; roche;merck; rnd; BD; GE; pierce; BioLegend....等*批发
